in.reuters.com Open in urlscan Pro
2600:9000:200d:1a00:a:1858:cf00:93a1  Public Scan

Submitted URL: http://feeds.reuters.com/~r/reuters/INhealth/~3/_FV_CUmpZcA/gsk-reports-positive-data-from-trial-of-endometrial-cancer-dr...
Effective URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINK...
Submission: On March 25 via manual from US

Summary

This website contacted 79 IPs in 6 countries across 44 domains to perform 278 HTTP transactions. The main IP is 2600:9000:200d:1a00:a:1858:cf00:93a1, located in United States and belongs to AMAZON-02 - Amazon.com, Inc., US. The main domain is in.reuters.com.
TLS certificate: Issued by Amazon on April 10th 2018. Valid for: a year.
This is the only time in.reuters.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 2a00:1450:400... 15169 (GOOGLE)
3 2600:9000:200... 16509 (AMAZON-02)
9 13.35.253.89 16509 (AMAZON-02)
2 2600:9000:200... 16509 (AMAZON-02)
1 2600:9000:200... 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a04:4e42::714 54113 (FASTLY)
1 2a00:1450:400... 15169 (GOOGLE)
1 54.228.236.185 16509 (AMAZON-02)
8 104.107.252.81 16625 (AKAMAI-AS)
1 99.86.0.85 16509 (AMAZON-02)
3 13.35.253.26 16509 (AMAZON-02)
10 104.18.135.13 13335 (CLOUDFLAR...)
1 13.35.253.108 16509 (AMAZON-02)
1 2600:9000:200... 16509 (AMAZON-02)
4 107.21.45.69 14618 (AMAZON-AES)
1 2600:9000:200... 16509 (AMAZON-02)
1 34.199.180.208 14618 (AMAZON-AES)
2 54.69.157.105 16509 (AMAZON-02)
2 2a03:2880:f01... 32934 (FACEBOOK)
5 2a00:1450:400... 15169 (GOOGLE)
1 2606:4700::68... 13335 (CLOUDFLAR...)
2 2a03:2880:f11... 32934 (FACEBOOK)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
2 5 104.121.166.105 16625 (AKAMAI-AS)
2 2606:4700:20:... 13335 (CLOUDFLAR...)
2 54.194.108.5 16509 (AMAZON-02)
1 2600:9000:200... 16509 (AMAZON-02)
1 34.200.61.129 14618 (AMAZON-AES)
1 23.201.172.224 16625 (AKAMAI-AS)
1 2606:4700:20:... 13335 (CLOUDFLAR...)
17 23.62.140.165 16625 (AKAMAI-AS)
1 13.35.253.126 16509 (AMAZON-02)
1 66.81.204.228 40034 (CONFLUENC...)
7 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
12 172.217.16.130 15169 (GOOGLE)
14 199.166.0.26 7415 (ADSAFE-1)
8 2a00:1450:400... 15169 (GOOGLE)
3 2.18.235.40 16625 (AKAMAI-AS)
7 2600:9000:200... 16509 (AMAZON-02)
6 2.18.232.7 16625 (AKAMAI-AS)
3 23.211.10.211 16625 (AKAMAI-AS)
1 1 35.177.17.175 16509 (AMAZON-02)
8 152.195.39.46 15133 (EDGECAST)
1 1 50.17.234.205 14618 (AMAZON-AES)
1 52.216.177.109 16509 (AMAZON-02)
5 18.130.64.138 16509 (AMAZON-02)
6 199.166.0.32 7415 (ADSAFE-1)
12 184.51.10.56 16625 (AKAMAI-AS)
13 104.244.39.20 7415 (ADSAFE-1)
1 34.227.6.108 14618 (AMAZON-AES)
4 23.211.0.4 16625 (AKAMAI-AS)
2 34.225.209.175 14618 (AMAZON-AES)
11 104.244.37.20 7415 (ADSAFE-1)
1 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
3 34.238.88.79 14618 (AMAZON-AES)
4 2a00:1450:400... 15169 (GOOGLE)
1 54.236.153.59 14618 (AMAZON-AES)
1 34.196.59.29 14618 (AMAZON-AES)
1 52.210.90.34 16509 (AMAZON-02)
2 107.23.33.56 14618 (AMAZON-AES)
5 2a02:26f0:10e... 20940 (AKAMAI-ASN1)
1 35.177.109.169 16509 (AMAZON-02)
2 2a00:1450:400... 15169 (GOOGLE)
2 104.16.87.26 13335 (CLOUDFLAR...)
1 9 173.241.240.220 36089 (OPENX-AS1)
1 34.224.155.9 14618 (AMAZON-AES)
7 208.100.17.185 32748 (STEADFAST)
2 104.16.38.14 13335 (CLOUDFLAR...)
1 5 173.241.240.143 36089 (OPENX-AS1)
2 208.100.17.188 32748 (STEADFAST)
1 208.100.17.174 32748 (STEADFAST)
3 185.33.223.80 29990 (ASN-APPNEXUS)
1 34.198.189.190 14618 (AMAZON-AES)
1 104.244.36.20 7415 (ADSAFE-1)
1 72.251.249.14 29791 (VOXEL-DOT...)
2 72.251.249.9 29791 (VOXEL-DOT...)
1 2600:9000:200... 16509 (AMAZON-02)
278 79
Apex Domain
Subdomains
Transfer
46 adsafeprotected.com
cdn.adsafeprotected.com
pixel.adsafeprotected.com
static.adsafeprotected.com
dt.adsafeprotected.com
286 KB
20 carambo.la
route.carambo.la
cdata.carambo.la
logging.carambo.la
inimage.carambo.la
content.carambo.la
analytics.carambo.la
xtr.carambo.la
media.carambo.la
232 KB
17 media.net
contextual.media.net
cdneast-xch.media.net
hbx-lg.media.net
118 KB
16 teads.tv
a.teads.tv
t.teads.tv
sync.teads.tv
be-ms.teads.tv
s8t.teads.tv
studio-t.teads.tv
566 KB
14 openx.net
us-ads.openx.net
eu-u.openx.net
33across-d.openx.net
192 KB
13 reuters.com
feeds.reuters.com
in.reuters.com
static.reuters.com
wireapi.reuters.com
www.reuters.com
553 KB
12 moatpixel.com
reutersdfpcw319687550988.s.moatpixel.com
5 KB
12 moatads.com
z.moatads.com
geo.moatads.com
mb.moatads.com
px.moatads.com
462 KB
11 tynt.com
cdn.tynt.com
sc.tynt.com
ic.tynt.com
de.tynt.com
8 KB
11 doubleclick.net
stats.g.doubleclick.net
securepubads.g.doubleclick.net
181 KB
10 googlesyndication.com
tpc.googlesyndication.com
pagead2.googlesyndication.com
136 KB
10 dianomi.com
www.dianomi.com
37 KB
9 s-onetag.com
get.s-onetag.com
dfp-gateway.s-onetag.com
onetag-geo.s-onetag.com
19 KB
9 evidon.com
c.evidon.com
iabmap.evidon.com
34 KB
7 googletagservices.com
www.googletagservices.com
167 KB
5 scorecardresearch.com
sb.scorecardresearch.com
3 KB
5 google-analytics.com
www.google-analytics.com
39 KB
5 betrad.com
l.betrad.com
c.betrad.com
11 KB
4 33across.com
cdn-sic.33across.com
sic.33across.com
ssc.33across.com
126 KB
4 googleapis.com
fonts.googleapis.com
4 KB
4 reutersmedia.net
s2.reutersmedia.net
static.reutersmedia.net
136 KB
3 lijit.com
ap.lijit.com
20 KB
3 adnxs.com
ib.adnxs.com
3 KB
3 tru.am
tru.am
beacon.tru.am
13 KB
3 google.de
www.google.de
adservice.google.de
451 B
3 google.com
www.google.com
adservice.google.com
524 B
3 consensu.org
vendorlist.consensu.org
evidon.mgr.consensu.org
cmp.teads.mgr.consensu.org
15 KB
3 chartbeat.com
static.chartbeat.com
mab.chartbeat.com
31 KB
2 gstatic.com
fonts.gstatic.com
19 KB
2 demdex.net
reuters.demdex.net
715 B
2 facebook.com
www.facebook.com
244 B
2 facebook.net
connect.facebook.net
60 KB
2 segment.io
api.segment.io
280 B
1 amazonaws.com
s3.amazonaws.com
497 B
1 pixel.watch
pixel.watch
320 B
1 mnet-ad.net
s.mnet-ad.net
356 B
1 chartbeat.net
ping.chartbeat.net
168 B
1 cloudflare.com
cdnjs.cloudflare.com
2 KB
1 segment.com
cdn.segment.com
64 KB
1 admantx.com
async01.admantx.com
257 B
1 ytimg.com
s.ytimg.com
8 KB
1 youtube.com
www.youtube.com
950 B
1 googletagmanager.com
www.googletagmanager.com
53 KB
1 reuters.tv
queso-cdn.prod.reuters.tv
13 KB
278 44
Domain Requested by
25 dt.adsafeprotected.com
14 pixel.adsafeprotected.com cdn.adsafeprotected.com
in.reuters.com
12 reutersdfpcw319687550988.s.moatpixel.com
10 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
in.reuters.com
10 www.dianomi.com static.reuters.com
www.dianomi.com
in.reuters.com
8 tpc.googlesyndication.com securepubads.g.doubleclick.net
8 c.evidon.com static.reuters.com
c.evidon.com
c.betrad.com
7 ic.tynt.com
7 analytics.carambo.la cdata.carambo.la
7 dfp-gateway.s-onetag.com get.s-onetag.com
7 www.googletagservices.com contextual.media.net
securepubads.g.doubleclick.net
cdn-sic.33across.com
6 33across-d.openx.net cdn-sic.33across.com
33across-d.openx.net
6 static.adsafeprotected.com pixel.adsafeprotected.com
in.reuters.com
6 hbx-lg.media.net
6 contextual.media.net static.reuters.com
contextual.media.net
5 eu-u.openx.net 1 redirects us-ads.openx.net
33across-d.openx.net
5 s8t.teads.tv a.teads.tv
in.reuters.com
5 geo.moatads.com z.moatads.com
5 z.moatads.com securepubads.g.doubleclick.net
a.teads.tv
5 cdneast-xch.media.net
5 sb.scorecardresearch.com 2 redirects in.reuters.com
5 www.google-analytics.com cdn.segment.com
www.google-analytics.com
in.reuters.com
5 static.reuters.com in.reuters.com
4 fonts.googleapis.com cdata.carambo.la
4 t.teads.tv
4 cdata.carambo.la in.reuters.com
cdata.carambo.la
4 a.teads.tv in.reuters.com
a.teads.tv
4 l.betrad.com in.reuters.com
3 ap.lijit.com in.reuters.com
ap.lijit.com
3 ib.adnxs.com cdn-sic.33across.com
3 us-ads.openx.net 1 redirects cdata.carambo.la
3 media.carambo.la
3 wireapi.reuters.com static.reuters.com
3 in.reuters.com static.reuters.com
2 de.tynt.com cdn.tynt.com
2 cdn-sic.33across.com cdn.tynt.com
cdn-sic.33across.com
2 fonts.gstatic.com cdata.carambo.la
2 static.reutersmedia.net cdata.carambo.la
2 pagead2.googlesyndication.com
2 content.carambo.la cdata.carambo.la
2 adservice.google.com www.googletagservices.com
2 adservice.google.de www.googletagservices.com
2 reuters.demdex.net in.reuters.com
2 tru.am www.googletagmanager.com
tru.am
2 www.facebook.com in.reuters.com
www.googletagmanager.com
2 connect.facebook.net cdn.segment.com
connect.facebook.net
2 api.segment.io cdn.segment.com
2 s2.reutersmedia.net in.reuters.com
2 static.chartbeat.com in.reuters.com
1 onetag-geo.s-onetag.com get.s-onetag.com
1 ssc.33across.com cdn-sic.33across.com
1 sic.33across.com cdn-sic.33across.com
1 sc.tynt.com cdn.tynt.com
1 cdn.tynt.com in.reuters.com
1 studio-t.teads.tv in.reuters.com
1 px.moatads.com
1 mb.moatads.com z.moatads.com
1 be-ms.teads.tv a.teads.tv
1 sync.teads.tv a.teads.tv
1 xtr.carambo.la cdata.carambo.la
1 cmp.teads.mgr.consensu.org a.teads.tv
1 inimage.carambo.la cdata.carambo.la
1 logging.carambo.la cdata.carambo.la
1 s3.amazonaws.com in.reuters.com
1 pixel.watch 1 redirects
1 route.carambo.la 1 redirects
1 s.mnet-ad.net
1 cdn.adsafeprotected.com contextual.media.net
1 beacon.tru.am tru.am
1 c.betrad.com in.reuters.com
1 ping.chartbeat.net
1 get.s-onetag.com www.googletagmanager.com
1 www.google.de in.reuters.com
1 www.google.com 1 redirects
1 stats.g.doubleclick.net 1 redirects
1 cdnjs.cloudflare.com www.dianomi.com
1 evidon.mgr.consensu.org c.evidon.com
1 vendorlist.consensu.org c.evidon.com
1 iabmap.evidon.com c.evidon.com
1 www.reuters.com www.googletagmanager.com
1 cdn.segment.com in.reuters.com
1 async01.admantx.com static.reuters.com
1 s.ytimg.com www.youtube.com
1 mab.chartbeat.com static.chartbeat.com
1 www.youtube.com in.reuters.com
1 www.googletagmanager.com in.reuters.com
1 queso-cdn.prod.reuters.tv in.reuters.com
1 feeds.reuters.com 1 redirects
278 88
Subject Issuer Validity Valid
in.reuters.com
Amazon
2018-04-10 -
2019-05-10
a year crt.sh
static.reuters.com
Amazon
2018-11-28 -
2019-12-28
a year crt.sh
*.chartbeat.com
Gandi Standard SSL CA 2
2018-04-02 -
2019-04-18
a year crt.sh
*.prod.reuters.tv
Amazon
2019-01-28 -
2020-02-28
a year crt.sh
*.google-analytics.com
Google Internet Authority G3
2019-03-01 -
2019-05-24
3 months crt.sh
*.google.com
Google Internet Authority G3
2019-03-01 -
2019-05-24
3 months crt.sh
f6.shared.global.fastly.net
GlobalSign CloudSSL CA - SHA256 - G3
2019-03-12 -
2019-09-12
6 months crt.sh
*.admantx.com
SSL.com RSA SSL subCA
2019-01-08 -
2021-04-07
2 years crt.sh
*.evidon.com
DigiCert ECC Secure Server CA
2019-02-01 -
2020-05-02
a year crt.sh
*.segment.com
DigiCert SHA2 Secure Server CA
2018-05-08 -
2019-07-18
a year crt.sh
wireapi.reuters.com
Amazon
2019-01-01 -
2020-02-01
a year crt.sh
ssl424245.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-02-28 -
2019-09-06
6 months crt.sh
www.reuters.com
Amazon
2018-04-10 -
2019-05-10
a year crt.sh
l.betrad.com
Go Daddy Secure Certificate Authority - G2
2017-04-25 -
2019-06-24
2 years crt.sh
vendorlist.consensu.org
Amazon
2019-03-06 -
2020-04-06
a year crt.sh
evidon.mgr.consensu.org
Amazon
2018-09-20 -
2019-10-20
a year crt.sh
*.segment.io
DigiCert SHA2 Secure Server CA
2018-05-10 -
2019-07-26
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2019-03-08 -
2019-06-06
3 months crt.sh
ssl412106.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-03-02 -
2019-09-08
6 months crt.sh
www.google.de
Google Internet Authority G3
2019-03-01 -
2019-05-24
3 months crt.sh
*.scorecardresearch.com
COMODO RSA Organization Validation Secure Server CA
2018-11-28 -
2019-12-26
a year crt.sh
ssl389962.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-01-10 -
2019-07-19
6 months crt.sh
*.demdex.net
DigiCert SHA2 High Assurance Server CA
2018-01-09 -
2021-02-12
3 years crt.sh
*.s-onetag.com
Go Daddy Secure Certificate Authority - G2
2018-06-19 -
2019-08-18
a year crt.sh
*.chartbeat.net
Thawte RSA CA 2018
2018-12-20 -
2020-01-01
a year crt.sh
*.betrad.com
DigiCert SHA2 Secure Server CA
2019-02-06 -
2020-05-07
a year crt.sh
*.media.net
DigiCert SHA2 Secure Server CA
2018-12-30 -
2020-03-30
a year crt.sh
*.adsafeprotected.com
COMODO RSA Domain Validation Secure Server CA
2018-08-20 -
2020-09-17
2 years crt.sh
*.mnet-ad.net
COMODO RSA Domain Validation Secure Server CA
2018-03-12 -
2019-04-16
a year crt.sh
*.g.doubleclick.net
Google Internet Authority G3
2019-03-01 -
2019-05-24
3 months crt.sh
tpc.googlesyndication.com
Google Internet Authority G3
2019-03-01 -
2019-05-24
3 months crt.sh
moatads.com
DigiCert ECC Secure Server CA
2018-11-10 -
2020-02-09
a year crt.sh
teads.tv
Let's Encrypt Authority X3
2019-03-11 -
2019-06-09
3 months crt.sh
*.carambo.la
DigiCert SHA2 Secure Server CA
2019-02-21 -
2021-02-25
2 years crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2018-12-03 -
2019-10-25
a year crt.sh
*.moatads.com
DigiCert SHA2 Secure Server CA
2018-04-27 -
2019-04-27
a year crt.sh
teads.mgr.consensu.org
Let's Encrypt Authority X3
2019-02-22 -
2019-05-23
3 months crt.sh
*.googleapis.com
Google Internet Authority G3
2019-03-01 -
2019-05-24
3 months crt.sh
*.teads.tv
Gandi Standard SSL CA 2
2018-04-13 -
2019-05-06
a year crt.sh
s8t.teads.tv
DigiCert ECC Secure Server CA
2018-05-23 -
2019-11-21
a year crt.sh
*.tynt.com
COMODO RSA Domain Validation Secure Server CA
2014-10-14 -
2019-10-13
5 years crt.sh
*.openx.net
DigiCert ECC Secure Server CA
2019-02-08 -
2020-05-12
a year crt.sh
*.33across.com
COMODO RSA Domain Validation Secure Server CA
2014-10-14 -
2019-10-13
5 years crt.sh
*.adnxs.com
DigiCert ECC Secure Server CA
2019-01-23 -
2021-03-08
2 years crt.sh
ssc.33across.com
Amazon
2018-05-15 -
2019-06-15
a year crt.sh
*.lijit.com
Go Daddy Secure Certificate Authority - G2
2018-03-11 -
2019-05-10
a year crt.sh

This page contains 35 frames:

Primary Page: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Frame ID: 7BE295F90A825E5151BDCD6488E4C04B
Requests: 175 HTTP requests in this frame

Frame: https://www.dianomi.com/smartads.epl?id=4765&num_ads=3&shuffle=0
Frame ID: 1B3014800A00F4047162F44D355C8BD1
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/recirculation.epl?id=104
Frame ID: F93A486B496B0A4077D98068531490A8
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/smartads.epl?id=4766&num_ads=8&shuffle=0
Frame ID: 0F4FAE47A2B94FE654364329F09B185D
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/recirculation.epl?id=105&start=6
Frame ID: AA50DEF89EBC5B34564359FCC20AB096
Requests: 1 HTTP requests in this frame

Frame: https://reuters.demdex.net/dest5.html?d_nsid=0
Frame ID: 5D740495F3EDEC8965046BB124A8EAD3
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: D23888320A2E84D787BAB7E68B828CAF
Requests: 1 HTTP requests in this frame

Frame: https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C109%2C113%2C118%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C3004&rtime=73&https=1&gdpr=1&gdprconsent=0
Frame ID: E599E970CFD7245F66B8987AD9C0C9A7
Requests: 1 HTTP requests in this frame

Frame: https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C109%2C113%2C118%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C3004&rtime=102&https=1&gdpr=1&gdprconsent=0
Frame ID: 05D76B2F48FC7BCEDF445BB9747622A7
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/pagead/js/r20190320/r20110914/abg_lite.js
Frame ID: 0EDBB7ACA94A800F6AC3BF44E5572EF1
Requests: 9 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/pagead/js/r20190320/r20110914/abg_lite.js
Frame ID: DBC1ABC2E09E6851418411E4F986A937
Requests: 9 HTTP requests in this frame

Frame: https://a.teads.tv/page/48951/tag
Frame ID: 6CD45CE1BC8FDEE975763AA9BA54A106
Requests: 6 HTTP requests in this frame

Frame: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Frame ID: 759C81F0EE02B21108E99D150612F1D5
Requests: 31 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=970x250&pubId=4711821530&chanId=38032032&placementId=4995561982&pubCreative=138264852094&pubOrder=2509720728&cb=1766020713&custom=leaderboard&custom2=400&custom3=0&adsafe_par&impId=75a39ccc-4f08-11e9-a64b-002590882ece
Frame ID: 2C4A7841880E655AC82CC2ADC189B064
Requests: 2 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x600&pubId=4704817679&chanId=38032032&placementId=4974347015&pubCreative=138263065185&pubOrder=2500420503&cb=873562457&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=75a2b1b2-4f08-11e9-9669-70106fb72ed4
Frame ID: 249A5372766D181D49962C3EC185AB4E
Requests: 2 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x280&pubId=20159232&chanId=38032032&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=1147991459&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=75a45f3d-4f08-11e9-9104-382c4ac630ed
Frame ID: D7D57A30C49CFAF7E1452010A2C69E62
Requests: 2 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=2x2&pubId=54423312&chanId=38032032&placementId=4741317042&pubCreative=138239093677&pubOrder=2107429564&cb=1138655010&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=75a375b2-4f08-11e9-9d27-70106fb72a54
Frame ID: C0C219F90D5B9F50D453DC0E133B977E
Requests: 2 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: 0B8A8B773191117476A40B429BB99E72
Requests: 1 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: 0495B8DE0BC92FFC55C2A0F77195A6F5
Requests: 1 HTTP requests in this frame

Frame: https://cmp.teads.mgr.consensu.org/index.html
Frame ID: CE7C89C484D1E5DCE516031E795C15A4
Requests: 1 HTTP requests in this frame

Frame: https://sync.teads.tv/iframe?pid=78309&userId=3195e548-c1cb-41c0-bec1-fd3768755b43&gdprIab={%22status%22:23,%22consent%22:%22%22,%22reason%22:230}&1553523338766
Frame ID: 98A6E42C826B249BF91081CA7AEE6DA6
Requests: 1 HTTP requests in this frame

Frame: https://a.teads.tv/media/format/v3/assets/default/player-sprite.svg
Frame ID: 7F598E5108DBD72C3C93B6DFB99E9B25
Requests: 2 HTTP requests in this frame

Frame: https://s8t.teads.tv/vpaid/6753877076500981
Frame ID: 440C8DD55E3939EE8A38AFA6F92052F9
Requests: 3 HTTP requests in this frame

Frame: https://s8t.teads.tv/sdk/2.0.0
Frame ID: 783C76A88FC227C7C32FF4511D569A60
Requests: 3 HTTP requests in this frame

Frame: https://cdn.tynt.com/siab.js
Frame ID: 7553FB14B43779FB99B7B8671DCC68CA
Requests: 12 HTTP requests in this frame

Frame: https://us-ads.openx.net/w/1.0/jstag
Frame ID: 40EA3A6EFA92FE329A64E0578FB3A9BB
Requests: 2 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?cc=1&plm=1&ph=94ef58655625200a8cfc5b15afcd0b94ad52d590
Frame ID: 458DB9B608ADF6896822F03D37721841
Requests: 1 HTTP requests in this frame

Frame: https://cdn.tynt.com/siab.js?Y77FaY9MHX&_ADTIME_&$RANDOM&%%CACHEBUSTER%%&
Frame ID: E28C10D0641FC03951776330160A5FA2
Requests: 1 HTTP requests in this frame

Frame: https://www.googletagservices.com/tag/js/gpt.js
Frame ID: 6A2CEEF796EEE39C9CB0ECF3BC878D3C
Requests: 7 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 72F66E05821E96F08EB00CAE98622C10
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: FD00F84904189939D6469F0EC3E0429A
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 6E13AA2041089BFBDD2950192522F822
Requests: 2 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: AB31666F71B531357CD6708449AC7F7C
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: 413D0DD34AB881FC6CE1D77C289137D9
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: A4809E24BEFDBEBD70E0810AEC592952
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. http://feeds.reuters.com/~r/reuters/INhealth/~3/_FV_CUmpZcA/gsk-reports-positive-data-from-trial-of-e... HTTP 301
    https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometri... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i

Overall confidence: 100%
Detected patterns
  • env /^_sf_(?:endpt|async_config)$/i

Overall confidence: 100%
Detected patterns
  • script /googletagservices\.com\/tag\/js\/gpt(?:_mobile)?\.js/i

Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i

Overall confidence: 100%
Detected patterns
  • env /^__google_ad_/i
  • env /^Goog_AdSense_/i

Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|(analytics))\.js/i
  • env /^gaGlobal$/i

Overall confidence: 100%
Detected patterns
  • env /^googletag$/i
  • env /^google_tag_manager$/i

Overall confidence: 100%
Detected patterns
  • html /<script[\s\S]*cdn\.segment\.com\/analytics.js[\s\S]*script>/i
  • script /cdn\.segment\.com\/analytics\.js/i
  • env /^analytics$/i

Overall confidence: 100%
Detected patterns
  • html /<iframe[^>]* (?:id="comscore"|scr=[^>]+comscore)|\.scorecardresearch\.com\/beacon\.js|COMSCORE\.beacon/i
  • script /\.scorecardresearch\.com\/beacon\.js|COMSCORE\.beacon/i
  • env /^_?COMSCORE$/i

Overall confidence: 100%
Detected patterns
  • env /^webpackJsonp$/i

Page Statistics

278
Requests

100 %
HTTPS

36 %
IPv6

44
Domains

88
Subdomains

79
IPs

6
Countries

3616 kB
Transfer

11419 kB
Size

11
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://feeds.reuters.com/~r/reuters/INhealth/~3/_FV_CUmpZcA/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG HTTP 301
    https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 58
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j73&tid=UA-24152976-22&cid=1135711109.1553523334&jid=1791515965&gjid=1733131&_gid=2031189717.1553523334&_u=aGBAgEAjQ~&z=1109292625 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=1135711109.1553523334&jid=1791515965&_v=j73&z=1109292625 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=1135711109.1553523334&jid=1791515965&_v=j73&z=1109292625&slf_rd=1&random=3473136454
Request Chain 67
  • https://sb.scorecardresearch.com/b?c1=2&c2=6035630&ns__t=1553523334337&ns_c=UTF-8&cv=3.1e&c8=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug%20%7C%20Reuters&c7=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1553523334337&ns_c=UTF-8&cv=3.1e&c8=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug%20%7C%20Reuters&c7=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&c9=
Request Chain 123
  • https://route.carambo.la/inimage/getlayer?pid=thms97&did=112441&wid=3&rdn=[RANDOM_NUMBER] HTTP 302
  • https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Request Chain 126
  • https://pixel.watch/q4m9 HTTP 302
  • https://s3.amazonaws.com/clickmeter.com/Web/static/pixel.gif
Request Chain 169
  • https://sb.scorecardresearch.com/p?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1553523338007&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=25751517&cs_ucfr=1 HTTP 302
  • https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1553523338007&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=25751517&cs_ucfr=1
Request Chain 247
  • https://us-ads.openx.net/w/1.0/acj?ai=f314b08e-347c-42c7-b4c2-bc97c8db0959&o=2236788485&callback=OX_2236788485&ju=https%3A//in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A+reuters%252FINhealth+%2528News+%252F+IN+%252F+Health%2529&jr=&auid=539343028&dims=&adxy=&res=1600x1200x24&plg=pm&ch=UTF-8&tz=0&ws=300x250&ifr=1&tws=1600x1200&mt=1 HTTP 302
  • https://us-ads.openx.net/w/1.0/acj?cc=1&ai=f314b08e-347c-42c7-b4c2-bc97c8db0959&o=2236788485&callback=OX_2236788485&ju=https%3A//in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A+reuters%252FINhealth+%2528News+%252F+IN+%252F+Health%2529&jr=&auid=539343028&dims=&adxy=&res=1600x1200x24&plg=pm&ch=UTF-8&tz=0&ws=300x250&ifr=1&tws=1600x1200&mt=1
Request Chain 248
  • https://eu-u.openx.net/w/1.0/pd?plm=1&ph=94ef58655625200a8cfc5b15afcd0b94ad52d590 HTTP 302
  • https://eu-u.openx.net/w/1.0/pd?cc=1&plm=1&ph=94ef58655625200a8cfc5b15afcd0b94ad52d590

278 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG
in.reuters.com/article/us-gsk-dostarlimab/
Redirect Chain
  • http://feeds.reuters.com/~r/reuters/INhealth/~3/_FV_CUmpZcA/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG
  • https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&ut...
128 KB
35 KB
Document
General
Full URL
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:1a00:a:1858:cf00:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
02786b36ef8ae43e6cd51b1670e3d95eea85dbbd5a53ff944b766f8284a14909

Request headers

:method
GET
:authority
in.reuters.com
:scheme
https
:path
/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
200
content-type
text/html;charset=UTF-8
content-length
35550
age
78
channel-name
health
content-encoding
gzip
date
Mon, 25 Mar 2019 14:15:32 GMT
expires
Mon, 25 Mar 2019 14:14:14 GMT
last-updateda
Tue, 19 Mar 2019 18:19:07 GMT
server
nginx
vary
Accept-Encoding
x-cache
Miss from cloudfront
via
1.1 f989b812753677758cd8909391e239ac.cloudfront.net (CloudFront)
x-amz-cf-id
bAAxatX-VEp7Cldnn_oY9Hj8NC9yUH03vPrOlRyi74qEYwQXrSyzFQ==

Redirect headers

Location
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Content-Type
text/html; charset=UTF-8
Content-Encoding
gzip
Date
Mon, 25 Mar 2019 14:15:32 GMT
Expires
Mon, 25 Mar 2019 14:15:32 GMT
Cache-Control
private, max-age=0
X-Content-Type-Options
nosniff
X-XSS-Protection
1; mode=block
Content-Length
335
Server
GSE
article.bundle.css
static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/
135 KB
14 KB
Stylesheet
General
Full URL
https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/article.bundle.css
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.89 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-89.fra6.r.cloudfront.net
Software
nginx /
Resource Hash
11edb75f32c33081d57b4b7686b0414bbee1743df4373187b97e60cc12dc039e

Request headers

:path
/resources_v2/react/release/article-2019-01-1-e6cf22b0/article.bundle.css
pragma
no-cache
accept-encoding
gzip, deflate, br
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/css,*/*;q=0.1
cache-control
no-cache
:authority
static.reuters.com
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
:scheme
https
:method
GET
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:09:11 GMT
content-encoding
gzip
last-modified
Thu, 28 Feb 2019 22:04:25 GMT
server
nginx
age
400
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=7200
accept-ranges
bytes
content-length
14248
via
1.1 2f471134491a4de5cfcaef646caf9dde.cloudfront.net (CloudFront)
x-amz-cf-id
UycxxWhIbudO_bYUrvbDSUU7M4c92PlbjlBWJ02qlFDzbqYnzZ4jhQ==
expires
Mon, 25 Mar 2019 16:08:53 GMT
common.bundle.css
static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/
478 KB
279 KB
Stylesheet
General
Full URL
https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.css
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.89 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-89.fra6.r.cloudfront.net
Software
nginx /
Resource Hash
da1558557545d89fbfa46db07072c3000c75d6a098a90408c024d0ce2ef7cf9c

Request headers

:path
/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.css
pragma
no-cache
accept-encoding
gzip, deflate, br
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/css,*/*;q=0.1
cache-control
no-cache
:authority
static.reuters.com
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
:scheme
https
:method
GET
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:09:11 GMT
content-encoding
gzip
last-modified
Thu, 28 Feb 2019 22:04:31 GMT
server
nginx
age
390
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=7200
accept-ranges
bytes
x-amz-cf-id
vNwYE0yg0JVD0bMpGTiAp_rOxdqD1BKoymurfsAaVMcxC7FC7NRyqg==
via
1.1 2f471134491a4de5cfcaef646caf9dde.cloudfront.net (CloudFront)
expires
Mon, 25 Mar 2019 16:09:03 GMT
chartbeat_mab.js
static.chartbeat.com/js/
18 KB
8 KB
Script
General
Full URL
https://static.chartbeat.com/js/chartbeat_mab.js
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:4a00:18:1fcd:348:2461 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
b48ef5a7bc3d64c9e962bd440b6071266a0b7fa786f5c9556e283d025ead506b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 13:15:00 GMT
content-encoding
gzip
last-modified
Thu, 25 Oct 2018 02:07:51 GMT
server
nginx
age
3633
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/x-javascript
status
200
cache-control
max-age=86400
x-amz-cf-id
xje7pM8TGENt4bvufY1cVM_mYc543YWB5ztL6AlMVywEQvtJW2f34Q==
via
1.1 e98abde3c6a5bc27d4bdd4168baa587d.cloudfront.net (CloudFront)
expires
Tue, 26 Mar 2019 13:15:00 GMT
embedder.bundle.js
queso-cdn.prod.reuters.tv/new/assets/
50 KB
13 KB
Script
General
Full URL
https://queso-cdn.prod.reuters.tv/new/assets/embedder.bundle.js
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:2e00:1e:ef1b:aa40:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx/1.14.0 (Ubuntu) /
Resource Hash
3ad6849c327eac0d747d48c9e8d0430e5599933b668c944154f8228ec48b19ac

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:13 GMT
content-encoding
gzip
x-origin
i-00ce000d2f7f228e6.queso.prod.us.reuters.tv
server
nginx/1.14.0 (Ubuntu)
age
73
vary
Accept-Encoding
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
status
200
last-modified
Thu, 21 Mar 2019 19:00:31 GMT
x-cache
Hit from cloudfront
access-control-allow-origin
*
x-amz-cf-id
rKf1Tjb7fnBlZrnBbRjzEUgr2CBK3USwgCjdVnn5IWRHE4OAvHvG5Q==
via
1.1 e4438a14707a01f6102dc21875d75080.cloudfront.net (CloudFront)
access-control-allow-headers
connection, range, accept-encoding, user-agent, referer, content-type
gtm.js
www.googletagmanager.com/
348 KB
53 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:80b::2008 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager (scaffolding) /
Resource Hash
77aa89a4f58bdf884b1895414d526769c93071f10dbb049938bc769ebbb8aae7
Security Headers
Name Value
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:32 GMT
content-encoding
br
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
server
Google Tag Manager (scaffolding)
access-control-allow-origin
http://www.googletagmanager.com
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
status
200
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
content-length
54453
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:32 GMT
784b347e0b396a146b780d1fc552f9ce.png
static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/
15 KB
2 KB
Image
General
Full URL
https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/784b347e0b396a146b780d1fc552f9ce.png
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.89 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-89.fra6.r.cloudfront.net
Software
nginx /
Resource Hash
7c603a0659e260e2a4487c5dea0d42768c61dfb2c715196ead40c8db21fc1621

Request headers

:path
/resources_v2/react/release/article-2019-01-1-e6cf22b0/784b347e0b396a146b780d1fc552f9ce.png
pragma
no-cache
accept-encoding
gzip, deflate, br
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
image/webp,image/apng,image/*,*/*;q=0.8
cache-control
no-cache
:authority
static.reuters.com
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
:scheme
https
:method
GET
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 00:11:41 GMT
content-encoding
gzip
last-modified
Thu, 28 Feb 2019 22:04:22 GMT
server
nginx
age
56865
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
image/png
status
200
cache-control
max-age=86400
accept-ranges
bytes
content-length
1718
via
1.1 2f471134491a4de5cfcaef646caf9dde.cloudfront.net (CloudFront)
x-amz-cf-id
4XnHzIkt8OAjElzuCfDwSgtwxPaIABv_bPVO9LGE6lw5MAZi55uR2g==
expires
Sun, 24 Mar 2019 22:27:45 GMT
/
s2.reutersmedia.net/resources/r/
802 B
1 KB
Image
General
Full URL
https://s2.reutersmedia.net/resources/r/?m=02&d=20190319&t=2&i=1368087844&r=LYNXNPEF2I1KH&w=20
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.89 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-89.fra6.r.cloudfront.net
Software
nginx /
Resource Hash
cdf37abc779725211fb9fc7dda24738b809f83075b4d19fee90638ed19da8c20

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Sun, 24 Mar 2019 11:43:24 GMT
via
1.1 2f471134491a4de5cfcaef646caf9dde.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Fri, 19 Apr 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Tue, 19 Mar 2019 18:24:25 GMT
server
nginx
age
7904
etag
"fea997241ad84e47b62b65be410a1682"
x-cache
Hit from cloudfront
x-amz-version-id
7jlf3sGT.2a_GunlahWtAoriyoyKOhgV
status
200
content-type
image/jpeg
content-length
802
x-amz-cf-id
UqXmb7L1Rn_K2t5PZLMzjuegux8b_lGd1f-p9s8bE2q5tEXmyEIPsQ==
common.bundle.js
static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/
720 KB
172 KB
Script
General
Full URL
https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.89 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-89.fra6.r.cloudfront.net
Software
nginx /
Resource Hash
b5faebd111e07583ed8e0bfbbee9a942ba8979fcdc759fa258368b74a487d397

Request headers

:path
/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
pragma
no-cache
accept-encoding
gzip, deflate, br
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
*/*
cache-control
no-cache
:authority
static.reuters.com
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
:scheme
https
:method
GET
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:09:54 GMT
content-encoding
gzip
last-modified
Thu, 28 Feb 2019 22:04:32 GMT
server
nginx
age
356
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=7200
accept-ranges
bytes
x-amz-cf-id
Ix69tN9wgF4nJ3wzBZPMK5SK7ZdwBbzewnvtFobrKitrP-dMaelN1A==
via
1.1 2f471134491a4de5cfcaef646caf9dde.cloudfront.net (CloudFront)
expires
Mon, 25 Mar 2019 16:09:37 GMT
article.bundle.js
static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/
321 KB
44 KB
Script
General
Full URL
https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/article.bundle.js
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.89 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-89.fra6.r.cloudfront.net
Software
nginx /
Resource Hash
82d4e605d2a736fb91d6256e79d772019f71cc5279f2713b1376f19a21128d41

Request headers

:path
/resources_v2/react/release/article-2019-01-1-e6cf22b0/article.bundle.js
pragma
no-cache
accept-encoding
gzip, deflate, br
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
*/*
cache-control
no-cache
:authority
static.reuters.com
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
:scheme
https
:method
GET
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:11:16 GMT
content-encoding
gzip
last-modified
Thu, 28 Feb 2019 22:04:26 GMT
server
nginx
age
284
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=7200
accept-ranges
bytes
content-length
45027
via
1.1 2f471134491a4de5cfcaef646caf9dde.cloudfront.net (CloudFront)
x-amz-cf-id
41lg__6mMzwbJh2a6qiXSGF9J8KQzlZqLpt57I-fFQJkN9rPdBhXFQ==
expires
Mon, 25 Mar 2019 16:10:49 GMT
iframe_api
www.youtube.com/
859 B
950 B
Script
General
Full URL
https://www.youtube.com/iframe_api
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:816::200e , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
YouTube Frontend Proxy /
Resource Hash
a6368fa1fc1fcf5df2e6f14d6731cab91089c9c5322b00668745dbf579d37f3e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
x-content-type-options
nosniff
server
YouTube Frontend Proxy
content-type
application/javascript
status
200
cache-control
no-cache
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
859
x-xss-protection
1; mode=block
expires
Tue, 27 Apr 1971 19:44:06 EST
/
mab.chartbeat.com/mab_strategy/headline_testing/get_strategy/
200 B
510 B
XHR
General
Full URL
https://mab.chartbeat.com/mab_strategy/headline_testing/get_strategy/?host=in.reuters.com&domain=in.reuters.com&path=%2Farticle%2Fus-gsk-dostarlimab-idINKCN1R02DG
Requested by
Host: static.chartbeat.com
URL: https://static.chartbeat.com/js/chartbeat_mab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a04:4e42::714 , European Union, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software
/
Resource Hash
a144f2c5946d910e318f43138264fef4887e59af57888a757674b5af3729d131

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
x-cacheable
YES
x-backend
default
age
0
x-cache
MISS, MISS
status
200
x-cache-hits
0
x-restarts
0
content-length
163
x-served-by
cache-fra19132-FRA
access-control-allow-origin
*
x-timer
S1553523333.179258,VS0,VE103
vary
Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
content-type
application/json
via
1.1 varnish, 1.1 varnish
cache-control
no-store, no-cache, must-revalidate, max-age=0, s-maxage=0
accept-ranges
bytes
expires
Sat, 23 Mar 2019 14:15:33 GMT
www-widgetapi.js
s.ytimg.com/yts/jsbin/www-widgetapi-vflRrDfuy/
20 KB
8 KB
Script
General
Full URL
https://s.ytimg.com/yts/jsbin/www-widgetapi-vflRrDfuy/www-widgetapi.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/iframe_api
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:821::200e , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
3cf7db9d05610a9898b552a5090814d8fff880fb5b81710e3a1e26cf05f66e57
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Fri, 22 Mar 2019 10:17:20 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
273493
status
200
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
7822
x-xss-protection
1; mode=block
last-modified
Thu, 21 Mar 2019 21:57:52 GMT
server
sffe
vary
Accept-Encoding, Origin
content-type
text/javascript
cache-control
public, max-age=691200
accept-ranges
bytes
timing-allow-origin
https://www.youtube.com
expires
Sat, 30 Mar 2019 10:17:20 GMT
truncated
/
49 KB
0
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
45610b21279531a97f9566b0f0f8a1d287a45ae4bc6bc545971af5cd7e393cc6

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Origin
https://in.reuters.com

Response headers

Content-Type
application/font-woff
truncated
/
49 KB
0
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f01d25f7a76e0682a7a43230c32bef653eaf28b8a6f7a683ebb88bf8c6aa4f50

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Origin
https://in.reuters.com

Response headers

Content-Type
application/font-woff
truncated
/
49 KB
0
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d7d62426c6b87d35cef5c2c873355aa44edffcf4a7f927f1c51b10694ea4f6ed

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Origin
https://in.reuters.com

Response headers

Content-Type
application/font-woff
truncated
/
71 KB
0
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ee0768f9d2def8b13df284410776f5d755109e77b5c0ca17d8895f65b343a0cd

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Origin
https://in.reuters.com

Response headers

Content-Type
application/font-woff
service
async01.admantx.com/admantx/
62 B
257 B
Script
General
Full URL
https://async01.admantx.com/admantx/service?request=%7B%22key%22%3A%22234330834c41105ad5ed794fa036e085b40225c44f9228bb9e2692f427917605%22%2C%20%22decorator%22%3A%22template.reuters%22%2C%20%22filter%22%3A%5B%22default%22%5D%2C%20%22method%22%3A%22descriptor%22%2C%20%22mode%22%3A%22async%22%2C%20%22type%22%3A%22URL%22%2C%20%22body%22%3A%22https%253A%252F%252Fin.reuters.com%252Farticle%252Fus-gsk-dostarlimab%252Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%253FfeedType%253DRSS%2526feedName%253Dhealth%2526utm_source%253Dfeedburner%2526utm_medium%253Dfeed%2526utm_campaign%253DFeed%25253A%252Breuters%25252FINhealth%252B%252528News%252B%25252F%252BIN%252B%25252F%252BHealth%252529%22%7D
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.228.236.185 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-228-236-185.eu-west-1.compute.amazonaws.com
Software
nginx/1.12.2 /
Resource Hash
b68ef84092a1b0e218c39af2a4133261f35e2f68c80378a322653922fa5fdc50

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Access-Control-Allow-Origin
*
Date
Mon, 25 Mar 2019 14:15:33 GMT
Server
nginx/1.12.2
Connection
keep-alive
Content-Length
62
Content-Type
text/plain; charset=UTF-8
evidon-sitenotice-tag.js
c.evidon.com/sitenotice/
40 KB
11 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
104.107.252.81 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-107-252-81.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
dff46486a11e8e9c5785ce5d037c4e9e507511c5cb404a044602c68a777b0e7b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
status
200
access-control-max-age
86400
content-length
10669
last-modified
Wed, 20 Mar 2019 19:57:18 GMT
server
Apache
etag
"a0688cb77159ce22f4bcb1519b8859fc:1553111839"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=86400, private;max-age=86400
access-control-allow-credentials
false
accept-ranges
bytes
access-control-allow-headers
*
expires
Tue, 26 Mar 2019 14:15:33 GMT
country.js
c.evidon.com/geo/
260 B
456 B
Script
General
Full URL
https://c.evidon.com/geo/country.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
104.107.252.81 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-107-252-81.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
f9784f57729f84391b084eed9e944e048f771129d65e9b58f34095fdfba86473

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
last-modified
Wed, 30 May 2018 22:23:16 GMT
server
Apache
access-control-allow-origin
*
etag
"c1e367d098d326049811561575dbda4a:1527718996"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS
content-type
application/x-javascript
status
200
access-control-max-age
86400
access-control-allow-credentials
false
accept-ranges
bytes
access-control-allow-headers
*
content-length
165
snthemes.js
c.evidon.com/sitenotice/1237/
36 KB
3 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/snthemes.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
104.107.252.81 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-107-252-81.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
490c6a95e66f9d9c29cb001434c4c8b252ceed75066b7d35a695266648b803ee

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
status
200
access-control-max-age
86400
content-length
3003
last-modified
Tue, 12 Mar 2019 21:46:19 GMT
server
Apache
etag
"fce56d5ae09d8d7811441f2410b96748:1552427179"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=86400, private;max-age=86400
access-control-allow-credentials
false
accept-ranges
bytes
access-control-allow-headers
*
expires
Tue, 26 Mar 2019 14:15:33 GMT
settings.js
c.evidon.com/sitenotice/1237/reuters/
6 KB
2 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/reuters/settings.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
104.107.252.81 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-107-252-81.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
2817e6f17de2973f0e5cba1ca2371a9d277467a0b639cd9141fa3bcb77a6e460

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
status
200
access-control-max-age
86400
content-length
1736
last-modified
Thu, 24 Jan 2019 19:14:53 GMT
server
Apache
etag
"53eca6a07520fe299254603d50bf2e19:1548357293"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=86400, private;max-age=86400
access-control-allow-credentials
false
accept-ranges
bytes
access-control-allow-headers
*
expires
Tue, 26 Mar 2019 14:15:33 GMT
analytics.min.js
cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/
301 KB
64 KB
Script
General
Full URL
https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
99.86.0.85 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-99-86-0-85.fra6.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
2e81e8eb235ae05f59b40689c70be201d956443e72caca782f2db21645384fef

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

x-amz-version-id
C6Bs9.kyG6gXKUBhNWBlp.DxyIcKoKQt
content-encoding
gzip
age
274
x-cache
Hit from cloudfront
status
200
date
Mon, 25 Mar 2019 14:11:00 GMT
x-amz-replication-status
COMPLETED
content-length
65205
via
1.1 d3039ad83798b26ecb9f9f1e666afe27.cloudfront.net (CloudFront)
last-modified
Fri, 22 Mar 2019 18:13:38 GMT
server
AmazonS3
etag
"7036bafcfeb3d5ed7b85af8d53e9a550"
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
content-type
text/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=300
accept-ranges
bytes
x-amz-cf-id
HjzLsSjSvkH2ylwY9RWHBP7SrOuqdJe8yICTF-6PnChiHHHwiv64Kw==
finance
wireapi.reuters.com/v7/feed/rcom/in/top-nav/
50 B
493 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/in/top-nav/finance?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.26 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-26.fra6.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

:path
/v7/feed/rcom/in/top-nav/finance?count=7
pragma
no-cache
origin
https://in.reuters.com
accept-encoding
gzip, deflate, br
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
*/*
cache-control
no-cache
:authority
wireapi.reuters.com
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
:scheme
https
:method
GET
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
via
1.1 linkerd, 1.1 c6b364b1181abfafd7a69f210841edca.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
status
404
x-amzn-requestid
7411d85c-4f08-11e9-8243-5907f8a2b514
vary
Origin
x-cache
Error from cloudfront
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
l5d-success-class
1.0
content-length
50
x-amz-apigw-id
XGhU5HSGIAMFeFg=
x-amzn-remapped-date
Mon, 25 Mar 2019 14:15:33 GMT
x-amz-cf-id
x7NZFgL3SCWshQM2NwIh1hsLWOLzOmFDExVCfm84N9jOIqHFLHnHWw==
x-amzn-remapped-connection
keep-alive
markets
wireapi.reuters.com/v7/feed/rcom/in/top-nav/finance/
50 B
492 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/in/top-nav/finance/markets?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.26 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-26.fra6.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

:path
/v7/feed/rcom/in/top-nav/finance/markets?count=7
pragma
no-cache
origin
https://in.reuters.com
accept-encoding
gzip, deflate, br
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
*/*
cache-control
no-cache
:authority
wireapi.reuters.com
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
:scheme
https
:method
GET
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
via
1.1 linkerd, 1.1 c6b364b1181abfafd7a69f210841edca.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
status
404
x-amzn-requestid
740fb57a-4f08-11e9-94b1-edaf9cb61858
vary
Origin
x-cache
Error from cloudfront
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
l5d-success-class
1.0
content-length
50
x-amz-apigw-id
XGhU5GIyIAMFdtQ=
x-amzn-remapped-date
Mon, 25 Mar 2019 14:15:33 GMT
x-amz-cf-id
uVmWHReD83r3m-xYm_TBZe1mAjPVJZUxrYohRTMOeA1ASTkgjLbZQA==
x-amzn-remapped-connection
keep-alive
top-news
wireapi.reuters.com/v7/feed/rcom/in/top-nav/news/
50 B
491 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/in/top-nav/news/top-news?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.26 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-26.fra6.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

:path
/v7/feed/rcom/in/top-nav/news/top-news?count=7
pragma
no-cache
origin
https://in.reuters.com
accept-encoding
gzip, deflate, br
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
*/*
cache-control
no-cache
:authority
wireapi.reuters.com
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
:scheme
https
:method
GET
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
via
1.1 linkerd, 1.1 c6b364b1181abfafd7a69f210841edca.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
status
404
x-amzn-requestid
740f4058-4f08-11e9-98e9-0748fb444219
vary
Origin
x-cache
Error from cloudfront
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
l5d-success-class
1.0
content-length
50
x-amz-apigw-id
XGhU5EKyIAMFwxw=
x-amzn-remapped-date
Mon, 25 Mar 2019 14:15:33 GMT
x-amz-cf-id
gWSPqOsFc3WWBav8gvbhwKGMIkbKj1W87NO0ZbtY2-lE-fdcHLsThQ==
x-amzn-remapped-connection
keep-alive
contextfeed.js
www.dianomi.com/js/
6 KB
2 KB
Script
General
Full URL
https://www.dianomi.com/js/contextfeed.js?
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/article.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
ec8b3cd2573ee83da12227aaf2c4040c42e3c10fa058db9c5c365bd55680ff4f

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
cf-cache-status
HIT
cf-polished
origSize=7003
status
200
cf-bgj
minify
last-modified
Thu, 21 Mar 2019 11:53:00 GMT
server
cloudflare
etag
W/"1b5b-584996144b444"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Host, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
4bd17f6369cbc763-AMS
expires
Mon, 25 Mar 2019 18:15:33 GMT
trendingstories.json
in.reuters.com/api/
19 KB
4 KB
Fetch
General
Full URL
https://in.reuters.com/api/trendingstories.json
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:1a00:a:1858:cf00:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
086f588ad27a084c11b408ccc9d0593d4f212a64d3e3980b289b3a1624f4d42c

Request headers

:path
/api/trendingstories.json
pragma
no-cache
cookie
_cb_ls=1
accept-encoding
gzip, deflate, br
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
*/*
cache-control
no-cache
:authority
in.reuters.com
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
:scheme
https
:method
GET
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
server
nginx
age
29
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
application/json;charset=UTF-8
status
200
x-amz-cf-id
9EzPZfBjRJu8-Um8vbcnn8A0BH9TFbAOp_CV_WmLLWSf0yPCcXS3fA==
via
1.1 f989b812753677758cd8909391e239ac.cloudfront.net (CloudFront)
expires
Mon, 25 Mar 2019 14:15:04 GMT
breakingNews
in.reuters.com/assets/
525 B
791 B
Fetch
General
Full URL
https://in.reuters.com/assets/breakingNews?view=json
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:1a00:a:1858:cf00:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
3a70587b8d37d4764aa4e3d8e8fadf3d7fb1abb461db10f7aff9cfe5173a61e6

Request headers

:path
/assets/breakingNews?view=json
pragma
no-cache
cookie
_cb_ls=1
accept-encoding
gzip, deflate, br
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
*/*
cache-control
no-cache
:authority
in.reuters.com
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
:scheme
https
:method
GET
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:06 GMT
via
1.1 f989b812753677758cd8909391e239ac.cloudfront.net (CloudFront)
server
nginx
age
54
x-cache
Hit from cloudfront
content-type
application/json;charset=UTF-8
status
200
content-length
525
x-amz-cf-id
o-VkdOAtvOA_gK-oWhHKmJAEp-8r9uBTsEoOo2ZS9hmDXVFUMX6S_Q==
expires
Mon, 25 Mar 2019 14:14:39 GMT
/
s2.reutersmedia.net/resources/r/
86 KB
87 KB
Image
General
Full URL
https://s2.reutersmedia.net/resources/r/?m=02&d=20190319&t=2&i=1368087844&r=LYNXNPEF2I1KH&w=1280
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.89 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-89.fra6.r.cloudfront.net
Software
nginx /
Resource Hash
146e9baf322645af7587b7681aecb0fc23910c2a83bda43f0014f0370fad3299

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Sun, 24 Mar 2019 11:43:39 GMT
via
1.1 2f471134491a4de5cfcaef646caf9dde.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Fri, 19 Apr 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Tue, 19 Mar 2019 18:24:57 GMT
server
nginx
etag
"5445425c996c296e0419636b0e76b551"
x-cache
RefreshHit from cloudfront
x-amz-version-id
nC4IplX4UiH12TsNYWuad0g0JBbETDer
status
200
content-type
image/jpeg
content-length
88478
x-amz-cf-id
mJz050wm-vfrmw90DVx8kNLUlF36Ek7l-6jUu32I_l-Mlop9WMRDVg==
ads.js
www.reuters.com/
112 B
504 B
Script
General
Full URL
https://www.reuters.com/ads.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.108 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-108.fra6.r.cloudfront.net
Software
nginx /
Resource Hash
7464555aae6d8d87b77f7170fba1698ff64f7454ded58627ca1819246e9a9969

Request headers

:path
/ads.js
pragma
no-cache
accept-encoding
gzip, deflate, br
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
*/*
cache-control
no-cache
:authority
www.reuters.com
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
:scheme
https
:method
GET
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
server
nginx
age
84
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
status
200
access-control-allow-origin
http://admin.reuters.com
access-control-allow-headers
Access-Control-Allow-Origin,charset
content-length
116
via
1.1 f0a97a8c56cd2bb79a1739863489ed4c.cloudfront.net (CloudFront)
x-amz-cf-id
3Sbx6_qkzRDy1wGvrjz-VPWo8-rkUo6Xq980_DGh0ALEEZH0-6udhw==
expires
Mon, 25 Mar 2019 14:14:08 GMT
en.js
c.evidon.com/sitenotice/1237/translations/
64 KB
4 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/translations/en.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
104.107.252.81 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-107-252-81.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
5277212dab850fc46e54bfe713c3c433f4939d6f320afea5c93f30bbfa1b1b48

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
status
200
access-control-max-age
86400
content-length
3453
last-modified
Thu, 24 May 2018 22:03:37 GMT
server
Apache
etag
"c970cb87178a521fb33092c00523293a:1527199417"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=86400, private;max-age=86400
access-control-allow-credentials
false
accept-ranges
bytes
access-control-allow-headers
*
expires
Tue, 26 Mar 2019 14:15:33 GMT
iabevidonmapping.js
iabmap.evidon.com/
6 KB
3 KB
Script
General
Full URL
https://iabmap.evidon.com/iabevidonmapping.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:e200:10:27b4:f500:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
c12cfe3245b034d5354184f739ae0b54bcfd061434643d69446737fb395eaf15

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 08:36:17 GMT
content-encoding
gzip
last-modified
Mon, 18 Mar 2019 18:46:52 GMT
server
AmazonS3
age
66033
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
x-amz-cf-id
xiRbq5Jc7-1LoMzlQW-3vbddwpcBSDCddRPVJLXTLCXnOP2EeRiklw==
via
1.1 7239cddab402255f71ebf4fa62183992.cloudfront.net (CloudFront)
evidon-cmp.js
c.evidon.com/sitenotice/
23 KB
7 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-cmp.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
104.107.252.81 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-107-252-81.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
6444118d84f1e81114a8f2fe394aa7b0edf6bf86668577a67d04e4f7e6bd5718

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
status
200
access-control-max-age
86400
content-length
6782
last-modified
Wed, 20 Mar 2019 19:57:19 GMT
server
Apache
etag
"696b5da2be219aa209cb3f50d4818f0e:1553111842"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=86400, private;max-age=86400
access-control-allow-credentials
false
accept-ranges
bytes
access-control-allow-headers
*
expires
Tue, 26 Mar 2019 14:15:33 GMT
evidon-banner.js
c.evidon.com/sitenotice/
8 KB
3 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-banner.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
104.107.252.81 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-107-252-81.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
4b51cad50779921c134fe5f8a46df29da7bdedf5f643c331d192b6057af97992

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
status
200
access-control-max-age
86400
content-length
2538
last-modified
Wed, 20 Mar 2019 19:57:19 GMT
server
Apache
etag
"41298c7c9394582aaf744ce4397a8521:1553111841"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=86400, private;max-age=86400
access-control-allow-credentials
false
accept-ranges
bytes
access-control-allow-headers
*
expires
Tue, 26 Mar 2019 14:15:33 GMT
2
l.betrad.com/site/v3/1237/5669/3/1/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/3/1/2/2?consent=0
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
107.21.45.69 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-107-21-45-69.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
204
date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
x-powered-by
Express
vary
Accept-Encoding
vendorlist.json
vendorlist.consensu.org/
77 KB
14 KB
XHR
General
Full URL
https://vendorlist.consensu.org/vendorlist.json
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-cmp.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:f200:1:af78:4c0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
206f0eabacd22ac264d69e707b23dbf1d62c7a71fec411fb1705d41d10f3d3b8

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Fri, 22 Mar 2019 07:03:53 GMT
content-encoding
gzip
vary
Accept-Encoding,Origin,Access-Control-Request-Headers,Access-Control-Request-Method
age
25539
x-cache
Hit from cloudfront
status
200
access-control-allow-origin
*
last-modified
Thu, 21 Mar 2019 16:00:22 GMT
server
AmazonS3
access-control-max-age
86400
access-control-allow-methods
GET
x-amz-version-id
_fia.YnZ1x5w_3lCYfgDlmWXHJCpA74h
via
1.1 a034346227db119f7e0813186ca2d2c2.cloudfront.net (CloudFront)
cache-control
max-age=259200
content-type
application/json; charset=utf-8
x-amz-cf-id
F6G2rwo_wdThoMDvY54cv05oq3Zu3pa2jzm0Z7T7i-zwWYU5RQmWYA==
21698
l.betrad.com/site/v3/1237/5669/3/1/2/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/3/1/2/2/21698?consent=0
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
107.21.45.69 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-107-21-45-69.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
204
date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
x-powered-by
Express
vary
Accept-Encoding
21698
l.betrad.com/site/v3/1237/5669/3/4/2/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/3/4/2/2/21698?consent=0
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
107.21.45.69 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-107-21-45-69.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
204
date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
x-powered-by
Express
vary
Accept-Encoding
context.pl
www.dianomi.com/cgi-bin/
2 KB
481 B
XHR
General
Full URL
https://www.dianomi.com/cgi-bin/context.pl?id=4
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
20a41dab8271e265f869e045bc7f7a96cf9263829ae739109fd4f319394dfcf3

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
server
cloudflare
status
200
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Host
content-type
application/json; charset=ISO-8859-1
access-control-allow-origin
https://in.reuters.com
cache-control
no-cache
access-control-allow-credentials
true
cf-ray
4bd17f63dbd9c763-AMS
expires
Mon, 25 Mar 2019 14:15:33 GMT
getcookie
evidon.mgr.consensu.org/iab/
169 B
381 B
Script
General
Full URL
https://evidon.mgr.consensu.org/iab/getcookie
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-cmp.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.199.180.208 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-199-180-208.compute-1.amazonaws.com
Software
/
Resource Hash
9b133863146a5f391e8cee0842cafc7498ae89b6f79edbecfc842055342c1fe2

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:34 GMT
access-control-allow-origin
*
x-amzn-requestid
74403c21-4f08-11e9-a18b-092441d07287
content-type
text/javascript
status
200
x-amzn-trace-id
Root=1-5c98e286-45d843e6106c6fb679e95694;Sampled=0
x-amz-apigw-id
XGhU8GDEoAMFuoA=
content-length
169
p
api.segment.io/v1/
21 B
140 B
XHR
General
Full URL
https://api.segment.io/v1/p
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.69.157.105 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-69-157-105.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
text/plain

Response headers

status
200
date
Mon, 25 Mar 2019 14:15:34 GMT
access-control-allow-origin
https://in.reuters.com
content-length
21
vary
Origin
content-type
application/json
fbevents.js
connect.facebook.net/en_US/
52 KB
15 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:216:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
6bb981959d783d83df88b9aa48738948c9a8a22c1a31b8cb5305d3e338ebf9a7
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
vary
Origin, Accept-Encoding
content-length
15216
x-xss-protection
0
pragma
public
x-fb-debug
zYcv6H2loOL5jjePqZP6rUpv+M3VVlZVNkzIusbSdP0z6E1Z2QQdtCrKKyaIMFFTP6UvKLSfadJoQKMCi+v/5A==
date
Mon, 25 Mar 2019 14:15:33 GMT
x-frame-options
DENY
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
analytics.js
www.google-analytics.com/
43 KB
17 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:824::200e , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
3e552578c7d450b023f2cd9d28f830be4335c3acc6c4ab6dadda0769f09e5f22
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Wed, 16 Jan 2019 20:01:45 GMT
server
Golfe2
age
1717
date
Mon, 25 Mar 2019 13:46:56 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
17543
expires
Mon, 25 Mar 2019 15:46:56 GMT
dianomi-context.css
www.dianomi.com/partner/dianomi/css/
169 B
277 B
Stylesheet
General
Full URL
https://www.dianomi.com/partner/dianomi/css/dianomi-context.css?v=1.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
99781410070a5dd4d753fdb8a46f4272082b5be64541dcfcb1b2d3c4aea09c6c

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
cf-cache-status
HIT
cf-polished
origSize=199
status
200
cf-bgj
minify
last-modified
Mon, 21 Jan 2019 12:43:41 GMT
server
cloudflare
etag
W/"c7-57ff735e16ce7"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Host, Accept-Encoding
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
4bd17f644e2fc763-AMS
expires
Mon, 25 Mar 2019 18:15:33 GMT
smartads.epl
www.dianomi.com/ Frame 1B30
0
0
Document
General
Full URL
https://www.dianomi.com/smartads.epl?id=4765&num_ads=3&shuffle=0
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/smartads.epl?id=4765&num_ads=3&shuffle=0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
accept-encoding
gzip, deflate, br
cookie
__cfduid=dd8e0510bc974f0854085f401899daac61553523333
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

status
200
date
Mon, 25 Mar 2019 14:15:33 GMT
content-type
text/html; charset=UTF-8
access-control-allow-origin
*
access-control-allow-credentials
true
vary
Host, Accept-Encoding, User-Agent
expires
now
pragma
no-cache
cache-control
no-cache,no-store,private
link
</img/a/sav2/82372/7/:SIZE.jpg>;rel=preload;as=image,</img/a/sav2/114588/6/:SIZE.jpg>;rel=preload;as=image,</img/a/sav2/105437/4/:SIZE.jpg>;rel=preload;as=image,</img/a/pss/2676/22.css>;rel=preload;as=style
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
4bd17f646e84c763-AMS
content-encoding
gzip
cf-h2-pushed
</img/a/sav2/82372/7/:SIZE.jpg>,</img/a/sav2/114588/6/:SIZE.jpg>,</img/a/sav2/105437/4/:SIZE.jpg>,</img/a/pss/2676/22.css>
videofeed.js
www.dianomi.com/js/
8 KB
2 KB
Script
General
Full URL
https://www.dianomi.com/js/videofeed.js?id=1236
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
b494d71dbc08cdcfe3522576523b805177a7939408aad5daf3a9571945b389db

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
cf-cache-status
HIT
cf-polished
origSize=10542
status
200
cf-bgj
minify
last-modified
Thu, 21 Mar 2019 11:46:27 GMT
server
cloudflare
etag
W/"292e-5849949dc879c"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Host, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
4bd17f645e48c763-AMS
expires
Mon, 25 Mar 2019 18:15:33 GMT
recirculation.epl
www.dianomi.com/ Frame F93A
0
0
Document
General
Full URL
https://www.dianomi.com/recirculation.epl?id=104
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/recirculation.epl?id=104
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
accept-encoding
gzip, deflate, br
cookie
__cfduid=dd8e0510bc974f0854085f401899daac61553523333
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

status
200
date
Mon, 25 Mar 2019 14:15:33 GMT
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
vary
Host, Accept-Encoding, User-Agent
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
4bd17f646ea1c763-AMS
content-encoding
gzip
smartads.epl
www.dianomi.com/ Frame 0F4F
0
0
Document
General
Full URL
https://www.dianomi.com/smartads.epl?id=4766&num_ads=8&shuffle=0
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/smartads.epl?id=4766&num_ads=8&shuffle=0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
accept-encoding
gzip, deflate, br
cookie
__cfduid=dd8e0510bc974f0854085f401899daac61553523333
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

status
200
date
Mon, 25 Mar 2019 14:15:33 GMT
content-type
text/html; charset=UTF-8
access-control-allow-origin
*
access-control-allow-credentials
true
vary
Host, Accept-Encoding, User-Agent
expires
now
pragma
no-cache
cache-control
no-cache,no-store,private
link
</img/a/sav2/112859/2/396x276.jpg>;rel=preload;as=image,</img/a/sav2/114587/6/396x276.jpg>;rel=preload;as=image,</img/a/sav2/54096/10/396x276.jpg>;rel=preload;as=image,</img/a/sav2/69359/13/396x276.jpg>;rel=preload;as=image,</img/a/pss/2677/13.css>;rel=preload;as=style,</img/a/sav2/112858/2/396x276.jpg>;rel=preload;as=image,</img/a/sav2/82376/7/396x276.jpg>;rel=preload;as=image,</img/a/sav2/109496/5/396x276.jpg>;rel=preload;as=image,</img/a/sav2/114588/6/396x276.jpg>;rel=preload;as=image,</img/a/sav2/113269/3/396x276.jpg>;rel=preload;as=image,</img/a/sav2/111698/7/396x276.jpg>;rel=preload;as=image,</img/a/sav2/113286/2/396x276.jpg>;rel=preload;as=image,</img/a/sav2/98433/10/396x276.jpg>;rel=preload;as=image,</img/a/pss/2677/13.css>;rel=preload;as=style
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
4bd17f647ebec763-AMS
content-encoding
gzip
cf-h2-pushed
</img/a/sav2/112859/2/396x276.jpg>,</img/a/sav2/114587/6/396x276.jpg>,</img/a/sav2/54096/10/396x276.jpg>,</img/a/sav2/69359/13/396x276.jpg>,</img/a/pss/2677/13.css>,</img/a/sav2/112858/2/396x276.jpg>,</img/a/sav2/82376/7/396x276.jpg>,</img/a/sav2/109496/5/396x276.jpg>,</img/a/sav2/114588/6/396x276.jpg>,</img/a/sav2/113269/3/396x276.jpg>,</img/a/sav2/111698/7/396x276.jpg>,</img/a/sav2/113286/2/396x276.jpg>,</img/a/sav2/98433/10/396x276.jpg>,</img/a/pss/2677/13.css>
recirculation.epl
www.dianomi.com/ Frame AA50
0
0
Document
General
Full URL
https://www.dianomi.com/recirculation.epl?id=105&start=6
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/recirculation.epl?id=105&start=6
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
accept-encoding
gzip, deflate, br
cookie
__cfduid=dd8e0510bc974f0854085f401899daac61553523333
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

status
200
date
Mon, 25 Mar 2019 14:15:33 GMT
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
vary
Host, Accept-Encoding, User-Agent
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
4bd17f648eebc763-AMS
content-encoding
gzip
lazyload.iife.min.js
cdnjs.cloudflare.com/ajax/libs/vanilla-lazyload/10.20.1/
5 KB
2 KB
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/vanilla-lazyload/10.20.1/lazyload.iife.min.js
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:c697 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
3c514d4fb8244af230a89d2203522c6a67a55a3f161cfd4fca9f53301c0588ff
Security Headers
Name Value
Strict-Transport-Security max-age=15780000; includeSubDomains

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
br
cf-cache-status
HIT
status
200
strict-transport-security
max-age=15780000; includeSubDomains
last-modified
Sun, 17 Feb 2019 22:45:49 GMT
server
cloudflare
etag
W/"5c69e41d-14cf"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
expires
Sat, 14 Mar 2020 14:15:33 GMT
cache-control
public, max-age=30672000
cf-ray
4bd17f647c94bebc-FRA
served-in-seconds
0.001
dianomi-max-200x38.png
www.dianomi.com/img/
31 KB
31 KB
Image
General
Full URL
https://www.dianomi.com/img/dianomi-max-200x38.png
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
cfe9da4bdec377e2f10a16320897a92198e50960a236af433ce1a1c013213bd6

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
cf-cache-status
HIT
status
200
content-length
31456
last-modified
Tue, 23 May 2017 10:48:47 GMT
server
cloudflare
etag
"7ae0-5502ebb78747a"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Host, Accept-Encoding
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=2628000
access-control-allow-credentials
true
accept-ranges
bytes
cf-ray
4bd17f648eedc763-AMS
expires
Thu, 25 Apr 2019 00:15:33 GMT
312961195854690
connect.facebook.net/signals/config/
186 KB
45 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/312961195854690?v=2.8.42&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:216:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
6e16d30cf64d4a2ff0614436310336b3cf414c79822f4348f8000fe62d67477e
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
vary
Origin, Accept-Encoding
content-length
45966
x-xss-protection
0
pragma
public
x-fb-debug
OSag4wDcF88Q8ExgFMxrhHjuM+ylINMEkaD8t6O+7tKsmce5/sqdDkvM2ZPMXlT61JKRQtR9q23WCpLBxNT4Uw==
date
Mon, 25 Mar 2019 14:15:33 GMT
x-frame-options
DENY
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
smartads_video_json.pl
www.dianomi.com/cgi-bin/
3 B
192 B
XHR
General
Full URL
https://www.dianomi.com/cgi-bin/smartads_video_json.pl?id=4729
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/videofeed.js?id=1236
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
ca3d163bab055381827226140568f3bef7eaac187cebd76878e0b63e9e442356

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
gzip
server
cloudflare
status
200
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Host
content-type
application/json; charset=utf-8
access-control-allow-origin
https://in.reuters.com
cache-control
private, no-cache, no-store, must-revalidate, max-age=0, pre-check=0, post-check=0
access-control-allow-credentials
true
cf-ray
4bd17f64dfe2c763-AMS
linkid.js
www.google-analytics.com/plugins/ua/
2 KB
1020 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:824::200e , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 13:16:31 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 21 Apr 2016 03:17:22 GMT
server
sffe
age
3542
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=3600
accept-ranges
bytes
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
856
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:16:31 GMT
js
www.google-analytics.com/gtm/
54 KB
20 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-KBK7743&cid=1135711109.1553523334
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:824::200e , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager (scaffolding) /
Resource Hash
de069646544a0a1ac42be17cde90c5b4d1ea08c6276af11bad3c40f60adac8eb
Security Headers
Name Value
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:33 GMT
content-encoding
br
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
server
Google Tag Manager (scaffolding)
access-control-allow-origin
http://www.googletagmanager.com
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
status
200
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
content-length
20570
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:33 GMT
truncated
/
38 B
0
Other
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
52dc24c0429ea6ccc5b579a6da8bb79bf41e471fe5108a62009f3c2e195551c0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Content-Type
image/webp
/
www.facebook.com/tr/
44 B
244 B
Image
General
Full URL
https://www.facebook.com/tr/?id=312961195854690&ev=PageView&dl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&rl=&if=false&ts=1553523334012&sw=1600&sh=1200&v=2.8.42&r=stable&a=seg&ec=0&o=30&fbp=fb.1.1553523333998.1529929311&it=1553523333891&coo=false&rqm=GET
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:34 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
content-length
44
expires
Mon, 25 Mar 2019 14:15:34 GMT
collect
www.google-analytics.com/
35 B
103 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j73&a=1334740966&t=pageview&_s=1&dl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG&dp=%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&ul=en-us&de=UTF-8&dt=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&_u=aGBAgEAjQ~&jid=1791515965&gjid=1733131&cid=1135711109.1553523334&tid=UA-24152976-22&_gid=2031189717.1553523334&cd2=Health&cd11=us-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug&cd4=Article%20-%20News&cd8=0&cd10=False&cd9=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG&cd19=Page%20Load&cd7=Desktop&cd14=INKCN1R02DG&cd6=IN&cd5=Article&cd17=Reuters%20Editorial&cd3=Sports%20%20-%20Health&cd1=Sports%20&cd13=111&cd18=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug&z=1994522828
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:824::200e , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 08 Mar 2019 22:54:17 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
1437677
content-type
image/gif
status
200
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
cache-control
no-cache, no-store, must-revalidate
access-control-allow-origin
*
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j73&tid=UA-24152976-22&cid=1135711109.1553523334&jid=1791515965&gjid=1733131&_gid=2031189717.1553523334&_u=aGBAgEAjQ~&z=1109292625
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=1135711109.1553523334&jid=1791515965&_v=j73&z=1109292625
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=1135711109.1553523334&jid=1791515965&_v=j73&z=1109292625&slf_rd=1&random=3473136454
42 B
109 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=1135711109.1553523334&jid=1791515965&_v=j73&z=1109292625&slf_rd=1&random=3473136454
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:81b::2003 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:34 GMT
x-content-type-options
nosniff
content-type
image/gif
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
42
x-xss-protection
1; mode=block
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:34 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=1135711109.1553523334&jid=1791515965&_v=j73&z=1109292625&slf_rd=1&random=3473136454
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
cache-control
no-cache, no-store, must-revalidate
content-type
text/html; charset=UTF-8
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
0
x-xss-protection
1; mode=block
expires
Fri, 01 Jan 1990 00:00:00 GMT
chartbeat_video.js
static.chartbeat.com/js/
66 KB
23 KB
Script
General
Full URL
https://static.chartbeat.com/js/chartbeat_video.js
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:4a00:18:1fcd:348:2461 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
d84a123811bd2d2ce924417daeb7a4e2622259ee306fc9c9e78182c8fe4319c4

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Sun, 24 Mar 2019 16:54:18 GMT
content-encoding
gzip
last-modified
Fri, 01 Mar 2019 13:43:37 GMT
server
nginx
age
76876
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/x-javascript
status
200
cache-control
max-age=86400
x-amz-cf-id
9vKNs92mhRtCftXu0QEpoCxaNNkxgLl9aF3Dw7RVv4RouXslgLhssQ==
via
1.1 e98abde3c6a5bc27d4bdd4168baa587d.cloudfront.net (CloudFront)
expires
Mon, 25 Mar 2019 16:54:18 GMT
beacon.js
sb.scorecardresearch.com/
1 KB
1 KB
Script
General
Full URL
https://sb.scorecardresearch.com/beacon.js
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.121.166.105 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-121-166-105.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
76c393f564f53c19e795307e622edc8657a603f7a816c2646385697286d11313

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:34 GMT
Content-Encoding
gzip
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
private, no-transform, max-age=86400
Connection
keep-alive
Content-Length
902
Expires
Tue, 26 Mar 2019 14:15:34 GMT
reuters.js
tru.am/scripts/custom/
1 KB
782 B
Script
General
Full URL
https://tru.am/scripts/custom/reuters.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a322 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6f23d93c9b8e3ca26f6fcc6be6a8d087e43a3f5795daa3c61017071642f66f3c

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:34 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 14 Jun 2018 18:27:56 GMT
server
cloudflare
etag
W/"40b7d4de06dae04ec0d6537ef2f54db8"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=14400
cf-ray
4bd17f67a88a980a-FRA
expires
Mon, 25 Mar 2019 18:15:34 GMT
dest5.html
reuters.demdex.net/ Frame 5D74
0
0
Document
General
Full URL
https://reuters.demdex.net/dest5.html?d_nsid=0
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.194.108.5 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-194-108-5.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

Host
reuters.demdex.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

Accept-Ranges
bytes
Cache-Control
max-age=21600
Content-Encoding
gzip
Content-Type
text/html
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Fri, 22 Mar 2019 09:58:19 GMT
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Pragma
no-cache
Vary
Accept-Encoding, User-Agent
X-TID
ZjoOzYHjRiA=
Content-Length
2764
Connection
keep-alive
event
reuters.demdex.net/
2 B
715 B
XHR
General
Full URL
https://reuters.demdex.net/event?_ts=1553523334275
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.194.108.5 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-194-108-5.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

DCS
dcs-prod-irl1-v025-0bb4ad565.edge-irl1.demdex.com 5.50.0.20190319164038 1ms
Pragma
no-cache
X-TID
n3FTtjqSSj4=
Vary
Origin
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Access-Control-Allow-Origin
https://in.reuters.com
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json;charset=utf-8
Content-Length
2
Expires
Thu, 01 Jan 1970 00:00:00 GMT
tag.min.js
get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/
46 KB
15 KB
Script
General
Full URL
https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:8a00:1f:287:d208:7ea1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
8baa355558d41a0af243bfc867f248d10107adfd104db64fff48879d04cd7c16

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

x-amz-version-id
5I6szdNYhabRlTI0ZFNKsaBVwTv5wCBa
content-encoding
gzip
last-modified
Thu, 14 Mar 2019 11:07:42 GMT
server
AmazonS3
age
246
date
Mon, 25 Mar 2019 14:11:33 GMT
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/javascript
status
200
cache-control
max-age=3600
x-amz-cf-id
Y5yu40kfShZTJsyVOpo_2Nt6iQkYzFiYADM3iBmTiaNe4RgUmIVHzA==
via
1.1 4446e317b7b7532307c7755d43835bff.cloudfront.net (CloudFront)
collect
www.google-analytics.com/
35 B
96 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j73&a=1334740966&t=timing&_s=2&dl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&dp=%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&ul=en-us&de=UTF-8&dt=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&plt=1520&pdt=5&dns=38&rrt=144&srt=47&tcp=16&dit=821&clt=821&_gst=1055&_gbt=1161&_u=6GBAiEAjR~&jid=&gjid=&cid=1135711109.1553523334&tid=UA-24152976-22&_gid=2031189717.1553523334&cd2=Health&cd11=us-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug&cd4=Article%20-%20News&cd8=0&cd10=False&cd9=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG&cd19=Page%20Load&cd7=Desktop&cd14=INKCN1R02DG&cd6=IN&cd5=Article&cd17=Reuters%20Editorial&cd3=Sports%20%20-%20Health&cd1=Sports%20&cd13=111&cd18=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug&z=721515197
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:824::200e , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 08 Mar 2019 22:54:17 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
1437677
content-type
image/gif
status
200
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
cache-control
no-cache, no-store, must-revalidate
access-control-allow-origin
*
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
i
api.segment.io/v1/
21 B
140 B
XHR
General
Full URL
https://api.segment.io/v1/i
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.69.157.105 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-69-157-105.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
text/plain

Response headers

status
200
date
Mon, 25 Mar 2019 14:15:34 GMT
access-control-allow-origin
https://in.reuters.com
content-length
21
vary
Origin
content-type
application/json
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=6035630&ns__t=1553523334337&ns_c=UTF-8&cv=3.1e&c8=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug%20%7C%20Reuters&c7=htt...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1553523334337&ns_c=UTF-8&cv=3.1e&c8=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug%20%7C%20Reuters&c7=ht...
0
248 B
Image
General
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1553523334337&ns_c=UTF-8&cv=3.1e&c8=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug%20%7C%20Reuters&c7=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&c9=
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.121.166.105 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-121-166-105.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:34 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1553523334337&ns_c=UTF-8&cv=3.1e&c8=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug%20%7C%20Reuters&c7=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&c9=
Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:34 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
ping
ping.chartbeat.net/
43 B
168 B
Image
General
Full URL
https://ping.chartbeat.net/ping?h=in.reuters.com&p=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab-idINKCN1R02DG&u=y8sn8DmpYjIDGSOa3&d=in.reuters.com&g=52639&g0=Health&g1=Reuters%20Editorial&g4=Article&n=1&f=00001&c=0&x=0&m=0&y=6967&o=1600&w=1200&j=45&R=1&W=0&I=0&E=0&e=0&r=&b=1520&_c=Feed%3A%20reuters%2FINhealth%20(News%20%2F%20IN%20%2F%20Health)&_m=feed&_x=feedburner&t=CU6H8ECn55slB2W7BYBOEIZdBJ4NqJ&V=112&i=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug%20%7C%20Reuters&tz=0&sn=1&sv=BSBjeMCxh2-ACKpazeBTLwH8BIGHbl&sd=1&im=06679cf0&_
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.200.61.129 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-200-61-129.compute-1.amazonaws.com
Software
/
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Mon, 25 Mar 2019 14:15:34 GMT
cache-control
no-cache, no-store, must-revalidate
expires
0
content-length
43
content-type
image/gif
ta-pagesocial-sdk.js
tru.am/scripts/
34 KB
12 KB
Script
General
Full URL
https://tru.am/scripts/ta-pagesocial-sdk.js
Requested by
Host: tru.am
URL: https://tru.am/scripts/custom/reuters.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a322 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
fb9007c254c493be4a067de535b19a30f5e5aef3d5b19f58b1c72d2c65a04f79

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:34 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Mon, 21 May 2018 10:49:23 GMT
server
cloudflare
etag
W/"8761e04182a1c11ff30f706f8052c8d6"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=86400
cf-ray
4bd17f67c8d6980a-FRA
expires
Tue, 26 Mar 2019 14:15:34 GMT
gdprnotice.js
c.betrad.com/pub/
34 KB
10 KB
Script
General
Full URL
https://c.betrad.com/pub/gdprnotice.js
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.201.172.224 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-201-172-224.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
c3cdd90682c611b09c2e5c4ce771243414465b8fc63fb17ab111ab018f4c6708

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:34 GMT
Content-Encoding
gzip
Last-Modified
Wed, 31 Jan 2018 16:54:34 GMT
Server
Apache
ETag
"97cdaa4b0481a4cf2212765390f26a04:1517417674"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=86400
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
10251
beacon
beacon.tru.am/
17 B
388 B
Fetch
General
Full URL
https://beacon.tru.am/beacon
Requested by
Host: tru.am
URL: https://tru.am/scripts/ta-pagesocial-sdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a222 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
27676ea482895bdddd3f3796f430a812e11364efc224227c86973a52398966c2

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
application/x-www-form-urlencoded;charset=UTF-8

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:34 GMT
content-encoding
br
server
cloudflare
status
200
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://in.reuters.com
cache-control
no-cache, private, max-age=0
cf-ray
4bd17f687f27c300-FRA
expires
Thu, 01 Jan 1970 00:00:00 UTC
15885.js
c.evidon.com/pub/c/1237/
3 KB
1 KB
Script
General
Full URL
https://c.evidon.com/pub/c/1237/15885.js
Requested by
Host: c.betrad.com
URL: https://c.betrad.com/pub/gdprnotice.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
104.107.252.81 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-107-252-81.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
d80e45b8ebadb6ecb006c36d672912bd30fb3416aaa59d925f4dbfd529439446

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:34 GMT
content-encoding
gzip
status
200
access-control-max-age
86400
content-length
952
last-modified
Wed, 05 Jul 2017 14:48:41 GMT
server
Apache
etag
"5a01bcb93dfe8ba589316635286c52d5:1499266121"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=86400
access-control-allow-credentials
false
accept-ranges
bytes
access-control-allow-headers
*
/
www.facebook.com/tr/ Frame D238
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
3271
pragma
no-cache
cache-control
no-cache
origin
https://in.reuters.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
accept-encoding
gzip, deflate, br
Origin
https://in.reuters.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://in.reuters.com
access-control-allow-credentials
true
content-length
0
server
proxygen-bolt
date
Mon, 25 Mar 2019 14:15:34 GMT
p.gif
l.betrad.com/pub/
0
120 B
Image
General
Full URL
https://l.betrad.com/pub/p.gif?pid=15885&ocid=1237&ii=1&nt=2&d=1&mb=0&r=0.9075602843080277
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
107.21.45.69 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-107-21-45-69.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
204
date
Mon, 25 Mar 2019 14:15:34 GMT
content-encoding
gzip
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
x-powered-by
Express
vary
Accept-Encoding
bidexchange.js
contextual.media.net/
333 KB
96 KB
Script
General
Full URL
https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=in.reuters.com&version=4.1&https=1
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
ecf0ed9914d45ab52dbf03fed3609c91e60d0478dac715167a37b21802d4558b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:35 GMT
Content-Encoding
gzip
Server
Apache
Vary
Accept-Encoding
X-MNET-H
E
Content-Type
text/javascript; charset=utf-8
Cache-Control
max-age=1800
Transfer-Encoding
chunked
Connection
keep-alive, Transfer-Encoding
Expires
Mon, 25 Mar 2019 14:45:35 GMT
iasPET.1.js
cdn.adsafeprotected.com/
10 KB
4 KB
Script
General
Full URL
https://cdn.adsafeprotected.com/iasPET.1.js
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=in.reuters.com&version=4.1&https=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.126 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-126.fra6.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
0af0d03a424f77c527ea1c62ea1518db6cfc115c18fa1aad533144badb68db70

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Sun, 24 Mar 2019 19:31:13 GMT
Content-Encoding
gzip
Last-Modified
Tue, 05 Mar 2019 18:41:46 GMT
Server
AmazonS3
Age
139832
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
application/javascript
Via
1.1 1b412557b82dda96e078541f9ee8dfb2.cloudfront.net (CloudFront)
Transfer-Encoding
chunked
Connection
keep-alive
X-Amz-Cf-Id
_vRsxinSHQLkX0rZjhQquuPX2YLE7BmIH2UoI7onHZ8wVG8bXsftWA==
Cookie set checksync.php
contextual.media.net/ Frame E599
0
0
Document
General
Full URL
https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C109%2C113%2C118%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C3004&rtime=73&https=1&gdpr=1&gdprconsent=0
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=in.reuters.com&version=4.1&https=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Host
contextual.media.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Accept-Encoding
gzip, deflate, br
Cookie
gdpr_status=1
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

Server
Apache
Content-Type
text/html; charset=UTF-8
Set-Cookie
gdpr_status=1; Expires=Thu, 26 Sep 2019 14:15:36 GMT; domain=.media.net; Path=/;
X-MNET-HL2
E
Vary
Accept-Encoding
Content-Encoding
gzip
Cache-Control
max-age=604800
Expires
Mon, 01 Apr 2019 14:15:36 GMT
Date
Mon, 25 Mar 2019 14:15:36 GMT
Content-Length
4485
Connection
keep-alive
hmmaster.js
contextual.media.net/
19 KB
7 KB
Script
General
Full URL
https://contextual.media.net/hmmaster.js?cid=8CUF1VN4G&p=hb&v=3.1.3&https=1&adt=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=in.reuters.com&version=4.1&https=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cc11628ee489395e239bc94ea6dc8d5b1908e6b957cc5c9a9e05a64793f77e28

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:36 GMT
Content-Encoding
gzip
Server
Apache
Vary
Accept-Encoding
X-MNET-H
E
Content-Type
text/html; charset=UTF-8
Cache-Control
max-age=1800
Connection
keep-alive
Content-Length
7348
Expires
Mon, 25 Mar 2019 14:45:36 GMT
px.gif
contextual.media.net/
43 B
324 B
Image
General
Full URL
https://contextual.media.net/px.gif?&ch=1&vn=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
8ac1703c1c34b2be426deda409d39258f82fae17f13e645f377f337a954aedde

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:36 GMT
Last-Modified
Wed, 19 Jul 2017 10:11:12 GMT
Server
Apache
Content-Type
image/gif
Cache-Control
max-age=1209600
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 08 Apr 2019 14:15:36 GMT
px.gif
s.mnet-ad.net/
43 B
356 B
Image
General
Full URL
https://s.mnet-ad.net/px.gif?&ch=2&vn=1
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
66.81.204.228 Road Town, Virgin Islands (British), ASN40034 (CONFLUENCE-NETWORK-INC - Confluence Networks Inc, VG),
Reverse DNS
o1-66-81-204-228.static.o1.com
Software
Apache /
Resource Hash
8ac1703c1c34b2be426deda409d39258f82fae17f13e645f377f337a954aedde

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:36 GMT
Last-Modified
Wed, 19 Jul 2017 10:11:12 GMT
Server
Apache
Content-Type
image/gif
Cache-Control
max-age=1209600
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=2, max=121
Content-Length
43
Expires
Mon, 08 Apr 2019 14:15:36 GMT
rtbsspub
cdneast-xch.media.net/AdExchange/
11 KB
1 KB
EventSource
General
Full URL
https://cdneast-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&ptrid=8PRL4E7N3&requestString=665471966*23%7C970x250~728x90%7C8CUF1VN4G%7C14313035~14313035%7C1.11%40665471966*29%7C728x90~970x250%7C11384%7C48618_266220_2~48618_266220_57%7C1%40665471966*33%7C970x250~728x90%7C8CUF1VN4G%7C14126315~14126315%7C1.23%40665471966*38%7C970x250~728x90%7C8CUF1VN4G%7C665471966_8CUF1VN4G~665471966_8CUF1VN4G%7C1.18%40665471966*51%7C970x250~728x90%7C973973%7C14162996~14162996%7C1.37%40665471966*59%7C970x250~728x90%7C8CUF1VN4G%7C_112891~_112891%7C1.18%40665471966*82%7C728x90~970x250%7C8CUF1VN4G%7C665471966_8CUF1VN4G~665471966_8CUF1VN4G%7C1.18%40665471966*97%7C728x90~970x250%7C8CUF1VN4G%7C665471966_8CUF1VN4G~665471966_8CUF1VN4G%7C1.18%40867385289*23%7C300x250~300x600%7C8CUF1VN4G%7C14313035~14313035%7C1.11%40867385289*29%7C300x600~300x250%7C11384%7C48618_266220_10~48618_266220_15%7C1%40867385289*33%7C300x600~300x250%7C8CUF1VN4G%7C14126316~14126316%7C1.23%40867385289*38%7C300x600~300x250%7C8CUF1VN4G%7C867385289_8CUF1VN4G~867385289_8CUF1VN4G%7C1.18%40867385289*51%7C300x600~300x250%7C973973%7C14162997~14162997%7C1.37%40867385289*59%7C300x600~300x250%7C8CUF1VN4G%7C_112891~_112891%7C1.18%40867385289*82%7C300x250~300x600%7C8CUF1VN4G%7C867385289_8CUF1VN4G~867385289_8CUF1VN4G%7C1.18%40867385289*97%7C300x250~300x600%7C8CUF1VN4G%7C867385289_8CUF1VN4G~867385289_8CUF1VN4G%7C1.18&crid=665471966%2C867385289&sd=1&requrl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner&bl=1&rt=5&dn=https://in.reuters.com&https=1&act=headerBid&prvReqId=124975829592397111553523335923&erTr=0&hlt=1&ugd=4&tr=0.9764585812516446&ndec=1&scrsize=1600x1200&taginfo=%7B%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A6967%7D&sid=8973&scc=1&nv=1&tmt=200&section=in.reuters%2Flife%2Fhealth%2Farticle&prid=8PRVCXX19&cc=DE&rc=HE&ct=FRANKFURT
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
0d86f42c59e0d5c9cfa54d68252681e3fc67fe6b12250e9353ffb75e7b0ebf8c

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Origin
https://in.reuters.com
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:36 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://in.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*
expires
Mon, 25 Mar 2019 14:15:36 GMT
Cookie set checksync.php
contextual.media.net/ Frame 05D7
0
0
Document
General
Full URL
https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C109%2C113%2C118%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C3004&rtime=102&https=1&gdpr=1&gdprconsent=0
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=in.reuters.com&version=4.1&https=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Host
contextual.media.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Accept-Encoding
gzip, deflate, br
Cookie
gdpr_status=1
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

Server
Apache
Content-Type
text/html; charset=UTF-8
Set-Cookie
gdpr_status=1; Expires=Thu, 26 Sep 2019 14:15:36 GMT; domain=.media.net; Path=/;
X-MNET-HL2
E
Vary
Accept-Encoding
Content-Encoding
gzip
Cache-Control
max-age=604800
Expires
Mon, 01 Apr 2019 14:15:36 GMT
Date
Mon, 25 Mar 2019 14:15:36 GMT
Content-Length
4485
Connection
keep-alive
gpt.js
www.googletagservices.com/tag/js/
32 KB
11 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=in.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:81f::2002 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
c9f8bb83cd34c1d421bfa0e597741ceeefe2c0ca535b556af24408a8de707b86
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"116 / 46 of 1000 / last-modified: 1553297005"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
10783
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:36 GMT
integrator.js
adservice.google.de/adsid/
109 B
171 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=in.reuters.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:806::2002 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-type
application/javascript; charset=UTF-8
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
104
x-xss-protection
1; mode=block
integrator.js
adservice.google.com/adsid/
109 B
171 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=in.reuters.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:809::2002 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-type
application/javascript; charset=UTF-8
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
104
x-xss-protection
1; mode=block
pubads_impl_319.js
securepubads.g.doubleclick.net/gpt/
160 KB
57 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_319.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
172.217.16.130 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s46-in-f2.1e100.net
Software
sffe /
Resource Hash
cf65e308f1c461e06038b45d5bfa27689e22241f6b673b7d540d35cdd0ca4c32
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 07 Mar 2019 16:13:36 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
58724
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:36 GMT
pub
pixel.adsafeprotected.com/services/
324 B
708 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_mpu_1908057_INKCN1R02DG,s:300.250,p:/4735792/in.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=b7c279e9-46ce-054d-6c10-f4bd237414c3
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
4ac25d017a457385759e549fe1d85a71eb47691f8bd3b61094f100a303dc820e

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

Date
Mon, 25 Mar 2019 14:15:36 GMT
X-Server-Name
app39ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://in.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
311 B
695 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:canvas_leaderboard_8232955139649689_INKCN1R02DG,s:728.90,p:/4735792/in.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=b7c279e9-46ce-054d-6c10-f4bd237414c3
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
88a6166fa6dd4c7268e1eefb1e70b390133fd2940d5f6445cc0c0c937b08b787

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

Date
Mon, 25 Mar 2019 14:15:36 GMT
X-Server-Name
app12ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://in.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
tc.js
contextual.media.net/
14 KB
8 KB
Script
General
Full URL
https://contextual.media.net/tc.js?&tpkey=TF6129H&size=2x2&v=12&nat=1&https=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=in.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
60a628485980712dc7dd6ac839c2e328c04e945b3e675b510827a632cdb88af2

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:36 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=172800
content-length
7926
expires
Wed, 27 Mar 2019 14:15:36 GMT
pub
pixel.adsafeprotected.com/services/
316 B
700 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_canvas_653991_INKCN1R02DG,s:2.2,p:/4735792/in.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=b7c279e9-46ce-054d-6c10-f4bd237414c3
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
083e9afdbf6c8112bd0514631879b933cdd193c56b738226aec672dec09def8d

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

Date
Mon, 25 Mar 2019 14:15:36 GMT
X-Server-Name
app41ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://in.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
312 B
696 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_native_3421327_INKCN1R02DG,s:2.2,p:/4735792/in.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=b7c279e9-46ce-054d-6c10-f4bd237414c3
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
1f0796eb2b7826dbb3bec622b30eba32e290381144a1b96b08546575f5777e39

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

Date
Mon, 25 Mar 2019 14:15:36 GMT
X-Server-Name
app36ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://in.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
314 B
698 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_connatix_9446036_INKCN1R02DG,s:1100.420,p:/4735792/in.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=b7c279e9-46ce-054d-6c10-f4bd237414c3
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
ca551709a399f6d3aa0aa1c8a3ad07dc8be5ea1236c110902b3aa812bbcbd6a5

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

Date
Mon, 25 Mar 2019 14:15:36 GMT
X-Server-Name
app16ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://in.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
313 B
697 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_bizdev_article_rr2_400784_INKCN1R02DG,s:300.280,p:/4735792/in.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=b7c279e9-46ce-054d-6c10-f4bd237414c3
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
28cb9032373bd7a48fceea492954b473347822ded61a27526cce1ac7d48c8b60

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

Date
Mon, 25 Mar 2019 14:15:36 GMT
X-Server-Name
app33ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://in.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
rtbsspub
cdneast-xch.media.net/AdExchange/
5 KB
1 KB
EventSource
General
Full URL
https://cdneast-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&ptrid=8PRL4E7N3&requestString=683386856*23%7C300x250%7C8CUF1VN4G%7C14313035%7C1.11%40683386856*29%7C300x250%7C11384%7C48618_266220_15%7C1%40683386856*33%7C300x250%7C8CUF1VN4G%7C14126329%7C1.23%40683386856*38%7C300x250%7C8CUF1VN4G%7C683386856_8CUF1VN4G%7C1.18%40683386856*51%7C300x250%7C973973%7C14163003%7C1.37%40683386856*59%7C300x250%7C8CUF1VN4G%7C_112891%7C1.18%40683386856*82%7C300x250%7C8CUF1VN4G%7C683386856_8CUF1VN4G%7C1.18%40683386856*97%7C300x250%7C8CUF1VN4G%7C683386856_8CUF1VN4G%7C1.18&crid=683386856&sd=1&requrl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner&bl=1&rt=5&dn=https://in.reuters.com&https=1&act=headerBid&prvReqId=310968011632489091553523336289&erTr=0&hlt=1&ugd=4&tr=0.6446567099286187&ndec=1&scrsize=1600x1200&taginfo=%7B%22683386856%22%3A%7B%22xps%22%3A1290%2C%22yps%22%3A403%7D%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A6967%7D&sid=8973&scc=1&nv=1&tmt=200&section=in.reuters%2Flife%2Fhealth%2Farticle&prid=8PRVCXX19&cc=DE&rc=HE&ct=FRANKFURT
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
efa53018168de90dbab20ff40675e17e7d847337627caf059c4dbb29d4a8a2be

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Origin
https://in.reuters.com
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:36 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://in.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*
expires
Mon, 25 Mar 2019 14:15:36 GMT
rtbsspub
cdneast-xch.media.net/AdExchange/
6 KB
1 KB
EventSource
General
Full URL
https://cdneast-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&ptrid=8PRL4E7N3&requestString=516837068*23%7C970x250~728x90%7C8CUF1VN4G%7C14313035~14313035%7C1.11%40516837068*29%7C970x250~728x90%7C11384%7C48618_266220_57~48618_266220_2%7C1%40516837068*33%7C970x250~728x90%7C8CUF1VN4G%7C14126346~14126346%7C1.23%40516837068*38%7C970x250~728x90%7C8CUF1VN4G%7C516837068_8CUF1VN4G~516837068_8CUF1VN4G%7C1.18%40516837068*51%7C728x90~970x250%7C973973%7C14163002~14163002%7C1.37%40516837068*59%7C970x250~728x90%7C8CUF1VN4G%7C_112891~_112891%7C1.18%40516837068*82%7C728x90~970x250%7C8CUF1VN4G%7C516837068_8CUF1VN4G~516837068_8CUF1VN4G%7C1.18%40516837068*97%7C970x250~728x90%7C8CUF1VN4G%7C516837068_8CUF1VN4G~516837068_8CUF1VN4G%7C1.18&crid=516837068&sd=1&requrl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner&bl=1&rt=5&dn=https://in.reuters.com&https=1&act=headerBid&prvReqId=419324208231482601553523336298&erTr=0&hlt=1&ugd=4&tr=0.297889062579642&ndec=1&scrsize=1600x1200&taginfo=%7B%22516837068%22%3A%7B%22xps%22%3A0%2C%22yps%22%3A0%7D%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A6967%7D&sid=8973&scc=1&nv=1&tmt=200&section=in.reuters%2Flife%2Fhealth%2Farticle&prid=8PRVCXX19&cc=DE&rc=HE&ct=FRANKFURT
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
68517d453d51f6476d856ef4c46f4152f36566fc724f8bd189027fc82edd0418

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Origin
https://in.reuters.com
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:36 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://in.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*
expires
Mon, 25 Mar 2019 14:15:36 GMT
rtbsspub
cdneast-xch.media.net/AdExchange/
1 KB
939 B
EventSource
General
Full URL
https://cdneast-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&ptrid=8PRL4E7N3&requestString=888243732*141%7C1x1_TF6129H_1%7C8CUF1VN4G%7C888243732_8CUF1VN4G%7C1.11%40888243732*3004%7C1x1_TF6129H_1%7C8CUF1VN4G%7C888243732_8CUF1VN4G%7C1.11&crid=888243732&sd=1&requrl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner&bl=1&rt=5&dn=https://in.reuters.com&https=1&act=headerBid&prvReqId=196076774847238581553523336303&erTr=0&hlt=1&ugd=4&tr=0.9299879685137773&ndec=1&scrsize=1600x1200&taginfo=%7B%22888243732%22%3A%7B%22xps%22%3A634.5%2C%22yps%22%3A1230%7D%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A6967%7D&sid=8973&scc=1&nv=1&tmt=200&section=in.reuters%2Flife%2Fhealth%2Farticle&at=3&prid=8PRVCXX19&cc=DE&rc=HE&ct=FRANKFURT
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
4bb59a50dcc6257d0f5d33a5a7331b5013d8a086eaf8077406c3aa8163501f68

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Origin
https://in.reuters.com
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:36 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://in.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*
expires
Mon, 25 Mar 2019 14:15:36 GMT
rtbsspub
cdneast-xch.media.net/AdExchange/
1 KB
936 B
EventSource
General
Full URL
https://cdneast-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&ptrid=8PRL4E7N3&requestString=243346798*141%7C1x1_TF6129H_1%7C8CUF1VN4G%7C243346798_8CUF1VN4G%7C1.11%40243346798*3004%7C1x1_TF6129H_1%7C8CUF1VN4G%7C243346798_8CUF1VN4G%7C1.11&crid=243346798&sd=1&requrl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner&bl=1&rt=5&dn=https://in.reuters.com&https=1&act=headerBid&prvReqId=346712667781963201553523336306&erTr=0&hlt=1&ugd=4&tr=0.2497896428370543&ndec=1&scrsize=1600x1200&taginfo=%7B%22243346798%22%3A%7B%22xps%22%3A634.5%2C%22yps%22%3A1337%7D%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A6967%7D&sid=8973&scc=1&nv=1&tmt=200&section=in.reuters%2Flife%2Fhealth%2Farticle&at=3&prid=8PRVCXX19&cc=DE&rc=HE&ct=FRANKFURT
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
2f8f81232d0a24a74e81a5c717efa4144cfeae6a4b8eacbebe95a7e3d60191e1

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Origin
https://in.reuters.com
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:36 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://in.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*
expires
Mon, 25 Mar 2019 14:15:36 GMT
ads
securepubads.g.doubleclick.net/gampad/
73 KB
15 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1493001722791933&correlator=1690453550855545&output=json_html&callback=googletag.impl.pubads.callbackProxy1&impl=fifs&adsid=NT&json_a=1&eid=21061864%2C21063066&vrg=319&npa=1&guci=1.2.0.0.2.1.0.0&plat=1%3A32776%2C2%3A32776%2C8%3A32776&sc=1&sfv=1-0-32&iu_parts=4735792%2Cin.reuters%2Clife%2Chealth%2Carticle&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=300x250%7C300x600%7C1x1%2C728x90%7C970x250%7C970x90%7C1100x100%7C1x1%2C320x50%7C2x2%7C1x1%7C1100x375%2C320x50%7C2x2%7C1x1%7C1100x375%7C3020x375%2C320x50%7C1100x420%7C1100x400%2C300x280&fluid=0%2C0%2Cheight%2Cheight%2Cheight%2C0&prev_scp=type%3Dmpu%26div_id%3D1908057%26pixel_distance%3D400%26articleID%3DINKCN1R02DG%26storychannel%3Dhealth%253BeverythingNews%26story%3D0%26template%3Darticle%26p_count%3D5%26asset%3Dimage%26id%3D75a2b1b2-4f08-11e9-9669-70106fb72ed4%26vw%3D40%2C50%2C60%2C70%2C80%26grm%3D40%2C50%2C60%2C70%2C80%26pub%3D40%2C50%2C60%2C70%2C80%26mnetDNB%3D1%26mnetPageID%3D3%26mnetCV%3D1%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dleaderboard%26div_id%3D8232955139649689%26pixel_distance%3D400%26articleID%3DINKCN1R02DG%26storychannel%3Dhealth%253BeverythingNews%26story%3D0%26template%3Darticle%26p_count%3D5%26asset%3Dimage%26id%3D75a39ccc-4f08-11e9-a64b-002590882ece%26vw%3D40%2C50%2C60%26grm%3D40%2C50%2C60%26pub%3D40%2C50%2C60%26mnetDNB%3D1%26mnetPageID%3D4%26mnetCV%3D1%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dcanvas%26div_id%3D653991%26pixel_distance%3D400%26articleID%3DINKCN1R02DG%26storychannel%3Dhealth%253BeverythingNews%26story%3D0%26template%3Darticle%26p_count%3D5%26asset%3Dimage%26id%3D75a375b2-4f08-11e9-9d27-70106fb72a54%26vw%3D40%2C50%2C60%2C70%26grm%3D40%2C50%2C60%2C70%2C80%26pub%3D40%2C50%2C60%2C70%26mnetDNB%3D1%26mnetPageID%3D5%26mnetCV%3D1%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dnative%26div_id%3D3421327%26pixel_distance%3D400%26articleID%3DINKCN1R02DG%26storychannel%3Dhealth%253BeverythingNews%26story%3D0%26template%3Darticle%26p_count%3D5%26asset%3Dimage%26id%3D75a68240-4f08-11e9-a98f-382c4ac630d1%26vw%3D40%2C50%2C60%2C70%26grm%3D40%2C50%2C60%2C70%26pub%3D40%2C50%2C60%2C70%26mnetDNB%3D1%26mnetPageID%3D6%26mnetCV%3D1%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dconnatix%26div_id%3D9446036%26pixel_distance%3D20000%26articleID%3DINKCN1R02DG%26storychannel%3Dhealth%253BeverythingNews%26story%3D0%26template%3Darticle%26p_count%3D5%26asset%3Dimage%26id%3D75a808d3-4f08-11e9-a0ff-002590882ecc%26vw%3D40%2C50%2C60%2C70%26grm%3D40%2C50%2C60%2C70%26pub%3D40%2C50%2C60%2C70%7Ctype%3Dbizdev_article_rr2%26div_id%3D400784%26pixel_distance%3D20000%26articleID%3DINKCN1R02DG%26storychannel%3Dhealth%253BeverythingNews%26story%3D0%26template%3Darticle%26p_count%3D5%26asset%3Dimage%26id%3D75a45f3d-4f08-11e9-9104-382c4ac630ed%26vw%3D40%2C50%2C60%26grm%3D40%2C50%2C60%26pub%3D40%2C50%2C60%2C70&cust_params=bidxc%3D1%26ntvPlacement%3D1093478%26admant%3Dother%26fr%3Dtrue%26adt%3DveryLow%26alc%3DveryLow%26dlm%3DveryLow%26drg%3DveryLow%26hat%3DveryLow%26off%3DveryLow%26vio%3Dlow&cookie_enabled=1&bc=15&abxe=1&lmt=1553523336&dt=1553523336616&dlt=1553523332982&idt=3281&frm=20&biw=1585&bih=1200&oid=3&adxs=0%2C0%2C0%2C0%2C0%2C0&adys=0%2C0%2C0%2C0%2C0%2C0&adks=3448428218%2C2788090944%2C904839814%2C272193186%2C326664031%2C2892408687&ucis=1%7C2%7C3%7C4%7C5%7C6&ifi=1&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&dssz=64&icsg=2818572288&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x-1%7C0x0%7C754x0%7C754x0%7C754x0%7C300x-1&msz=300x-1%7C0x0%7C2x2%7C2x2%7C1100x420%7C300x-1&blev=1&bisch=1&ga_vid=2047291356.1553523337&ga_sid=1553523337&ga_hid=1334740966&fws=128%2C128%2C128%2C128%2C128%2C128
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
172.217.16.130 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s46-in-f2.1e100.net
Software
cafe /
Resource Hash
9776fb4402707939346bf12db9d01cd2ad0fc9cdb981ef59d83533993e179995
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
14578
x-xss-protection
1; mode=block
google-lineitem-id
4974347015,4995561982,4741317042,-2,-2,139199112
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138263065185,138264852094,138239093677,-2,-2,138204787707
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
https://in.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_319.js
securepubads.g.doubleclick.net/gpt/
67 KB
25 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
172.217.16.130 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s46-in-f2.1e100.net
Software
sffe /
Resource Hash
c11b9a046106f278a5fb5411e95c1ba5d6f06daf9e4bfa98da51c523e4157388
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 07 Mar 2019 16:13:36 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
25393
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:36 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-32/html/
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-32/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:820::2001 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Purpose
prefetch
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

log
hbx-lg.media.net/
35 B
185 B
Image
General
Full URL
https://hbx-lg.media.net/log?logid=aplog&pid=8PRL4E7N3&itype=HB&dn=in.reuters.com&cid=8CUF1VN4G&svr=2019032512_577&servname=c8-web-20&gdpr=1&csex=0&csstr=&ugd=4&vid=00001553523335963031123517443224&vsid=&sd=1&gtd=100&inid=0&gfd=&cc=DE&sc=HE&ct=FRANKFURT&abte=CONTROL&adbd=0&amp=0&version=4.1&sB=true&cors=true&disB=false&ice=0&vw=1585&vh=1200&pht=6967&cl=&__rk=0&app=0&rtype=&pvid=0&prvAccId=&prvApiId=&exid=&pcId=0000EEA&adj0=0&adj1=0&adj2=0&adj3=0&prvReqId=&crid=683386856&g=0&size=300x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0&cbdp=0&ckfl=&cs=&mnet_ckfl=&cat=&attr=&advId=&advNm=&advUrl=&dfpBd=0&nms=1&di=&dt=&epc=&ogbdp=0&s=1&snm=success&dbf=1&bdata=&cmpid=&bId=&pcrid=&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=0&exp=&bfs=0&seat=&nbr=&ba=0&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=&ybnca_bbid=&acid=222509044919402561553523336287&act=headerBid&dtfdl=-1&dspltime=287&ttfd=717&rtime=&dtc=&rtbsv2=&apid=&wsip=&ltime=&abs=&top=403&btm=403&lft=1140&rght=1440&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint=&spProfile=&spSource=&spIvt=&spID=&refVisId=&osnbr=&brf=0&iwb=0&toconsider=0&actltime=212&acsn=1&dfpDiv=dpslot_mpu_1908057_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=%7C&lper=10&pvid=59&prvAccId=112891&prvApiId=&exid=8&pcId=0000EEA&adj0=0&adj1=0&adj2=15&adj3=0&prvReqId=310968011632489091553523336289&crid=683386856&g=0&size=300x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=1&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=1&di=&dt=O&epc=&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=683386856&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.18&exp=sfl%3Dfalse%7Cmd_rq%3D1%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dfalse%7Cfl_rl%3D1%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=5&ba=169&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=222509044919402561553523336287&act=headerBid&dtfdl=-1&dspltime=287&ttfd=717&rtime=&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553518277c5-2x1061036&ltime=140&abs=0&top=403&btm=403&lft=1140&rght=1440&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=0&mx_GCID=0&mx_bsProfile=0&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=0&actltime=212&acsn=1&dfpDiv=dpslot_mpu_1908057_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=38&prvAccId=683386856&prvApiId=8CUF1VN4G&exid=25&pcId=0000EEA&adj0=0&adj1=0&adj2=15&adj3=0&prvReqId=310968011632489091553523336289&crid=683386856&g=0&size=300x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=1&di=&dt=O&epc=683386856&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=683386856&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.18&exp=sfl%3Dfalse%7Cmd_rq%3D1%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dfalse%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=5&ba=168&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=222509044919402561553523336287&act=headerBid&dtfdl=-1&dspltime=287&ttfd=717&rtime=&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553518277c5-2x1061036&ltime=141&abs=0&top=403&btm=403&lft=1140&rght=1440&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=0&mx_GCID=0&mx_bsProfile=0&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=0&actltime=212&acsn=1&dfpDiv=dpslot_mpu_1908057_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=97&prvAccId=683386856&prvApiId=8CUF1VN4G&exid=9&pcId=0000EEA&adj0=0&adj1=0&adj2=15&adj3=0&prvReqId=310968011632489091553523336289&crid=683386856&g=0&size=300x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=1&di=&dt=O&epc=683386856&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=683386856&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.18&exp=sfl%3Dfalse%7Cmd_rq%3D1%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dfalse%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=5&ba=168&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=222509044919402561553523336287&act=headerBid&dtfdl=-1&dspltime=287&ttfd=717&rtime=&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553518277c5-2x1061036&ltime=141&abs=0&top=403&btm=403&lft=1140&rght=1440&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=0&mx_GCID=0&mx_bsProfile=0&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=0&actltime=212&acsn=1&dfpDiv=dpslot_mpu_1908057_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=82&prvAccId=683386856&prvApiId=8CUF1VN4G&exid=35&pcId=0000EEA&adj0=0&adj1=0&adj2=15&adj3=0&prvReqId=310968011632489091553523336289&crid=683386856&g=0&size=300x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=1&di=&dt=O&epc=683386856&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=683386856&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.18&exp=sfl%3Dfalse%7Cmd_rq%3D1%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dfalse%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=3&ba=155&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=222509044919402561553523336287&act=headerBid&dtfdl=-1&dspltime=287&ttfd=717&rtime=19&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553518277c5-2x1061036&ltime=155&abs=0&top=403&btm=403&lft=1140&rght=1440&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=3&mx_GCID=0&mx_bsProfile=4&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=1&actltime=212&acsn=1&dfpDiv=dpslot_mpu_1908057_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=51&prvAccId=14163003&prvApiId=973973&exid=4&pcId=0000EEA&adj0=10&adj1=10&adj2=10&adj3=0&prvReqId=310968011632489091553523336289&crid=683386856&g=0&size=300x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=1&di=&dt=O&epc=14163003&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=683386856&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.37&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dfalse%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=3&ba=148&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=222509044919402561553523336287&act=headerBid&dtfdl=-1&dspltime=287&ttfd=717&rtime=25&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553518277c5-2x1061036&ltime=162&abs=0&top=403&btm=403&lft=1140&rght=1440&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=3&mx_GCID=0&mx_bsProfile=4&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=1&actltime=212&acsn=1&dfpDiv=dpslot_mpu_1908057_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&requrl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner&kwrf=&epurl=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache Tomcat /
Resource Hash
796c46ec10bc9105545f6f90d51593921b69956bd9087eb72bee83f40ad86f90

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:36 GMT
server
Apache Tomcat
access-control-allow-origin
*
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
content-length
35
expires
Mon, 25 Mar 2019 14:15:36 GMT
log
hbx-lg.media.net/
35 B
185 B
Image
General
Full URL
https://hbx-lg.media.net/log?logid=aplog&pid=8PRL4E7N3&itype=HB&dn=in.reuters.com&cid=8CUF1VN4G&svr=2019032512_577&servname=c8-web-20&gdpr=1&csex=0&csstr=&ugd=4&vid=00001553523335963031123517443224&vsid=&sd=1&gtd=100&inid=0&gfd=&cc=DE&sc=HE&ct=FRANKFURT&abte=CONTROL&adbd=0&amp=0&version=4.1&sB=true&cors=true&disB=false&ice=0&vw=1585&vh=1200&pht=6967&cl=&__rk=0&app=0&rtype=&pvid=33&prvAccId=14126329&prvApiId=&exid=4&pcId=0000EEA&adj0=10&adj1=0&adj2=10&adj3=0&prvReqId=310968011632489091553523336289&crid=683386856&g=0&size=300x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=1&di=&dt=O&epc=14126329&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=683386856&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.23&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dfalse%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=3&ba=126&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=222509044919402561553523336287&act=headerBid&dtfdl=-1&dspltime=287&ttfd=717&rtime=48&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553518277c5-2x1061036&ltime=184&abs=0&top=403&btm=403&lft=1140&rght=1440&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=4&mx_GCID=0&mx_bsProfile=2&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=1&actltime=212&acsn=1&dfpDiv=dpslot_mpu_1908057_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=29&prvAccId=&prvApiId=11384&exid=24&pcId=0000EEA&adj0=0&adj1=0&adj2=0&adj3=0&prvReqId=310968011632489091553523336289&crid=683386856&g=0&size=300x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=1&di=&dt=O&epc=48618&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=683386856&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.00&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dfalse%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=3&ba=156&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=222509044919402561553523336287&act=headerBid&dtfdl=-1&dspltime=287&ttfd=717&rtime=15&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553518277c5-2x1061036&ltime=154&abs=0&top=403&btm=403&lft=1140&rght=1440&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=0&mx_GCID=0&mx_bsProfile=1&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=1&actltime=212&acsn=1&dfpDiv=dpslot_mpu_1908057_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=23&prvAccId=14313035&prvApiId=&exid=4&pcId=0000EEA&adj0=0&adj1=0&adj2=10&adj3=0&prvReqId=310968011632489091553523336289&crid=683386856&g=0&size=300x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=1&di=&dt=O&epc=14313035&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=683386856&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.11&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dfalse%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=3&ba=102&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=222509044919402561553523336287&act=headerBid&dtfdl=-1&dspltime=287&ttfd=717&rtime=75&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553518277c5-2x1061036&ltime=209&abs=0&top=403&btm=403&lft=1140&rght=1440&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=0&mx_GCID=0&mx_bsProfile=1&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=1&actltime=212&acsn=1&dfpDiv=dpslot_mpu_1908057_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=0&prvAccId=&prvApiId=&exid=&pcId=0000EEA&adj0=0&adj1=0&adj2=0&adj3=0&prvReqId=&crid=516837068&g=0&size=728x90&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0&cbdp=0&ckfl=&cs=&mnet_ckfl=&cat=&attr=&advId=&advNm=&advUrl=&dfpBd=0&nms=1&di=&dt=&epc=&ogbdp=0&s=1&snm=success&dbf=1&bdata=&cmpid=&bId=&pcrid=&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=0&exp=&bfs=0&seat=&nbr=&ba=0&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=&ybnca_bbid=&acid=426165120090144771553523336297&act=headerBid&dtfdl=-1&dspltime=291&ttfd=721&rtime=&dtc=&rtbsv2=&apid=&wsip=&ltime=&abs=&top=0&btm=0&lft=0&rght=0&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint=&spProfile=&spSource=&spIvt=&spID=&refVisId=&osnbr=&brf=0&iwb=0&toconsider=0&actltime=299&acsn=1&dfpDiv=canvas_leaderboard_8232955139649689_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=%7C&lper=10&pvid=59&prvAccId=112891&prvApiId=&exid=8&pcId=0000EEA&adj0=0&adj1=0&adj2=15&adj3=0&prvReqId=419324208231482601553523336298&crid=516837068&g=0&size=970x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=1&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=2&di=&dt=O&epc=&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=516837068&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.18&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dtrue%7Cfl_rl%3D1%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=5&ba=171&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=426165120090144771553523336297&act=headerBid&dtfdl=-1&dspltime=291&ttfd=721&rtime=&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553510113c4-2x10614181&ltime=133&abs=0&top=0&btm=0&lft=0&rght=0&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=0&mx_GCID=0&mx_bsProfile=0&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=0&actltime=299&acsn=1&dfpDiv=canvas_leaderboard_8232955139649689_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=38&prvAccId=516837068&prvApiId=8CUF1VN4G&exid=25&pcId=0000EEA&adj0=0&adj1=0&adj2=15&adj3=0&prvReqId=419324208231482601553523336298&crid=516837068&g=0&size=970x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=2&di=&dt=O&epc=516837068&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=516837068&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.18&exp=sfl%3Dfalse%7Cmd_rq%3D1%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dtrue%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=5&ba=170&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=426165120090144771553523336297&act=headerBid&dtfdl=-1&dspltime=291&ttfd=721&rtime=&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553510113c4-2x10614181&ltime=134&abs=0&top=0&btm=0&lft=0&rght=0&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=0&mx_GCID=0&mx_bsProfile=0&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=0&actltime=299&acsn=1&dfpDiv=canvas_leaderboard_8232955139649689_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&requrl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner&kwrf=&epurl=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache Tomcat /
Resource Hash
796c46ec10bc9105545f6f90d51593921b69956bd9087eb72bee83f40ad86f90

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:36 GMT
server
Apache Tomcat
access-control-allow-origin
*
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
content-length
35
expires
Mon, 25 Mar 2019 14:15:36 GMT
log
hbx-lg.media.net/
35 B
185 B
Image
General
Full URL
https://hbx-lg.media.net/log?logid=aplog&pid=8PRL4E7N3&itype=HB&dn=in.reuters.com&cid=8CUF1VN4G&svr=2019032512_577&servname=c8-web-20&gdpr=1&csex=0&csstr=&ugd=4&vid=00001553523335963031123517443224&vsid=&sd=1&gtd=100&inid=0&gfd=&cc=DE&sc=HE&ct=FRANKFURT&abte=CONTROL&adbd=0&amp=0&version=4.1&sB=true&cors=true&disB=false&ice=0&vw=1585&vh=1200&pht=6967&cl=&__rk=0&app=0&rtype=&pvid=97&prvAccId=516837068&prvApiId=8CUF1VN4G&exid=9&pcId=0000EEA&adj0=0&adj1=0&adj2=15&adj3=0&prvReqId=419324208231482601553523336298&crid=516837068&g=0&size=970x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=2&di=&dt=O&epc=516837068&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=516837068&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.18&exp=sfl%3Dfalse%7Cmd_rq%3D1%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dtrue%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=5&ba=171&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=426165120090144771553523336297&act=headerBid&dtfdl=-1&dspltime=291&ttfd=721&rtime=&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553510113c4-2x10614181&ltime=134&abs=0&top=0&btm=0&lft=0&rght=0&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=0&mx_GCID=0&mx_bsProfile=0&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=0&actltime=299&acsn=1&dfpDiv=canvas_leaderboard_8232955139649689_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=33&prvAccId=14126346&prvApiId=&exid=4&pcId=0000EEA&adj0=10&adj1=0&adj2=10&adj3=0&prvReqId=419324208231482601553523336298&crid=516837068&g=0&size=970x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=2&di=&dt=O&epc=14126346&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=516837068&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.23&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dtrue%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=3&ba=163&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=426165120090144771553523336297&act=headerBid&dtfdl=-1&dspltime=291&ttfd=721&rtime=17&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553510113c4-2x10614181&ltime=142&abs=0&top=0&btm=0&lft=0&rght=0&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=4&mx_GCID=0&mx_bsProfile=2&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=1&actltime=299&acsn=1&dfpDiv=canvas_leaderboard_8232955139649689_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=82&prvAccId=516837068&prvApiId=8CUF1VN4G&exid=35&pcId=0000EEA&adj0=0&adj1=0&adj2=15&adj3=0&prvReqId=419324208231482601553523336298&crid=516837068&g=0&size=728x90&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=2&di=&dt=O&epc=516837068&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=516837068&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.18&exp=sfl%3Dfalse%7Cmd_rq%3D1%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dtrue%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=3&ba=156&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=426165120090144771553523336297&act=headerBid&dtfdl=-1&dspltime=291&ttfd=721&rtime=27&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553510113c4-2x10614181&ltime=149&abs=0&top=0&btm=0&lft=0&rght=0&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=4&mx_GCID=0&mx_bsProfile=2&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=1&actltime=299&acsn=1&dfpDiv=canvas_leaderboard_8232955139649689_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=51&prvAccId=14163002&prvApiId=973973&exid=4&pcId=0000EEA&adj0=10&adj1=10&adj2=10&adj3=0&prvReqId=419324208231482601553523336298&crid=516837068&g=0&size=728x90&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=2&di=&dt=O&epc=14163002&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=516837068&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.37&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dtrue%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=3&ba=154&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=426165120090144771553523336297&act=headerBid&dtfdl=-1&dspltime=291&ttfd=721&rtime=29&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553510113c4-2x10614181&ltime=151&abs=0&top=0&btm=0&lft=0&rght=0&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=3&mx_GCID=0&mx_bsProfile=6&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=1&actltime=299&acsn=1&dfpDiv=canvas_leaderboard_8232955139649689_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=29&prvAccId=&prvApiId=11384&exid=24&pcId=0000EEA&adj0=0&adj1=0&adj2=0&adj3=0&prvReqId=419324208231482601553523336298&crid=516837068&g=0&size=970x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=2&di=&dt=O&epc=48618&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=516837068&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.00&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dtrue%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=3&ba=171&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=426165120090144771553523336297&act=headerBid&dtfdl=-1&dspltime=291&ttfd=721&rtime=7&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553510113c4-2x10614181&ltime=135&abs=0&top=0&btm=0&lft=0&rght=0&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=0&mx_GCID=0&mx_bsProfile=1&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=1&actltime=299&acsn=1&dfpDiv=canvas_leaderboard_8232955139649689_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&requrl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner&kwrf=&epurl=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache Tomcat /
Resource Hash
796c46ec10bc9105545f6f90d51593921b69956bd9087eb72bee83f40ad86f90

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:36 GMT
server
Apache Tomcat
access-control-allow-origin
*
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
content-length
35
expires
Mon, 25 Mar 2019 14:15:36 GMT
log
hbx-lg.media.net/
35 B
185 B
Image
General
Full URL
https://hbx-lg.media.net/log?logid=aplog&pid=8PRL4E7N3&itype=HB&dn=in.reuters.com&cid=8CUF1VN4G&svr=2019032512_577&servname=c8-web-20&gdpr=1&csex=0&csstr=&ugd=4&vid=00001553523335963031123517443224&vsid=&sd=1&gtd=100&inid=0&gfd=&cc=DE&sc=HE&ct=FRANKFURT&abte=CONTROL&adbd=0&amp=0&version=4.1&sB=true&cors=true&disB=false&ice=0&vw=1585&vh=1200&pht=6967&cl=&__rk=0&app=0&rtype=&pvid=23&prvAccId=14313035&prvApiId=&exid=4&pcId=0000EEA&adj0=0&adj1=0&adj2=10&adj3=0&prvReqId=419324208231482601553523336298&crid=516837068&g=0&size=970x250&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=1&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=unknown&dfpBd=0.00&nms=2&di=&dt=O&epc=14313035&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=516837068&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.11&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dtrue%7Cfl_rl%3D1%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=3&ba=8&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=426165120090144771553523336297&act=headerBid&dtfdl=-1&dspltime=291&ttfd=721&rtime=175&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553510113c4-2x10614181&ltime=298&abs=0&top=0&btm=0&lft=0&rght=0&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=0&mx_GCID=0&mx_bsProfile=1&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=1&actltime=299&acsn=1&dfpDiv=canvas_leaderboard_8232955139649689_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=0&prvAccId=&prvApiId=&exid=&pcId=0000EEA&adj0=0&adj1=0&adj2=0&adj3=0&prvReqId=&crid=888243732&g=0&size=2x2&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0&cbdp=0&ckfl=&cs=&mnet_ckfl=&cat=&attr=&advId=&advNm=&advUrl=&dfpBd=0&nms=1&di=&dt=&epc=&ogbdp=0&s=1&snm=success&dbf=1&bdata=&cmpid=&bId=&pcrid=&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=0&exp=&bfs=0&seat=&nbr=&ba=0&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=&ybnca_bbid=&acid=228278063015894221553523336301&act=headerBid&dtfdl=-1&dspltime=294&ttfd=724&rtime=&dtc=&rtbsv2=&apid=&wsip=&ltime=&abs=&top=1230&btm=1230&lft=257&rght=1012&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint=&spProfile=&spSource=&spIvt=&spID=&refVisId=&osnbr=&brf=0&iwb=0&toconsider=0&actltime=128&acsn=1&dfpDiv=dpslot_canvas_653991_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=%7C&lper=10&pvid=141&prvAccId=888243732&prvApiId=8CUF1VN4G&exid=3044&pcId=0000EEA&adj0=0&adj1=0&adj2=10&adj3=0&prvReqId=196076774847238581553523336303&crid=888243732&g=0&size=2x2&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=null&dfpBd=0.00&nms=1&di=&dt=O&epc=888243732&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=888243732&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.11&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dfalse%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=5&ba=176&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=228278063015894221553523336301&act=headerBid&dtfdl=-1&dspltime=294&ttfd=724&rtime=&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553509768c5-2x1062195&ltime=124&abs=0&top=1230&btm=1230&lft=257&rght=1012&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=0&mx_GCID=0&mx_bsProfile=0&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=0&actltime=128&acsn=1&dfpDiv=dpslot_canvas_653991_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=3004&prvAccId=888243732&prvApiId=8CUF1VN4G&exid=3048&pcId=0000EEA&adj0=0&adj1=0&adj2=10&adj3=0&prvReqId=196076774847238581553523336303&crid=888243732&g=0&size=2x2&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=1&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=null&dfpBd=0.00&nms=1&di=&dt=O&epc=888243732&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=888243732&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.11&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dfalse%7Cfl_rl%3D1%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=3&ba=176&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=228278063015894221553523336301&act=headerBid&dtfdl=-1&dspltime=294&ttfd=724&rtime=9&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1553509768c5-2x1062195&ltime=125&abs=0&top=1230&btm=1230&lft=257&rght=1012&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=4&mx_GCID=0&mx_bsProfile=2&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=1&actltime=128&acsn=1&dfpDiv=dpslot_canvas_653991_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&pvid=0&prvAccId=&prvApiId=&exid=&pcId=0000EEA&adj0=0&adj1=0&adj2=0&adj3=0&prvReqId=&crid=243346798&g=0&size=2x2&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0&cbdp=0&ckfl=&cs=&mnet_ckfl=&cat=&attr=&advId=&advNm=&advUrl=&dfpBd=0&nms=1&di=&dt=&epc=&ogbdp=0&s=1&snm=success&dbf=1&bdata=&cmpid=&bId=&pcrid=&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=0&exp=&bfs=0&seat=&nbr=&ba=0&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=&ybnca_bbid=&acid=184552912274112131553523336306&act=headerBid&dtfdl=-1&dspltime=295&ttfd=725&rtime=&dtc=&rtbsv2=&apid=&wsip=&ltime=&abs=&top=1337&btm=1337&lft=257&rght=1012&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint=&spProfile=&spSource=&spIvt=&spID=&refVisId=&osnbr=&brf=0&iwb=0&toconsider=0&actltime=127&acsn=1&dfpDiv=dpslot_native_3421327_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=%7C&lper=10&pvid=141&prvAccId=243346798&prvApiId=8CUF1VN4G&exid=3044&pcId=0000EEA&adj0=0&adj1=0&adj2=10&adj3=0&prvReqId=346712667781963201553523336306&crid=243346798&g=0&size=2x2&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=null&dfpBd=0.00&nms=1&di=&dt=O&epc=243346798&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=243346798&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.11&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dfalse%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=5&ba=175&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=184552912274112131553523336306&act=headerBid&dtfdl=-1&dspltime=295&ttfd=725&rtime=&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1546437397c5-2x1060141&ltime=123&abs=0&top=1337&btm=1337&lft=257&rght=1012&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=0&mx_GCID=0&mx_bsProfile=0&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=0&actltime=127&acsn=1&dfpDiv=dpslot_native_3421327_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&requrl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner&kwrf=&epurl=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache Tomcat /
Resource Hash
796c46ec10bc9105545f6f90d51593921b69956bd9087eb72bee83f40ad86f90

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:36 GMT
server
Apache Tomcat
access-control-allow-origin
*
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
content-length
35
expires
Mon, 25 Mar 2019 14:15:36 GMT
log
hbx-lg.media.net/
35 B
185 B
Image
General
Full URL
https://hbx-lg.media.net/log?logid=kfk&evtid=abdlog&pid=8PRL4E7N3&itype=HB&dn=in.reuters.com&cid=8CUF1VN4G&svr=2019032512_577&servname=c8-web-20&gdpr=1&csex=0&csstr=&ugd=4&vid=00001553523335963031123517443224&vsid=&sd=1&gtd=100&inid=0&gfd=&cc=DE&sc=HE&ct=FRANKFURT&abte=CONTROL&adbd=0&amp=0&version=4.1&sB=true&cors=true&disB=false&ice=0&vw=1585&vh=1200&pht=6967&cl=&__rk=0&app=0&rtype=&abd=2&dend=&diend=&distart=&dstart=&requrl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner&kwrf=&epurl=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache Tomcat /
Resource Hash
796c46ec10bc9105545f6f90d51593921b69956bd9087eb72bee83f40ad86f90

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:36 GMT
server
Apache Tomcat
access-control-allow-origin
*
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
content-length
35
expires
Mon, 25 Mar 2019 14:15:36 GMT
abg_lite.js
tpc.googlesyndication.com/pagead/js/r20190320/r20110914/ Frame 0EDB
29 KB
11 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190320/r20110914/abg_lite.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:820::2001 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
22319cb3b15cdd7ecfd35159216d2223c53d0127690078f07651d1e46090b4db
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Wed, 20 Mar 2019 12:57:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
436674
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
10971
x-xss-protection
1; mode=block
server
cafe
etag
543703436663340921
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 03 Apr 2019 12:57:43 GMT
m_window_focus_non_hydra.js
tpc.googlesyndication.com/pagead/js/r20190320/r20110914/client/ext/ Frame 0EDB
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190320/r20110914/client/ext/m_window_focus_non_hydra.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:820::2001 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
4dd51e6b250e15946ca0af835e0511093c82c5678115aac3055645d889a1681a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Wed, 20 Mar 2019 12:57:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
436674
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
1049
x-xss-protection
1; mode=block
server
cafe
etag
9573447915536422037
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 03 Apr 2019 12:57:43 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 0EDB
79 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:81f::2002 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
60fdb35f6ad4bb9182219967e37128a310ac24a1ce67bc8cadb11ad956de8aac
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1553253327984164"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
29871
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:37 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame 0EDB
295 KB
92 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , European Union, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
c5a714898ef3772037e79d2a72a4be13d1933dcd98c52c6ca43aac138990abe3

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
Last-Modified
Wed, 13 Mar 2019 15:49:13 GMT
Server
AmazonS3
x-amz-request-id
2A43DDB6F779DE9A
ETag
"78835628a18260088d1f83fb5ae835ac"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=25870
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
93473
x-amz-id-2
2chWFz9iBhnpX2LueZI/ny1Yg3cbKIpCxDn0suu6U800WKoxZhh9OqmKpSJUXqjSOdcsmrU0VWQ=
9666344281932910687
tpc.googlesyndication.com/simgad/ Frame 0EDB
47 KB
48 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/9666344281932910687
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:820::2001 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
c27d1864c396dafb6dbe4f4646f182c1a3d817e6d4e27b3fad4e6c4ceb9ccb5a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Thu, 14 Mar 2019 00:29:52 GMT
x-content-type-options
nosniff
age
999945
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
48622
x-xss-protection
1; mode=block
last-modified
Mon, 04 Mar 2019 07:10:27 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 13 Mar 2020 00:29:52 GMT
4974347015
dfp-gateway.s-onetag.com/1/4735792/
112 B
535 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/4974347015
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:c600:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
fbc7dfc344e77520010894e63b438d714b423106c9aef004ddcf21e15b114397

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
via
1.1 c05282a87474a55ae2a8dd2aa77d1233.cloudfront.net (CloudFront), 1.1 d89eaba973a5c1614ea9f0994f5e8a12.cloudfront.net (CloudFront)
x-amzn-requestid
76310fbd-4f08-11e9-8e81-17e30aef4f28
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5c98e289-18f4cf8481927b2061f2f918;Sampled=0
x-amz-apigw-id
XGhVcE3eSK4FuAQ=
content-length
112
x-amz-cf-id
W3cR95Du7VZQ37_UoHdkXwTv3l6TObFXGRib_GXA6V2Ck67qZzSahQ==
osd.js
www.googletagservices.com/activeview/js/current/
77 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:81f::2002 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
3da096eadec42f2ee70ba0d51e8a54704543b5b67a957732d8c244cd90b731ab
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1553253327984164"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
29012
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:37 GMT
abg_lite.js
tpc.googlesyndication.com/pagead/js/r20190320/r20110914/ Frame DBC1
29 KB
11 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190320/r20110914/abg_lite.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:820::2001 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
22319cb3b15cdd7ecfd35159216d2223c53d0127690078f07651d1e46090b4db
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Wed, 20 Mar 2019 12:57:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
436674
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
10971
x-xss-protection
1; mode=block
server
cafe
etag
543703436663340921
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 03 Apr 2019 12:57:43 GMT
m_window_focus_non_hydra.js
tpc.googlesyndication.com/pagead/js/r20190320/r20110914/client/ext/ Frame DBC1
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190320/r20110914/client/ext/m_window_focus_non_hydra.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:820::2001 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
4dd51e6b250e15946ca0af835e0511093c82c5678115aac3055645d889a1681a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Wed, 20 Mar 2019 12:57:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
436674
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
1049
x-xss-protection
1; mode=block
server
cafe
etag
9573447915536422037
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 03 Apr 2019 12:57:43 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame DBC1
79 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:81f::2002 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
60fdb35f6ad4bb9182219967e37128a310ac24a1ce67bc8cadb11ad956de8aac
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1553253327984164"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
29871
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:37 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame DBC1
295 KB
92 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , European Union, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
c5a714898ef3772037e79d2a72a4be13d1933dcd98c52c6ca43aac138990abe3

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
Last-Modified
Wed, 13 Mar 2019 15:49:13 GMT
Server
AmazonS3
x-amz-request-id
2A43DDB6F779DE9A
ETag
"78835628a18260088d1f83fb5ae835ac"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=25870
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
93473
x-amz-id-2
2chWFz9iBhnpX2LueZI/ny1Yg3cbKIpCxDn0suu6U800WKoxZhh9OqmKpSJUXqjSOdcsmrU0VWQ=
5725122821530103991
tpc.googlesyndication.com/simgad/ Frame DBC1
64 KB
64 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/5725122821530103991
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:820::2001 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
0c7058f172497e5587aef179cedbadedc9d02abe80271542c77197b29968d970
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Sat, 16 Mar 2019 09:43:21 GMT
x-content-type-options
nosniff
age
793936
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
65121
x-xss-protection
1; mode=block
last-modified
Fri, 15 Mar 2019 18:03:59 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 15 Mar 2020 09:43:21 GMT
4995561982
dfp-gateway.s-onetag.com/1/4735792/
112 B
544 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/4995561982
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:c600:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
2e6224436b6a35ffc181585c3f9e0bf5b89bed3fd5000257ad5e5b29ed59e631

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:06:09 GMT
via
1.1 2f471134491a4de5cfcaef646caf9dde.cloudfront.net (CloudFront), 1.1 d89eaba973a5c1614ea9f0994f5e8a12.cloudfront.net (CloudFront)
age
568
x-amzn-requestid
23f7d33e-4f07-11e9-80cb-4fd9224957ac
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5c98e051-1c645ad1318dbbafdf156dea;Sampled=0
x-amz-apigw-id
XGf8yFD_yK4FiKA=
content-length
112
x-amz-cf-id
JMGdWQXo0EppYHAfT8ZVAlnAWQ7CZUz9FHGikU2e9Vqro0I4_Qv-FQ==
tag
a.teads.tv/page/48951/ Frame 6CD4
3 KB
1 KB
Script
General
Full URL
https://a.teads.tv/page/48951/tag
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , European Union, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
4ac950f8088629c4d35e54e04eb5c18543ebc15b23873d351b57e3b6118e064d

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
content-encoding
gzip
access-control-allow-origin
*
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
status
200
cache-control
private, must-revalidate, max-age=3600
access-control-allow-credentials
true
content-length
993
expires
Mon, 25 Mar 2019 15:15:37 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 6CD4
79 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:81f::2002 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
60fdb35f6ad4bb9182219967e37128a310ac24a1ce67bc8cadb11ad956de8aac
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1553253327984164"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
29871
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:37 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame 6CD4
295 KB
92 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.211.10.211 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-211-10-211.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
c5a714898ef3772037e79d2a72a4be13d1933dcd98c52c6ca43aac138990abe3

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
Last-Modified
Wed, 13 Mar 2019 15:49:13 GMT
Server
AmazonS3
x-amz-request-id
EB9012129A73D798
ETag
"78835628a18260088d1f83fb5ae835ac"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=30715
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
93473
x-amz-id-2
G70aSUkYJG+OF/Dz+WUZ2GnqAMa3cbI/mQk/luUz+p4FTouiY8fZj5ZL5QvhDt7L4u3xGTKE6mw=
4741317042
dfp-gateway.s-onetag.com/1/4735792/
116 B
547 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/4741317042
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:c600:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
57a5832e107631b871e4ed9b7af901c7cb9ee1e698b027e82b41f31fe69c1f17

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 13:20:14 GMT
via
1.1 92ab13182d4b89ed20b3b5c10adc4f23.cloudfront.net (CloudFront), 1.1 d89eaba973a5c1614ea9f0994f5e8a12.cloudfront.net (CloudFront)
age
3323
x-amzn-requestid
b98c3a85-4f00-11e9-a6ac-2978f8a4e027
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5c98d58e-f1704dec423da759345a69b8;Sampled=0
x-amz-apigw-id
XGZOPHJ2SK4FhFg=
content-length
116
x-amz-cf-id
BBQ0uRsSwPwptGfc7UYjY7eXqcOUXMbwEO85R01j7psWLCfXJYkD_w==
Carambola_layer_152.min.js
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/ Frame 759C
Redirect Chain
  • https://route.carambo.la/inimage/getlayer?pid=thms97&did=112441&wid=3&rdn=[RANDOM_NUMBER]
  • https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
445 KB
111 KB
Script
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 Ashburn, United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40FC) /
Resource Hash
0e39b51dcc333757c9c3bd279c035939ecfd59be5cb1187e4670d2dd9a58894d

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
content-encoding
deflate
x-amz-request-id
DF444D18C3C16762
x-cache
HIT
status
200
access-control-max-age
3000
content-length
113527
x-amz-id-2
+mEAv/X5d6OFSCli18TRysOZVe89GvzbpwZIuxnjVz/23c/a9PiuP6QgbIHH4WgBuo3jipsyrqY=
last-modified
Mon, 25 Mar 2019 13:32:12 GMT
server
ECS (fcn/40FC)
etag
"faa5c019f952f59d215a8265d7e692a8"
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
accept-ranges
bytes

Redirect headers

Location
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Date
Mon, 25 Mar 2019 14:15:37 GMT
Server
nginx/1.12.1
Connection
keep-alive
X-Powered-By
Express
Content-Length
0
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 759C
79 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:81f::2002 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
60fdb35f6ad4bb9182219967e37128a310ac24a1ce67bc8cadb11ad956de8aac
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1553253327984164"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
29871
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:37 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame 759C
295 KB
92 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.211.10.211 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-211-10-211.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
c5a714898ef3772037e79d2a72a4be13d1933dcd98c52c6ca43aac138990abe3

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
Last-Modified
Wed, 13 Mar 2019 15:49:13 GMT
Server
AmazonS3
x-amz-request-id
EB9012129A73D798
ETag
"78835628a18260088d1f83fb5ae835ac"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=30715
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
93473
x-amz-id-2
G70aSUkYJG+OF/Dz+WUZ2GnqAMa3cbI/mQk/luUz+p4FTouiY8fZj5ZL5QvhDt7L4u3xGTKE6mw=
pixel.gif
s3.amazonaws.com/clickmeter.com/Web/static/ Frame 759C
Redirect Chain
  • https://pixel.watch/q4m9
  • https://s3.amazonaws.com/clickmeter.com/Web/static/pixel.gif
807 B
497 B
Image
General
Full URL
https://s3.amazonaws.com/clickmeter.com/Web/static/pixel.gif
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.177.109 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
3ca19e57c9a2465ae4df271316ba4d29e7ff7f113a2a2c5297780c0b7a0ac09d

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:39 GMT
Content-Encoding
gzip
Last-Modified
Thu, 04 Sep 2014 09:19:24 GMT
Server
AmazonS3
x-amz-request-id
13E2B8893D11ECE6
ETag
"09b0993d4c8ad6bf26391f80a7dce73b"
Content-Type
image/gif
Cache-Control
no-cache,max-age=2678400,public
Accept-Ranges
bytes
Content-Length
70
x-amz-id-2
PLqoOdc5FHA5seBp6D3or3fR8LvNG3Y14QreDOvocwN3s6Uy2jWvHF5h9hkzius6MD98J+xTENM=

Redirect headers

Date
Mon, 25 Mar 2019 14:15:36 GMT
X-Rate-Limit-Limit
20s
X-Rate-Limit-Remaining
299
Location
https://s3.amazonaws.com/clickmeter.com/Web/static/pixel.gif
X-Rate-Limit-Reset
2019-03-25T14:15:57.5743590Z
Engine
clickmeter.redirect, version 2.0
Connection
keep-alive
Content-Length
0
139199112
dfp-gateway.s-onetag.com/1/4735792/
114 B
545 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/139199112
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:c600:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
58d94b06f15b9a1ea02b26e3a0454a7921cda64a5769657e333cba9d9a0bb485

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 13:40:59 GMT
via
1.1 170fdbe261f5e85186a08817806feba2.cloudfront.net (CloudFront), 1.1 d89eaba973a5c1614ea9f0994f5e8a12.cloudfront.net (CloudFront)
age
2078
x-amzn-requestid
9fd95fc8-4f03-11e9-8fe2-25f2a138ed1e
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5c98da6b-ac995120e3b0c9339f6c55e7;Sampled=0
x-amz-apigw-id
XGcQ0GURyK4FaOw=
content-length
114
x-amz-cf-id
K6TfBZnl1UTxeFQqZkA443RIeHAAqVVKWS-htKDR5YhkkvaeoI7CPw==
view
securepubads.g.doubleclick.net/pcs/ Frame 0EDB
0
278 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsssUToS4MGwobGnUXTWGmEGJYFF7mvVKCWjL_g1JkLsrHmWu839I9e84V3FTLh_ZK8ibu_YMiOcKjUR6K-NigRBXJrWetHfbKibc-OhuMIcwH5cVGuBjn5soniIyO53Dt8UvVR9_ZRPCWiO3jP4PBe8N7AZMXODU-Oe53pwGmKo7qNKKFinHoqb4ksU5syCAIcgf-5poz2r-jif0BZYQIKVM_wHkb2aSztTENiaC7grXEMmBHbXeb41w1wq0-bOD1WelCxYPYBxtNge4lPfB4-SFrw&sai=AMfl-YT77kLiki1W9GTleksVy-B6jsdyC0grUUC2W9qun2sPP-Bj-ja6Qx4-GImPF-adJ07rWnxADYG4ooUHvnfMR73vclWsamIJbCZlQyT-ZA&sig=Cg0ArKJSzPldEc27YnwvEAE&adurl=
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
172.217.16.130 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s46-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
x-content-type-options
nosniff
content-type
image/gif
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
cache-control
private
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
0
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:37 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame DBC1
0
253 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstkH9x5Y8qAVriRPCe33RFj4YEmozwch30tFl_pXd5a8V5IttlNY5O5Io6oa4rCUCLMynls8mNkz0RvHhFtMGVZPHmWw_bxBbOB3lM-YkyBAw4_1ca2SsJuOYpKN_NjcdaBStnpY1j_SnzOLPik_5CHDbI51JdSQ1wXi9_uZtP8Xr_sOt_s-2XcOdMmzjbfuUvlEkxON2p8zcFTYvH-0JWnUYax9G0s9BO7Ns-tN2nSrdtLZxTWFZtXNIxdU6OJNKdyGqR8fA7jmPaOmVlgrKnaHJdYKUMeCRXyAPjHL20LN6g&sai=AMfl-YRhxCbqzKvLCeG5R24EkvGZp5h-oAVCHEBduOGCeGzbbWoXR-iASHe7feOdL2LkjC6i3jymh_8KJmMcrYw-eJlYivI-VELpApk76TbcVA&sig=Cg0ArKJSzBYyUNIJk1PwEAE&adurl=
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
172.217.16.130 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s46-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
x-content-type-options
nosniff
content-type
image/gif
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
cache-control
private
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
0
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:37 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 6CD4
0
245 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstuiC1NzDQLGzmF2Zll1DouXma3cNkjKIih4kF6V_EJBa90kts7F-q_eFhdt2fdej8oXEIQzghyVbwJ90qFt8ATDQCw3YoqMY3V5OVT2nxHzJih9sM1vnMIUNF9lKpFZc2wX1pyexKCQTGIYDwhgZnDWkG7UUPrjjqpkqGAtw4EAvm7GSXb7_Z0BnsDTQnmJarIvPjz7nkHT7KM6p9muZdQHacnt0eEqkWpoZLcQsy64kxB93SFl26FjNR0ngJ-LPyvETh2ALZjutuejmD8vZIMX7g&sai=AMfl-YSIWJiBZAFDuhje_N7tm9tbMNadaYS65FeyGoWM8IN2kXcc9ChsgGELXtdjYHTx6P7KMZxZ_3dho-iTTDfv2MfwyZTTtCy5lgCkzqReXw&sig=Cg0ArKJSzKUZ8l2ISXvvEAE&urlfix=1&adurl=
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
172.217.16.130 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s46-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
x-content-type-options
nosniff
content-type
image/gif
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
cache-control
private
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
0
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:37 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 759C
0
255 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstoeRVymTbD3Kl7IxhYSRrB291HkbbtXWrDSrc8cDuiNF1SRf1i2Azke7-al3p_8nTfrxuO47VmBvvEC9RBUTz3rEJaFQAcEg0ruIKnwmEeRnZFIhGEdmaElWYK2sLphqsZjfB_fGpTVhRwd1hJs3KQ1jP_1k2x7DErrdYV1onU7TmKTGhKr4Xgo0Fa2MisifRTswKnJDZSJzTDDgEI5rOgbDewP6zGuu8aDkXUqJYE7J9jXme_WskuZY4q-0WzcMLgP9aDXCh-lEn-johL3w&sai=AMfl-YTBTocsqAxJTAOjrf2KTGbfoQkNwKGKuny6YiXDDXzGp2PWh4iGwcEbbHMGoAj4LFCedd607mLpF4HO8mb-czrF8FdOP0A9t8qlxVQjNQ&sig=Cg0ArKJSzJPrTfXXAdCsEAE&urlfix=1&adurl=
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
172.217.16.130 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s46-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
x-content-type-options
nosniff
content-type
image/gif
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
cache-control
private
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
0
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:37 GMT
truncated
/ Frame DBC1
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
1a74494c99d46aa44458591e0724b24afd1847632472895735fc5a10b6075154

Request headers

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame 2C4A
44 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=970x250&pubId=4711821530&chanId=38032032&placementId=4995561982&pubCreative=138264852094&pubOrder=2509720728&cb=1766020713&custom=leaderboard&custom2=400&custom3=0&adsafe_par&impId=75a39ccc-4f08-11e9-a64b-002590882ece
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
8a36294c08a28c71073ce603810e15d375cb5392cd32c76971d686f6e0564549

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
X-Server-Name
app41ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
truncated
/ Frame 0EDB
210 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
1ece21a14a99e3913393d4d4dcf707713cb1e7bc8b0a9043f9081e076581484d

Request headers

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame 249A
44 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x600&pubId=4704817679&chanId=38032032&placementId=4974347015&pubCreative=138263065185&pubOrder=2500420503&cb=873562457&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=75a2b1b2-4f08-11e9-9669-70106fb72ed4
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
59fe519ac2a0c1fce428cbc990749a5630ddcbbd05b48fcfa0ebd3ea7ad2b56a

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
X-Server-Name
app45ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
4995561982
dfp-gateway.s-onetag.com/1/4735792/
112 B
543 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/4995561982
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:c600:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
2e6224436b6a35ffc181585c3f9e0bf5b89bed3fd5000257ad5e5b29ed59e631

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:06:09 GMT
via
1.1 2f471134491a4de5cfcaef646caf9dde.cloudfront.net (CloudFront), 1.1 d89eaba973a5c1614ea9f0994f5e8a12.cloudfront.net (CloudFront)
age
568
x-amzn-requestid
23f7d33e-4f07-11e9-80cb-4fd9224957ac
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5c98e051-1c645ad1318dbbafdf156dea;Sampled=0
x-amz-apigw-id
XGf8yFD_yK4FiKA=
content-length
112
x-amz-cf-id
M_JfXNv-JCIOhYG5oxiyJaN_b0COfQQ0xOYpi-ijwUc29uIhD6EY6Q==
4741317042
dfp-gateway.s-onetag.com/1/4735792/
116 B
546 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/4741317042
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:c600:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
57a5832e107631b871e4ed9b7af901c7cb9ee1e698b027e82b41f31fe69c1f17

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 13:20:14 GMT
via
1.1 92ab13182d4b89ed20b3b5c10adc4f23.cloudfront.net (CloudFront), 1.1 d89eaba973a5c1614ea9f0994f5e8a12.cloudfront.net (CloudFront)
age
3323
x-amzn-requestid
b98c3a85-4f00-11e9-a6ac-2978f8a4e027
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5c98d58e-f1704dec423da759345a69b8;Sampled=0
x-amz-apigw-id
XGZOPHJ2SK4FhFg=
content-length
116
x-amz-cf-id
rYzorjqb8jUe257vR5rmX3U1lchxWMEtZT-0BfjLw6gwen6YduuJlg==
139199112
dfp-gateway.s-onetag.com/1/4735792/
114 B
543 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/139199112
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:c600:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
58d94b06f15b9a1ea02b26e3a0454a7921cda64a5769657e333cba9d9a0bb485

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 13:40:59 GMT
via
1.1 170fdbe261f5e85186a08817806feba2.cloudfront.net (CloudFront), 1.1 d89eaba973a5c1614ea9f0994f5e8a12.cloudfront.net (CloudFront)
age
2078
x-amzn-requestid
9fd95fc8-4f03-11e9-8fe2-25f2a138ed1e
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5c98da6b-ac995120e3b0c9339f6c55e7;Sampled=0
x-amz-apigw-id
XGcQ0GURyK4FaOw=
content-length
114
x-amz-cf-id
lhlbFp8KFzUq9ypw4cHaD4jhhZ108GqTtATqFCr4tbQ6e0ZLvomb7g==
truncated
/ Frame 759C
209 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
71585936e03aaa0996c8240a34d0224ceed3ec8e523c4eb34905c3be9a02baab

Request headers

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame D7D5
44 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x280&pubId=20159232&chanId=38032032&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=1147991459&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=75a45f3d-4f08-11e9-9104-382c4ac630ed
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
a53cace67554f81442e51e226b5d85179cbde388f477a6847d867e6c6cdadda6

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
X-Server-Name
app41ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
truncated
/ Frame 6CD4
208 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
26634beb0e97c92114659791ef1d7050ddd1f16064091252f574fcc0eb700fcd

Request headers

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame C0C2
44 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=2x2&pubId=54423312&chanId=38032032&placementId=4741317042&pubCreative=138239093677&pubOrder=2107429564&cb=1138655010&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=75a375b2-4f08-11e9-9d27-70106fb72a54
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
f9c3d3eeaec20f8de08ff53907538a31f77119f3bc08a44c8a9749d27b2fe594

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
X-Server-Name
app41ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
teads-format.min.js
a.teads.tv/media/format/v3/
697 KB
185 KB
Script
General
Full URL
https://a.teads.tv/media/format/v3/teads-format.min.js
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/page/48951/tag
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , European Union, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
3b420041dd63461e2edc880aa82dc9c06a0c6fb0e7404eec6391840be8cbfe04

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
content-encoding
gzip
last-modified
Fri, 22 Mar 2019 10:29:22 GMT
x-amz-request-id
ECEB660164862224
etag
"0ca3d7cf58bf02a818f18526847bd9d0"
vary
Accept-Encoding
content-type
text/javascript;charset=utf-8
status
200
cache-control
private, must-revalidate, max-age=600
x-bucket
1
accept-ranges
bytes
content-length
188293
x-amz-id-2
sXg0OUpXO/LaL6UKPB9AqaamL6AJrIx7SZz1E6hQtgJiOzPECTnZZ43Xs52yVRtWPQnZkRulZiU=
expires
Mon, 25 Mar 2019 14:25:37 GMT
n.js
geo.moatads.com/ Frame 6CD4
120 B
384 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=(%2BIb%7Cj8o%3FJ(jkkeL07ta_*JRM!6t9B%2CN%3Ey)%2ChXbvU37_*NhSfBghz%5D*vOJ%23_%3DNoUA%5DRgBU_Gr1%3E%3AHuFTn%3ADXqJHZ%3BR%23yAb%2Bho8bYLaXBjA%3AmQ)%3CF!tAbjrzJ%3BgoVYGVxc%40lQQV%23tc3%2Fh%7C%3FVKV%3BW5.NO)Wx%7C*E%24%3D!L2ux%7Ci_lOfxECSR23_hFAkD%3Dv%3CN%5B.%22%24b_o%3FtVD%5D%5BpN%7CQF%40Sy7%7B%2CNr1U*%26ujMUU8fvb%26%22B&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBnyBBBNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF7HfC7Kn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=0&qa=0&qb=0&qi=0&qj=0&po=1-0020002000002100&qr=0&i=REUTERSDFPCW3&hp=1&cm=9&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&o=3&t=1553523337354&de=790533181865&m=0&ar=7a728edb041-clean&q=2&cb=0&cu=1553523337354&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=54423312%3A2107429564%3A4741317042%3A138239093677&zMoatTP=canvas&zMoatStory=0&zMoatAU=%2F4735792%2Fin.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=38032032&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=38032032&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=38032032&qs=1&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&zMoatBlacklist=true&bo=3735912&bd=38032032&dfp=0%2C1&la=38032032&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&fs=161206&na=1759155310&cs=0&callback=MoatSuperV26.gna590610
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.130.64.138 Cambridge, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-130-64-138.eu-west-2.compute.amazonaws.com
Software
nginx/1.7.9 /
Resource Hash
95a2e9aed9e09d7581a742007ff2808dbec5e5f5894d94943c0150410163d536

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Server
nginx/1.7.9
Etag
"2fb0529476f57d6a2148dc884bba0958450c944d"
Content-Type
text/html; charset=UTF-8
Cache-Control
max-age=900
Connection
keep-alive
Timing-Allow-Origin
*
Content-Length
120
n.js
geo.moatads.com/
119 B
383 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=(%2BIb%7Cj8o%3FJ(jkkeL07ta_*JRM!6t9B%2CN%3Ey)%2ChXbvU37_*NhSfBghz%5D*vOJ%23_%3DNoUA%5DRgBU_Gr1%3E%3AHuFTn%3ADXqJHZ%3BR%23yAb%2Bho8bYLaXBjA%3AmQ)%3CF!tAbjrzJ%3BgoVYGVxc%40lQQV%23tc3%2Fh%7C%3FVKV%3BW5.NO)Wx%7C*E%24%3D!L2ux%7Ci_lOfxECSR23_hFAkD%3Dv%3CN%5B.%22%24b_o%3FtVD%5D%5BpN%7CQF%40Sy7%7B%2CNr1U*%26ujMUU8fvb%26%22B&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBnyBBBNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF7HfC7Kn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=0&qa=0&qb=0&qi=0&qj=0&po=1-0020002000002100&qr=0&i=REUTERSDFPCW3&hp=1&cm=9&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&o=3&t=1553523337354&de=790533181865&m=0&ar=7a728edb041-clean&q=3&cb=0&cu=1553523337354&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=54423312%3A2107429564%3A4741317042%3A138239093677&zMoatTP=canvas&zMoatStory=0&zMoatAU=%2F4735792%2Fin.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=38032032&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=38032032&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=38032032&qs=1&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&zMoatBlacklist=true&bo=3735912&bd=38032032&dfp=0%2C1&la=38032032&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&fs=161206&na=1887700625&cs=0&callback=MoatDataJsonpRequest
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.130.64.138 Cambridge, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-130-64-138.eu-west-2.compute.amazonaws.com
Software
nginx/1.7.9 /
Resource Hash
c6f72f2813eb9bf94f41334602e76ab3a3950c10ae0990b19943eeaebe8dfde8

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Server
nginx/1.7.9
Etag
"4ead95287d0dac07dcf38088a908ede02fd7d4d2"
Content-Type
text/html; charset=UTF-8
Cache-Control
max-age=900
Connection
keep-alive
Timing-Allow-Origin
*
Content-Length
119
n.js
geo.moatads.com/ Frame 0EDB
120 B
384 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=(%2BIb%7Cj8o%3FJ(jkkeL07ta_*JRM!6t9B%2CN%3Ey)%2ChXbvU37_*NhSfBghz%5D*vOJ%23_%3DNoUA%5DRgBU_Gr1%3E%3AHuFTn%3ADXqJHZ%3BR%23yAb%2Bho8bYLaXBjA%3AmQ)%3CF!tAbjrzJ%3BgoVYGVxc%40lQQV%23tc3%2Fh%7C%3FVKV%3BW5.NO)Wx%7C*E%24%3D!L2ux%7Ci_lOfxECSR23_hFAkD%3Dv%3CN%5B.%22%24b_o%3FtVD%5D%5BpN%7CQF%40Sy7%7B%2CNr1U*%26ujMUU8fvb%26%22B&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBnyBBBNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF7HfC7Kn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=0&qa=0&qb=0&qi=0&qj=0&po=1-0020002000002100&qr=0&i=REUTERSDFPCW3&hp=1&cm=7&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&o=3&t=1553523337420&de=942128211182&m=0&ar=7a728edb041-clean&q=7&cb=0&cu=1553523337420&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4704817679%3A2500420503%3A4974347015%3A138263065185&zMoatTP=mpu&zMoatStory=0&zMoatAU=%2F4735792%2Fin.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=38032032&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=38032032&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=38032032&qs=1&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&zMoatBlacklist=true&bo=3735912&bd=38032032&dfp=0%2C1&la=38032032&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&fs=161206&na=2030311439&cs=0&callback=MoatSuperV26.gna749816
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.130.64.138 Cambridge, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-130-64-138.eu-west-2.compute.amazonaws.com
Software
nginx/1.7.9 /
Resource Hash
5ac16a501f716813dec0c475081cb4122b79779d5de129259cf5048f7fa7a2ff

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Server
nginx/1.7.9
Etag
"d3c47eafe186bc04e117a6d778e9572d3fc80b6e"
Content-Type
text/html; charset=UTF-8
Cache-Control
max-age=900
Connection
keep-alive
Timing-Allow-Origin
*
Content-Length
120
n.js
geo.moatads.com/ Frame DBC1
121 B
385 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=(%2BIb%7Cj8o%3FJ(jkkeL07ta_*JRM!6t9B%2CN%3Ey)%2ChXbvU37_*NhSfBghz%5D*vOJ%23_%3DNoUA%5DRgBU_Gr1%3E%3AHuFTn%3ADXqJHZ%3BR%23yAb%2Bho8bYLaXBjA%3AmQ)%3CF!tAbjrzJ%3BgoVYGVxc%40lQQV%23tc3%2Fh%7C%3FVKV%3BW5.NO)Wx%7C*E%24%3D!L2ux%7Ci_lOfxECSR23_hFAkD%3Dv%3CN%5B.%22%24b_o%3FtVD%5D%5BpN%7CQF%40Sy7%7B%2CNr1U*%26ujMUU8fvb%26%22B&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBnyBBBNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF7HfC7Kn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=0&qa=0&qb=0&qi=0&qj=0&po=1-0020002000002100&qr=0&i=REUTERSDFPCW3&hp=1&cm=8&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&o=3&t=1553523337511&de=918585623931&m=0&ar=7a728edb041-clean&q=12&cb=0&cu=1553523337511&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4711821530%3A2509720728%3A4995561982%3A138264852094&zMoatTP=leaderboard&zMoatStory=0&zMoatAU=%2F4735792%2Fin.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=38032032&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=38032032&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=38032032&qs=1&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&zMoatBlacklist=true&bo=3735912&bd=38032032&dfp=0%2C1&la=38032032&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&fs=161206&na=1784751782&cs=0&callback=MoatSuperV26.gna870056
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.130.64.138 Cambridge, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-130-64-138.eu-west-2.compute.amazonaws.com
Software
nginx/1.7.9 /
Resource Hash
c81712eca20b5e5bdb4349735583beff2fac3eae2bed58a7ac7ec84f7987de2c

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Server
nginx/1.7.9
Etag
"a1c33e620225c812726215c4baab9da476d83aaa"
Content-Type
text/html; charset=UTF-8
Cache-Control
max-age=900
Connection
keep-alive
Timing-Allow-Origin
*
Content-Length
121
main.17.4.178.js
static.adsafeprotected.com/ Frame 2C4A
153 KB
49 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.17.4.178.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=970x250&pubId=4711821530&chanId=38032032&placementId=4995561982&pubCreative=138264852094&pubOrder=2509720728&cb=1766020713&custom=leaderboard&custom2=400&custom3=0&adsafe_par&impId=75a39ccc-4f08-11e9-a64b-002590882ece
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
2d90ad9018fcaf71b7bfa876f1b5051a67b17986918b9fb8779e0e6a6dc438e9

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Mar 2019 20:01:35 GMT
X-Server-Name
app42ami.ami.303net.pvt
ETag
"5c914a9f-c134"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
49460
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
n.js
geo.moatads.com/ Frame 759C
119 B
383 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=(%2BIb%7Cj8o%3FJ(jkkeL07ta_*JRM!6t9B%2CN%3Ey)%2ChXbvU37_*NhSfBghz%5D*vOJ%23_%3DNoUA%5DRgBU_Gr1%3E%3AHuFTn%3ADXqJHZ%3BR%23yAb%2Bho8bYLaXBjA%3AmQ)%3CF!tAbjrzJ%3BgoVYGVxc%40lQQV%23tc3%2Fh%7C%3FVKV%3BW5.NO)Wx%7C*E%24%3D!L2ux%7Ci_lOfxECSR23_hFAkD%3Dv%3CN%5B.%22%24b_o%3FtVD%5D%5BpN%7CQF%40Sy7%7B%2CNr1U*%26ujMUU8fvb%26%22B&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBnyBBBNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF7HfC7Kn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=0&qa=0&qb=0&qi=0&qj=0&po=1-0020002000002100&qr=0&i=REUTERSDFPCW3&hp=1&cm=6&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&o=3&t=1553523337647&de=261264286308&m=0&ar=7a728edb041-clean&q=17&cb=0&cu=1553523337647&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=20159232%3A277213512%3A139199112%3A138204787707&zMoatTP=bizdev_article_rr2&zMoatStory=0&zMoatAU=%2F4735792%2Fin.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=20000&zMoatRawSlicer1=3735912&zMoatRawSlicer2=38032032&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=38032032&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=38032032&qs=1&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&bo=3735912&bd=38032032&dfp=0%2C1&la=38032032&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&fs=161206&na=392200585&cs=0&callback=MoatSuperV26.gna15459
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.130.64.138 Cambridge, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-130-64-138.eu-west-2.compute.amazonaws.com
Software
nginx/1.7.9 /
Resource Hash
e6455d8e78d8ee3c169d4014f94bde87579dc9e406d94adbf69f80bedc4a05f6

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Server
nginx/1.7.9
Etag
"b0a554a323942b34f9820e0f6903037d70400558"
Content-Type
text/html; charset=UTF-8
Cache-Control
max-age=900
Connection
keep-alive
Timing-Allow-Origin
*
Content-Length
119
main.17.4.178.js
static.adsafeprotected.com/ Frame D7D5
153 KB
49 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.17.4.178.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x280&pubId=20159232&chanId=38032032&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=1147991459&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=75a45f3d-4f08-11e9-9104-382c4ac630ed
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
2d90ad9018fcaf71b7bfa876f1b5051a67b17986918b9fb8779e0e6a6dc438e9

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Mar 2019 20:01:35 GMT
X-Server-Name
app42ami.ami.303net.pvt
ETag
"5c914a9f-c134"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
49460
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
main.17.4.178.js
static.adsafeprotected.com/ Frame 249A
153 KB
49 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.17.4.178.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x600&pubId=4704817679&chanId=38032032&placementId=4974347015&pubCreative=138263065185&pubOrder=2500420503&cb=873562457&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=75a2b1b2-4f08-11e9-9669-70106fb72ed4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
2d90ad9018fcaf71b7bfa876f1b5051a67b17986918b9fb8779e0e6a6dc438e9

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Mar 2019 20:01:35 GMT
X-Server-Name
app42ami.ami.303net.pvt
ETag
"5c914a9f-c134"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
49460
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
main.17.4.178.js
static.adsafeprotected.com/ Frame C0C2
153 KB
49 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.17.4.178.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=2x2&pubId=54423312&chanId=38032032&placementId=4741317042&pubCreative=138239093677&pubOrder=2107429564&cb=1138655010&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=75a375b2-4f08-11e9-9d27-70106fb72a54
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
2d90ad9018fcaf71b7bfa876f1b5051a67b17986918b9fb8779e0e6a6dc438e9

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Mar 2019 20:01:35 GMT
X-Server-Name
app36ami.ami.303net.pvt
ETag
"5c914a9f-c134"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
49460
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=14&fi=0&apd=28&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=in.reuters.com&L1id=4704817679&L2id=2500420503&L3id=4974347015&L4id=138263065185&S1id=3735912&S2id=38032032&ord=1553523337420&r=942128211182&t=meas&bedc=1&q=1&nu=1&ib=1&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
184.51.10.56 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a184-51-10-56.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:37 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=268&fi=0&apd=282&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=in.reuters.com&L1id=4704817679&L2id=2500420503&L3id=4974347015&L4id=138263065185&S1id=3735912&S2id=38032032&ord=1553523337420&r=942128211182&t=hdn&bedc=1&q=2&nu=1&ib=1&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
184.51.10.56 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a184-51-10-56.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:37 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=268&fi=0&apd=282&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=in.reuters.com&L1id=4704817679&L2id=2500420503&L3id=4974347015&L4id=138263065185&S1id=3735912&S2id=38032032&ord=1553523337420&r=942128211182&t=nht&bedc=1&q=3&nu=1&ib=1&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
184.51.10.56 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a184-51-10-56.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:37 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=17&fi=1&apd=33&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=in.reuters.com&L1id=4711821530&L2id=2509720728&L3id=4995561982&L4id=138264852094&S1id=3735912&S2id=38032032&ord=1553523337511&r=918585623931&t=meas&bedc=1&q=1&nu=1&ib=1&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
184.51.10.56 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a184-51-10-56.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:37 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=17&fi=1&apd=33&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=in.reuters.com&L1id=4711821530&L2id=2509720728&L3id=4995561982&L4id=138264852094&S1id=3735912&S2id=38032032&ord=1553523337511&r=918585623931&t=fv&bedc=1&q=2&nu=1&ib=1&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
184.51.10.56 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a184-51-10-56.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:37 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=186&fi=1&apd=202&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=in.reuters.com&L1id=4711821530&L2id=2509720728&L3id=4995561982&L4id=138264852094&S1id=3735912&S2id=38032032&ord=1553523337511&r=918585623931&t=hdn&bedc=1&q=3&nu=1&ib=1&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
184.51.10.56 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a184-51-10-56.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:37 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=186&fi=1&apd=202&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=in.reuters.com&L1id=4711821530&L2id=2509720728&L3id=4995561982&L4id=138264852094&S1id=3735912&S2id=38032032&ord=1553523337511&r=918585623931&t=nht&bedc=1&q=4&nu=1&ib=1&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
184.51.10.56 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a184-51-10-56.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:37 GMT
sca.17.4.95.js
static.adsafeprotected.com/ Frame 0B8A
81 KB
20 KB
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app36ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=970x250&pubId=4711821530&chanId=38032032&placementId=4995561982&pubCreative=138264852094&pubOrder=2509720728&cb=1766020713&custom=leaderboard&custom2=400&custom3=0&adsafe_par&impId=75a39ccc-4f08-11e9-a64b-002590882ece&adsafe_url=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&adsafe_type=abdfq&adsafe_jsinfo=,id:ebb091c9-7026-aa6d-8f59-8e12f233d78e,c:7SN20M,sl:inView,em:true,fr:true,mn:app41ami,pt:1-5-15,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rlJTBw3+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1c3|1c4|1c5|1d*.10764|1d1|1e1|1f1|1g,idMap:1d*,pl:,rend:1,renddet:IMG.qs,rmeas:1,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:162,oid:76318448-4f08-11e9-aaec-70106fb72a54,v:17.4.178,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
X-Server-Name
app41ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=ebb091c9-7026-aa6d-8f59-8e12f233d78e&tv={c:7SN20O,pingTime:-8,time:163,type:l,es:0,sc:1,ha:1,gm:1,slTimes:{i:164,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:160,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[26~100],as:[26~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rlJTBw3+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1c3|1c4|1c5|1d*.10764|1d1|1e1|1f1|1g,idMap:1d*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
X-Server-Name
dt61ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=ebb091c9-7026-aa6d-8f59-8e12f233d78e&tv={c:7SN21f,pingTime:0,time:190,type:pf,im:{pBlk:179},clog:[{piv:100,vs:i,r:,w:970,h:250,t:160}],es:0,sc:1,ha:1,gm:1,slTimes:{i:190,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:160,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[52~100],as:[52~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rlJTBw3+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1c3|1c4|1c5|1d*.10764|1d1|1e1|1f1|1g,idMap:1d*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
X-Server-Name
dt61ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
AddLogs
logging.carambo.la/ Frame 759C
0
176 B
XHR
General
Full URL
https://logging.carambo.la/AddLogs
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.227.6.108 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-227-6-108.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-type
application/x-www-form-urlencoded

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:35 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
af175f5eda447ac6e80ce6aa2288a174_ecfe92f71a7b6b22a2121600bb29d2e026461ff0_incontent_unified_3.json
inimage.carambo.la/1/thms97/112441/ Frame 759C
243 B
544 B
XHR
General
Full URL
https://inimage.carambo.la/1/thms97/112441/af175f5eda447ac6e80ce6aa2288a174_ecfe92f71a7b6b22a2121600bb29d2e026461ff0_incontent_unified_3.json
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 Ashburn, United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
c089d5570af7c19f84b5c9825bfbc9a100a4bfae105993c65bab9c6d41f74dbd

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
server
AmazonS3
x-amz-request-id
40126344631A2DA1
status
403
etag
"ae2146172b36dab16780d08eade3c8c1"
vary
Origin, Access-Control-Request-Headers, Access-Control-Request-Method
access-control-allow-methods
GET
content-type
application/xml
access-control-allow-origin
*
access-control-max-age
3000
x-amz-id-2
MHxuowC+haxX9qk5hUUn8c272tC28bOfi2XfkiuS7kc5KD8wlLOqfK+QggOUkx7700fyZ6XszaQ=
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=ebb091c9-7026-aa6d-8f59-8e12f233d78e&tv={c:7SN224,pingTime:-2,time:241,type:a,im:{sf:0,pom:1,prf:{beA:416,beZ:417,mfA:548,cmA:549,inA:549,inZ:558,prA:558,prZ:566,si:578,poA:581,bl:594,poZ:595,cmZ:595,mfZ:595,loA:606,loZ:609,ltA:657,ltZ:657,mdA:425,mdZ:505}},sca:{dfp:{df:4,sz:970.250,dom:div}},env:{gca:1},clog:[{piv:100,vs:i,r:,w:970,h:250,t:160}],es:0,sc:1,ha:1,gm:1,slTimes:{i:242,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:160,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[104~100],as:[104~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rlJTBw3+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1c3|1c4|1c5|1d*.10764|1d1|1e1|1f1|1g,idMap:1d*,rend:1,renddet:IMG.qs,rmeas:1,slid:[google_ads_iframe_/4735792/in.reuters/life/health/article_1,google_ads_iframe_/4735792/in.reuters/life/health/article_1__container__,canvas_leaderboard_8232955139649689_INKCN1R02DG],sinceFw:76,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
X-Server-Name
dt61ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=300x280&pubId=20159232&chanId=38032032&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=1147991459&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=75a45f3d-4f08-11e9-9104-382c4ac630ed&adsafe_url=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&adsafe_type=abdfq&adsafe_jsinfo=,id:77cf5641-de21-056e-a270-230bdbd95488,c:7SN22g,sl:outOfView,em:true,fr:true,mn:app41ami,pt:1-5-15,wc:0.0.1600.1200,ac:1140.2925.300.280,am:i,cc:1140.2925.300.280,piv:0,obst:0,th:0,reas:l,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rlJTBxd+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1c3|1c4|1c5|1d1|1d2|1e1|1f*.10764|1f1|1g,idMap:1f*,pl:,rend:1,renddet:DIV.qs.sn,rmeas:1,es:0,sc:0,ha:1,gm:1,tt:jload,thd:1,et:181,oid:763a3758-4f08-11e9-9d27-70106fb72a54,v:17.4.178,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
X-Server-Name
app41ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
log
hbx-lg.media.net/
35 B
185 B
Image
General
Full URL
https://hbx-lg.media.net/log?logid=aplog&pid=8PRL4E7N3&itype=HB&dn=in.reuters.com&cid=8CUF1VN4G&svr=2019032512_577&servname=c8-web-20&gdpr=1&csex=0&csstr=&ugd=4&vid=00001553523335963031123517443224&vsid=&sd=1&gtd=100&inid=0&gfd=&cc=DE&sc=HE&ct=FRANKFURT&abte=CONTROL&adbd=0&amp=0&version=4.1&sB=true&cors=true&disB=false&ice=0&vw=1585&vh=1200&pht=7289&cl=&__rk=0&app=0&rtype=&pvid=3004&prvAccId=243346798&prvApiId=8CUF1VN4G&exid=3048&pcId=0000EEA&adj0=0&adj1=0&adj2=10&adj3=0&prvReqId=346712667781963201553523336306&crid=243346798&g=0&size=2x2&sec=in.reuters%2Flife%2Fhealth%2Farticle&chnl=&prspt=headerBid&rfc=0&tref=0&fpuReq=0&bdp=0.00&cbdp=0.00&ckfl=0&cs=&mnet_ckfl=0&cat=&attr=&advId=&advNm=&advUrl=null&dfpBd=0.00&nms=1&di=&dt=O&epc=243346798&ogbdp=0.00&s=2&snm=nobid&dbf=1&bdata=&cmpid=&bId=&pcrid=243346798&ruct=0&brs=&brr=&iurl=&htps=0&ptype=20&pbidflr=1.11&exp=sfl%3Dfalse%7Cbfl%3D-100%7Crc%3D1%7Chr_ck%3Dfalse%7Cdbr%3D0%7Ctkd%3Dnull&bfs=1&seat=&nbr=3&ba=172&ybnca_gbid=&ybnca_erpm=&ybnca_vbid=&yogbdp=&yErpmFlag=0&ybnca_bbid=&acid=184552912274112131553523336306&act=headerBid&dtfdl=-1&dspltime=295&ttfd=725&rtime=9&dtc=east&rtbsv2=&apid=3&wsip=c12-nv1e-mowx-web-as-1546437397c5-2x1060141&ltime=126&abs=0&top=1337&btm=1337&lft=257&rght=1012&ttm=0&vtm=0&sttm=0&svtm=0&mnrfc=0&mnrf=0&invw=0&patkey=&patint%3C%3E=&spProfile=0&spSource=0&spIvt=3&spID=&mx_bsBucket=3&mx_GCID=0&mx_bsProfile=2&mx_KBB=0&mx_UC=0&mx_sbp=-10&refVisId=&osnbr=&brf=0&iwb=0&toconsider=1&actltime=127&acsn=1&dfpDiv=dpslot_native_3421327_INKCN1R02DG&dfpAdPath=&dfpPos=&sbdrid=&bbdrid=&td=r%3Dstr%7Cab%3D0%7C&lper=10&requrl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner&kwrf=&epurl=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache Tomcat /
Resource Hash
796c46ec10bc9105545f6f90d51593921b69956bd9087eb72bee83f40ad86f90

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:37 GMT
server
Apache Tomcat
access-control-allow-origin
*
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
content-length
35
expires
Mon, 25 Mar 2019 14:15:37 GMT
p2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/p?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1553523338007&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_s...
  • https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1553523338007&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_...
43 B
309 B
Image
General
Full URL
https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1553523338007&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=25751517&cs_ucfr=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.121.166.105 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-121-166-105.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
24e480e4659fbae818853a38f8a3036f529f539024dc3e772c0b594ce02ea9db

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Expires
Mon, 01 Jan 1990 00:00:00 GMT
Connection
keep-alive
Content-Length
43
Content-Type
image/gif

Redirect headers

Location
https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1553523338007&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=25751517&cs_ucfr=1
Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=placementCall&pageId=48951&pid=78309&gid=[insertionId]&slot=native&env=js-web&pfid=[pfid]&f=1&ts=1553523338005&fv=2.21.54-for-3319
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.211.0.4 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-211-0-4.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Mon, 25 Mar 2019 14:15:38 GMT
cache-control
max-age=0, no-cache, no-store
content-type
image/gif
content-length
23
expires
Mon, 25 Mar 2019 14:15:38 GMT
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=slotAvailable&pageId=48951&pid=78309&gid=[insertionId]&slot=native&env=js-web&pfid=[pfid]&f=1&ts=1553523338005&fv=2.21.54-for-3319
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.211.0.4 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-211-0-4.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Mon, 25 Mar 2019 14:15:38 GMT
cache-control
max-age=0, no-cache, no-store
content-type
image/gif
content-length
23
expires
Mon, 25 Mar 2019 14:15:38 GMT
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=77cf5641-de21-056e-a270-230bdbd95488&tv={c:7SN24K,pingTime:-2,time:335,type:a,im:{sf:0,pom:1,prf:{beA:379,beZ:381,mfA:552,cmA:553,inA:553,inZ:554,prA:554,prZ:557,si:560,poA:561,poZ:561,cmZ:561,mfZ:561,loA:571,loZ:572,ltA:713,ltZ:713,mdA:381,mdZ:423}},sca:{dfp:{df:4,sz:300.280,dom:body}},env:{gca:1},clog:[{piv:0,vs:o,r:l,w:300,h:280,t:181}],es:0,sc:0,ha:1,gm:1,slTimes:{i:0,o:335,n:0,pp:0,pm:0},slEvents:[{sl:o,t:181,wc:0.0.1600.1200,ac:1140.2925.300.280,am:i,cc:1140.2925.300.280,piv:0,obst:0,th:0,reas:l,bkn:{piv:[161~0],as:[161~300.280]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rlJTBxd+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1c3|1c4|1c5|1d1|1d2|1e1|1f*.10764|1f1|1g,idMap:1f*,rend:1,renddet:DIV.qs.sn,rmeas:1,slid:[google_ads_iframe_/4735792/in.reuters/life/health/article_5,google_ads_iframe_/4735792/in.reuters/life/health/article_5__container__,dpslot_bizdev_article_rr2_400784_INKCN1R02DG,INKCN1R02DG],sinceFw:152,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
dt61ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
sca.17.4.95.js
static.adsafeprotected.com/ Frame 0495
81 KB
0
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Response headers

Date
Mon, 25 Mar 2019 14:15:37 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app36ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=300x600&pubId=4704817679&chanId=38032032&placementId=4974347015&pubCreative=138263065185&pubOrder=2500420503&cb=873562457&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=75a2b1b2-4f08-11e9-9669-70106fb72ed4&adsafe_url=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&adsafe_type=abdfq&adsafe_jsinfo=,id:c546919d-8bb7-702a-c085-df658dd8fbd9,c:7SN25s,sl:inView,em:true,fr:true,mn:app45ami,pt:1-5-15,wc:0.0.1600.1200,ac:1140.685.300.600,am:i,cc:1140.685.300.600,piv:86,obst:0,th:0,reas:,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1c2|1c3|1c4|1c5|1d1|1d2|1e1|1f1|1g,idMap:1c*,pl:,rend:1,renddet:IMG.qs,rmeas:1,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:372,oid:763aac8b-4f08-11e9-9059-70106fb3114e,v:17.4.178,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
app41ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=2x2&pubId=54423312&chanId=38032032&placementId=4741317042&pubCreative=138239093677&pubOrder=2107429564&cb=1138655010&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=75a375b2-4f08-11e9-9d27-70106fb72a54&adsafe_url=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&adsafe_type=abdfq&adsafe_jsinfo=,id:f5247e9b-52cd-408c-188e-2e22e65a3693,c:7SN25G,sl:inView,em:true,fr:true,mn:app41ami,pt:1-5-15,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rlJTBxr+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1c3|1c4|1c5|1c6|1d1|1d2|1e*.10764|1e1|1f1|1g,idMap:1e*,pl:,rend:0,renddet:WINDOW,rmeas:0,es:0,sc:0,ha:1,gm:1,tt:jload,thd:1,et:380,oid:763db9d9-4f08-11e9-9d27-70106fb72a54,v:17.4.178,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 New York, United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
app45ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
GetInContentInfo
content.carambo.la/ Frame 759C
0
371 B
Fetch
General
Full URL
https://content.carambo.la/GetInContentInfo
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.225.209.175 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-209-175.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Access-Control-Request-Method
POST
Origin
https://in.reuters.com
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Access-Control-Request-Headers
content-type

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:37 GMT
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Access-Control-Allow-Origin
https://in.reuters.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
content-type
Content-Length
0
Expires
-1
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=f5247e9b-52cd-408c-188e-2e22e65a3693&tv={c:7SN261,pingTime:0,time:400,type:pf,clog:[{piv:100,vs:i,r:,w:2,h:2,t:379}],es:0,sc:0,ha:1,gm:1,slTimes:{i:400,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:379,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[27~100],as:[27~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1c6|1d1|1d2|1e*.10764|1e1|1f1|1g,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
dt61ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c546919d-8bb7-702a-c085-df658dd8fbd9&tv={c:7SN26J,pingTime:-2,time:450,type:a,im:{sf:0,pom:1,prf:{beA:418,beZ:420,mfA:780,cmA:780,inA:780,inZ:782,prA:782,prZ:786,si:790,poA:790,poZ:796,cmZ:796,mfZ:796,loA:820,loZ:821,ltA:868,ltZ:868,mdA:420,mdZ:470}},sca:{dfp:{df:4,sz:300.600,dom:div}},env:{gca:1},clog:[{piv:86,vs:i,r:,w:300,h:600,t:371}],es:0,sc:1,ha:1,gm:1,slTimes:{i:450,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:371,wc:0.0.1600.1200,ac:1140.685.300.600,am:i,cc:1140.685.300.600,piv:86,obst:0,th:0,reas:,bkn:{piv:[87~75],as:[87~300.600]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1c2|1c3|1c4|1c5|1d1|1d2|1e.10764|1e1|1f1|1g,idMap:1c*,rend:1,renddet:IMG.qs,rmeas:1,slid:[google_ads_iframe_/4735792/in.reuters/life/health/article_0,google_ads_iframe_/4735792/in.reuters/life/health/article_0__container__,dpslot_mpu_1908057_INKCN1R02DG,INKCN1R02DG],sinceFw:78,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
dt61ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=f5247e9b-52cd-408c-188e-2e22e65a3693&tv={c:7SN26M,pingTime:-2,time:447,type:a,im:{sf:0,pom:1,prf:{beA:385,beZ:387,mfA:757,cmA:758,inA:758,inZ:759,prA:759,prZ:762,si:765,poA:765,poZ:765,cmZ:765,mfZ:765,loA:786,loZ:788,ltA:831,ltZ:831,mdA:387,mdZ:471}},sca:{dfp:{df:4,sz:100.100,dom:div},ha1:{res1:1,ps:1,ts:1553523338103,psfr:1}},env:{gca:1},clog:[{piv:100,vs:i,r:,w:2,h:2,t:379}],es:0,sc:0,ha:1,gm:1,slTimes:{i:447,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:379,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[74~100],as:[74~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1c6|1d1|1d2|1e*.10764|1e1|1f1|1g,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0,slid:[google_ads_iframe_/4735792/in.reuters/life/health/article_2,google_ads_iframe_/4735792/in.reuters/life/health/article_2__container__,dpslot_canvas_653991_INKCN1R02DG,INKCN1R02DG],sinceFw:66,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.37.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
daldt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
dt47dal.dal.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=ebb091c9-7026-aa6d-8f59-8e12f233d78e&tv={c:7SN281,pingTime:-10,time:610,type:s,mvn:ZnNjPTEyLHNkPTMsbm89Nyxhc3A9MQ--,fsc:17.4.95v220002022020220000022002222000022220202020222222222220002222022002222200002220222022222222222000220200000022220222220222222222222202222222222222222222222222222222222222200000022022020020000002002202022022022222222000000000020222202022022222000000020000000000000000000002220002220000022200222202220022200200222022202220222222220020222222000220000222202222202222000002002002222222222220022202200022002220222202,sd:MTcuNC45NXYxMjAwfHwxNjAwfHwxfHwxfHwyNHx8MTIwMHx8MHx8MHx8MXx8bGFuZHNjYXBlLXByaW1hcnl8fDI0fHw0LzN8fDQvM3x8MHx8MTYwMA--,no:MTcuNC45NXZNb3ppbGxhfHxOZXRzY2FwZXx8bnx8OHx8bnx8MHx8bnx8TGludXggeDg2XzY0fHxHZWNrb3x8MjAwMzAxMDd8fDB8fE1vemlsbGEvNS4wIChNYWNpbnRvc2g7IEludGVsIE1hYyBPUyBYIDEwXzEzXzUpIEFwcGxlV2ViS2l0LzUzNy4zNiAoS0hUTUwsIGxpa2UgR2Vja28pIENocm9tZS82Ny4wLjMzOTYuODcgU2FmYXJpLzUzNy4zNnx8MXx8MXx8R29vZ2xlIEluYy58fG4-,asp:1553523338224||5b95c42b8adc5f2e3b03f6fa2ec24132||bf486f3aba4c432632bded0f99a7bd42||597b76d2d8ece8cb9f37302a2c80a0d3||95db5d3575d95d8c14e10320166cbe33||ea1132e9c5f54f9adc4337ee929d5561||d28da0df569fd44fd5b547769298a7c0||6a2ccdb29d2c6a35d16e25a226cd04b0||1529428597,im:{pWait:171},env:{ar:self.0}}
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
dt61ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
index.html
cmp.teads.mgr.consensu.org/ Frame CE7C
0
0
Document
General
Full URL
https://cmp.teads.mgr.consensu.org/index.html
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:293::2c92 , European Union, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash

Request headers

Host
cmp.teads.mgr.consensu.org
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

x-amz-id-2
kGI/LkmsIcd2daPyZ44T91Tgh3nqFBaPCP2I5Rt/ZLlg5M5DrVepYy/Ac/ZfkFjnOAPn7svobKA=
x-amz-request-id
B87A212102411FA1
Last-Modified
Fri, 14 Sep 2018 07:42:32 GMT
ETag
"e7d6c2974a38b7ff77a560e83789f66a"
Accept-Ranges
bytes
Content-Type
text/html
Content-Length
583
Server
AmazonS3
Cache-Control
max-age=300
Expires
Mon, 25 Mar 2019 14:20:38 GMT
Date
Mon, 25 Mar 2019 14:15:38 GMT
Connection
keep-alive
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=77cf5641-de21-056e-a270-230bdbd95488&tv={c:7SN29N,time:648,type:e,env:{ar:ebb091c9-7026-aa6d-8f59-8e12f233d78e.1},es:0,sc:0,ha:1,gm:1,slTimes:{i:0,o:648,n:0,pp:0,pm:0},slEvents:[{sl:o,t:181,wc:0.0.1600.1200,ac:1140.2925.300.280,am:i,cc:1140.2925.300.280,piv:0,obst:0,th:0,reas:l,bkn:{piv:[474~0],as:[474~300.280]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:84,fm:rlJTBxd+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1d1|1d2|1e.10764|1e1|1f*.10764|1f1|1g,idMap:1f*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.37.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
daldt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
dt47dal.dal.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c546919d-8bb7-702a-c085-df658dd8fbd9&tv={c:7SN29T,time:646,type:e,env:{ar:ebb091c9-7026-aa6d-8f59-8e12f233d78e.2},es:0,sc:1,ha:1,gm:1,slTimes:{i:646,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:371,wc:0.0.1600.1200,ac:1140.685.300.600,am:i,cc:1140.685.300.600,piv:86,obst:0,th:0,reas:,bkn:{piv:[283~75],as:[283~300.600]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:114,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1c2|1c3|1c4|1c5|1d1|1d2|1e.10764|1e1|1f1|1g,idMap:1c*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
dt61ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=f5247e9b-52cd-408c-188e-2e22e65a3693&tv={c:7SN29X,time:644,type:e,env:{ar:ebb091c9-7026-aa6d-8f59-8e12f233d78e.3},es:0,sc:0,ha:1,gm:1,slTimes:{i:644,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:379,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[271~100],as:[271~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:180,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1c6|1d1|1d2|1e*.10764|1e1|1f1|1g,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.37.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
daldt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
dt59dal.dal.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
ad
a.teads.tv/page/48951/
4 KB
2 KB
XHR
General
Full URL
https://a.teads.tv/page/48951/ad?windowWidth=1600&windowHeight=1200&windowDepth=1&windowReferrerUrl=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&page=%7B%22id%22%3A48951%2C%22placements%22%3A%5B%7B%22id%22%3A78309%2C%22validity%22%3A%7B%22status%22%3Atrue%2C%22reasons%22%3A%5B%5D%7D%2C%22player%22%3A%7B%22width%22%3A755%2C%22height%22%3A425%7D%2C%22slotType%22%3A%22native%22%7D%5D%2C%22gdpr_iab%22%3A%7B%22status%22%3A23%2C%22consent%22%3A%22%22%2C%22reason%22%3A230%7D%7D&userId=3195e548-c1cb-41c0-bec1-fd3768755b43&formatVersion=2.21.54&env=js-web&netBw=10&ttfb=46
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , European Union, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
4567d5c16bac5949e5f6e06d032478f0cca65fdfd3a8b30af2e6edda37fb280f

Request headers

Accept
application/json; charset=UTF-8
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:38 GMT
content-encoding
gzip
status
200
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://in.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
1615
expires
Mon, 25 Mar 2019 14:15:38 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=1&tuv=857&tet=1044&fi=0&apd=1058&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=in.reuters.com&L1id=4704817679&L2id=2500420503&L3id=4974347015&L4id=138263065185&S1id=3735912&S2id=38032032&ord=1553523337420&r=942128211182&t=iv&bedc=1&q=4&nu=1&ib=1&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
184.51.10.56 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a184-51-10-56.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:38 GMT
GetInContentInfo
content.carambo.la/ Frame 759C
3 KB
1 KB
Fetch
General
Full URL
https://content.carambo.la/GetInContentInfo
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.225.209.175 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-209-175.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
ef10755ae767bc000f36cd102120b4c828d6c3284212b870dc498cb69898093c

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
application/json; charset=utf-8

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:36 GMT
Content-Encoding
deflate
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
text/html
Access-Control-Allow-Origin
https://in.reuters.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
1025
Expires
-1
activeview
pagead2.googlesyndication.com/pcs/ Frame 0EDB
42 B
115 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsu7wM_o7wZrAalk9Fl0TUT30ykaGyo1qzbtUjaf-qAM0l3jjVPaoI72zHIivpXIaINRdw1i6fcwOWUX_iDvBEXVzp4pRfAfpYmpySs&sig=Cg0ArKJSzOBF9jxDpSKlEAE&adk=3448428218&tt=1403&bs=1585%2C1200&mtos=0,1083,1083,1083,1083&tos=0,1083,0,0,0&p=685,1140,1285,1440&mcvt=1083&rs=3&ht=0&tfs=357&tls=1440&mc=0.85&lte=0.85&bas=0&bac=0&avms=geo&rst=1553523337075&rpt=222&isd=0&msd=0&lm=2&oseid=3&xdi=0&ps=1600%2C7289&ss=1600%2C1200&pt=38&deb=1-4-4-11-11-38-56-9&tvt=1411&r=v&id=osdim&vs=4&uc=11&upc=1&tgt=DIV&cl=1&cec=5&clc=1&cac=0&cd=300x600&v=20190322
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
172.217.16.130 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s46-in-f2.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:38 GMT
x-content-type-options
nosniff
content-type
image/gif
server
cafe
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, must-revalidate
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
42
x-xss-protection
1; mode=block
expires
Fri, 01 Jan 1990 00:00:00 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame DBC1
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsuKxvA1X1QqcroWKNKyT86iYupBNlwTcG5ERQOgcKInEVcoOUFyiXfLydn8-mK3sZ2y4-1YASIDYvF4OV4nhA2xjy1E_ZRnSRbzPJA&sig=Cg0ArKJSzJeTv0lWK6m0EAE&adk=2788090944&tt=1403&bs=1585%2C1200&mtos=1083,1083,1083,1083,1083&tos=1083,0,0,0,0&p=92,315,342,1285&mcvt=1083&rs=3&ht=0&tfs=357&tls=1440&mc=1&lte=1&bas=0&bac=0&la=1&avms=geo&rst=1553523337093&rpt=231&isd=0&msd=0&lm=2&oseid=3&xdi=0&ps=1600%2C7289&ss=1600%2C1200&pt=38&deb=1-4-4-11-11-38-56-9&tvt=1411&r=v&id=osdim&vs=4&uc=11&upc=1&tgt=DIV&cl=1&cec=5&clc=1&cac=0&cd=970x250&v=20190322
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
172.217.16.130 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s46-in-f2.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:38 GMT
x-content-type-options
nosniff
content-type
image/gif
server
cafe
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, must-revalidate
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
42
x-xss-protection
1; mode=block
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=1&tuv=960&tet=1148&fi=1&apd=1164&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=in.reuters.com&L1id=4711821530&L2id=2509720728&L3id=4995561982&L4id=138264852094&S1id=3735912&S2id=38032032&ord=1553523337511&r=918585623931&t=iv&bedc=1&q=5&nu=1&ib=1&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
184.51.10.56 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a184-51-10-56.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:38 GMT
SetPageRequestGeo
analytics.carambo.la/ Frame 759C
35 B
331 B
Fetch
General
Full URL
https://analytics.carambo.la/SetPageRequestGeo
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.238.88.79 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-238-88-79.compute-1.amazonaws.com
Software
/
Resource Hash
a3b59cf3c15a5896f4224c367d24e647fe14e411b8024dcc87aa37783e0cf110

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:39 GMT
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://in.reuters.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
35
Expires
-1
css
fonts.googleapis.com/ Frame 759C
9 KB
745 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:500,300,700,400
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:81b::200a , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
ca29a9646f1d38999895936bf9cc7e6c841aac0d6a6bd15f1ba503383e890ffe
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Mon, 25 Mar 2019 14:15:38 GMT
server
ESF
access-control-allow-origin
*
date
Mon, 25 Mar 2019 14:15:38 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
status
200
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:38 GMT
css
fonts.googleapis.com/
9 KB
791 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:500,300,700,400
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:81b::200a , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
ca29a9646f1d38999895936bf9cc7e6c841aac0d6a6bd15f1ba503383e890ffe
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Mon, 25 Mar 2019 14:15:38 GMT
server
ESF
access-control-allow-origin
*
date
Mon, 25 Mar 2019 14:15:38 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
status
200
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:38 GMT
css
fonts.googleapis.com/ Frame 759C
24 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,600,300,700,800
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:81b::200a , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
734371ae3281d7a36957ab5d66796041b7cfa199ecc0a58c51cad5322587cc3e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Mon, 25 Mar 2019 14:15:38 GMT
server
ESF
access-control-allow-origin
*
date
Mon, 25 Mar 2019 14:15:38 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
status
200
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:38 GMT
css
fonts.googleapis.com/
24 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,600,300,700,800
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:81b::200a , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
734371ae3281d7a36957ab5d66796041b7cfa199ecc0a58c51cad5322587cc3e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Mon, 25 Mar 2019 14:15:38 GMT
server
ESF
access-control-allow-origin
*
date
Mon, 25 Mar 2019 14:15:38 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
status
200
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:38 GMT
Knowledge-Medium.woff
static.reutersmedia.net/resources_v2/fonts/ Frame 759C
24 KB
24 KB
Font
General
Full URL
https://static.reutersmedia.net/resources_v2/fonts/Knowledge-Medium.woff
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.89 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-89.fra6.r.cloudfront.net
Software
nginx /
Resource Hash
ae62fb7dca96004b13d628bf9deaa48d592259489d50369e6998929cfafe590f

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Sun, 24 Mar 2019 18:54:09 GMT
content-encoding
gzip
age
69746
x-cache
Hit from cloudfront
status
200
content-length
24497
via
1.1 f038e7175be9761825b2eefc2b0a832e.cloudfront.net (CloudFront)
last-modified
Wed, 29 Mar 2017 00:52:23 GMT
server
nginx
vary
Accept-Encoding
content-type
application/x-font-woff
access-control-allow-origin
*
cache-control
max-age=604800
accept-ranges
bytes
x-amz-cf-id
L2gAdvcPtnJLR9dBaeNr0s_i8UDxT5USozZhsopiLhztWOWmXSQNWQ==
expires
Sun, 17 Mar 2019 18:53:10 GMT
Knowledge-Regular.woff
static.reutersmedia.net/resources_v2/fonts/ Frame 759C
24 KB
24 KB
Font
General
Full URL
https://static.reutersmedia.net/resources_v2/fonts/Knowledge-Regular.woff
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.89 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-89.fra6.r.cloudfront.net
Software
nginx /
Resource Hash
4e75f5bbf505e72bd2fc760536a94e16ee82202ec60757a8815a0273dc5ae85d

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Sat, 23 Mar 2019 16:15:13 GMT
content-encoding
gzip
age
165625
x-cache
Hit from cloudfront
status
200
content-length
24249
via
1.1 f038e7175be9761825b2eefc2b0a832e.cloudfront.net (CloudFront)
last-modified
Wed, 29 Mar 2017 00:52:26 GMT
server
nginx
vary
Accept-Encoding
content-type
application/x-font-woff
access-control-allow-origin
*
cache-control
max-age=604800
accept-ranges
bytes
x-amz-cf-id
4GlRPq3Hh_Go18TcEb4KhM1eP2MsyXjWO8tptt1_5LKZS7h3s019Cw==
expires
Sat, 30 Mar 2019 16:15:13 GMT
cbolaIcons.woff
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/css/fonts/ Frame 759C
4 KB
4 KB
Font
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/css/fonts/cbolaIcons.woff?phtwnv
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 Ashburn, United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40DC) /
Resource Hash
c85a8e7c2d1d0583578b2afd3a1ce469797bfa5c9d5598cba25f51f839348ec8

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:38 GMT
last-modified
Mon, 25 Mar 2019 13:31:57 GMT
server
ECS (fcn/40DC)
x-amz-request-id
8BA3D94135ACD018
etag
"dae3eb8c820d3bbb16a17610dece1c88"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
application/octet-stream
status
200
cache-control
max-age=63072000,s-maxage=63072000
x-cache
HIT
accept-ranges
bytes
access-control-allow-origin
*
content-length
3832
x-amz-id-2
pznuGSKwQb6MFlm3R4H+XNSqPVl1pR/755VJ3+V361LX4K5KxgZ1RhelQJTdCshRNFiCv4F6YEo=
SetPageElementsRequestNew
analytics.carambo.la/ Frame 759C
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetPageElementsRequestNew
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.236.153.59 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-236-153-59.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
GetAds
xtr.carambo.la/ Frame 759C
6 KB
2 KB
Fetch
General
Full URL
https://xtr.carambo.la/GetAds
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.196.59.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-196-59-29.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
3d858c48241a603112056117a38ec1080ec75fde215a540498e6d6c12268896e

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
Content-Encoding
deflate
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
text/html
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
keep-alive
Content-Length
1714
Expires
-1
3416_3_10.jpg
media.carambo.la/Images/ Frame 759C
10 KB
11 KB
Image
General
Full URL
https://media.carambo.la/Images/3416_3_10.jpg
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 Ashburn, United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (dcb/7EC9) /
Resource Hash
64d149eb162e7815255c1431fb2ba07c00b871f3146bd1c889c89851ec302ff5

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:38 GMT
last-modified
Thu, 11 May 2017 11:05:47 GMT
server
ECS (dcb/7EC9)
x-amz-request-id
6BDB9EEF81D3D4AA
etag
"dfd485bbfe66d217e73da9de01623ff7"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
status
200
x-cache
HIT
accept-ranges
bytes
access-control-allow-origin
*
content-length
10658
x-amz-id-2
bF6Hn+QKyb+587Y03kXNZY++qgmBkjh9Gy6b9SYoQ/809rip74m4CtjU4+rqxLoX85MMR1suLKA=
4702_3_10.jpg
media.carambo.la/Images/ Frame 759C
19 KB
19 KB
Image
General
Full URL
https://media.carambo.la/Images/4702_3_10.jpg
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 Ashburn, United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/419E) /
Resource Hash
975e6969cc083d374166ad06d0fc6863b4cf2cb7fd90f46314c38ea5d77cd0ec

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:37 GMT
last-modified
Thu, 11 May 2017 11:05:08 GMT
server
ECS (fcn/419E)
x-amz-request-id
098509F3DABE6734
etag
"a699d560f82b6abf509d48632621e85a"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
status
200
x-cache
HIT
accept-ranges
bytes
access-control-allow-origin
*
content-length
19048
x-amz-id-2
MxkSJvER4B0NygVBSCZvc+GuteoBk7PWPQVvB5G0NozW32IxYRUi10ABLk9Y108kGEHT6HLdIGw=
2150_3_10.jpg
media.carambo.la/Images/ Frame 759C
9 KB
9 KB
Image
General
Full URL
https://media.carambo.la/Images/2150_3_10.jpg
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 Ashburn, United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40AD) /
Resource Hash
ec54f770e5f1b9567d276aaabf61f841cde499706f5a2ceb9437cf06bd7d2b85

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:38 GMT
last-modified
Thu, 11 May 2017 11:06:52 GMT
server
ECS (fcn/40AD)
x-amz-request-id
50CAD7F2DFECB755
etag
"387f4036599ec46967235f0721f4de14"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
status
200
x-cache
HIT
accept-ranges
bytes
access-control-allow-origin
*
content-length
8718
x-amz-id-2
JPZWBxf2WKAIMD5mLPnQ16juwvk3oZcHu6t4bhezP2bgmw0c0mJVlh5V+6X4qbFgLvc+JKS3rOQ=
iframe
sync.teads.tv/ Frame 98A6
0
0
Document
General
Full URL
https://sync.teads.tv/iframe?pid=78309&userId=3195e548-c1cb-41c0-bec1-fd3768755b43&gdprIab={%22status%22:23,%22consent%22:%22%22,%22reason%22:230}&1553523338766
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , European Union, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
akka-http/10.1.5 /
Resource Hash

Request headers

:method
GET
:authority
sync.teads.tv
:scheme
https
:path
/iframe?pid=78309&userId=3195e548-c1cb-41c0-bec1-fd3768755b43&gdprIab={%22status%22:23,%22consent%22:%22%22,%22reason%22:230}&1553523338766
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
accept-encoding
gzip, deflate, br
cookie
tt_viewer=145e717f-0036-4512-acc2-83980c5d4e9d
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

status
200
content-type
text/html; charset=UTF-8
server
akka-http/10.1.5
content-length
1368
expires
Mon, 25 Mar 2019 14:15:38 GMT
cache-control
max-age=0, no-cache, no-store
pragma
no-cache
date
Mon, 25 Mar 2019 14:15:38 GMT
set-cookie
tt_exelate=; Expires=Tue, 26 Mar 2019 14:15:38 GMT; Domain=.teads.tv tt_bluekai=; Expires=Tue, 26 Mar 2019 14:15:38 GMT; Domain=.teads.tv tt_emetriq=; Expires=Tue, 26 Mar 2019 14:15:38 GMT; Domain=.teads.tv tt_liveramp=; Expires=Tue, 26 Mar 2019 14:15:38 GMT; Domain=.teads.tv tt_neustar=; Expires=Tue, 26 Mar 2019 14:15:38 GMT; Domain=.teads.tv
nurl
be-ms.teads.tv/
34 KB
34 KB
XHR
General
Full URL
https://be-ms.teads.tv/nurl?payload=GOXjBCCx9hEowLcTMmkJB-DzyQk4RD8RJ7H0JpuM5z8hzczMzMzM3D8oj9YLMi4iEwgIEgNVU0QaCmltcHJlc3Npb24qFwoTCAoSA1VTRBoKaW1wcmVzc2lvbhABOENB8ZjWSO0s4j9QAFgCYABpmpmZmZmZ2T84AUIDRVVSSAFQAFgAcgZqcy13ZWJ4AIABCIoBBmlucmVhZJIBOQgFEJQCGN9SIN3kAioFNzY4ODcwo-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-crxQQnZ314oDzoOGsAQ==&psid=54468&auction_currency=USD&pscid=882&scid=7633&sid=174675&auction_price=rX8u7tLywSASZz14MVuhq58Q
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.210.90.34 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-210-90-34.eu-west-1.compute.amazonaws.com
Software
akka-http/10.1.7 /
Resource Hash
b5605c49d6a00754b08b5175fbdfae03be4ed39a2781637a5e6bc1f80dcca007

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

Date
Mon, 25 Mar 2019 14:15:38 GMT
Server
akka-http/10.1.7
Access-Control-Max-Age
1728000
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
application/xml; charset=UTF-8
Access-Control-Allow-Origin
https://in.reuters.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
Origin, X-Requested-With, Content-Type, Accept, Accept-Encoding, Accept-Language, Host, Referer, User-Agent
Content-Length
34621
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=adReceived&pageId=48951&pid=78309&gid=[insertionId]&slot=native&env=js-web&pfid=[pfid]&f=1&ts=1553523338005&fv=2.21.54-for-3319
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.211.0.4 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-211-0-4.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Mon, 25 Mar 2019 14:15:38 GMT
cache-control
max-age=0, no-cache, no-store
content-type
image/gif
content-length
23
expires
Mon, 25 Mar 2019 14:15:38 GMT
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=ebb091c9-7026-aa6d-8f59-8e12f233d78e&tv={c:7SN2i6,pingTime:1,time:1235,type:p,clog:[{piv:100,vs:i,r:,w:970,h:250,t:160}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1235,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:160,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1097~100],as:[1097~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:50,fm:rlJTBw3+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1d*.10764|1d1|1e.10764|1e1|1f.10764|1f1|1g,idMap:1d*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.37.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
daldt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
dt59dal.dal.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=ebb091c9-7026-aa6d-8f59-8e12f233d78e&tv={c:7SN2i6,pingTime:1,time:1236,type:pf,clog:[{piv:100,vs:i,r:,w:970,h:250,t:160}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1236,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:160,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1098~100],as:[1098~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:50,fm:rlJTBw3+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1d*.10764|1d1|1e.10764|1e1|1f.10764|1f1|1g,idMap:1d*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.37.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
daldt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
dt47dal.dal.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=ebb091c9-7026-aa6d-8f59-8e12f233d78e&tv={c:7SN2i7,pingTime:1,time:1236,type:c,clog:[{piv:100,vs:i,r:,w:970,h:250,t:160}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1236,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:160,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1098~100],as:[1098~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:50,fm:rlJTBw3+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1d*.10764|1d1|1e.10764|1e1|1f.10764|1f1|1g,idMap:1d*,rend:1,renddet:IMG.qs,rmeas:1,metricId:publ1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
dt61ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=ebb091c9-7026-aa6d-8f59-8e12f233d78e&tv={c:7SN2i7,pingTime:1,time:1236,type:c,clog:[{piv:100,vs:i,r:,w:970,h:250,t:160}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1236,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:160,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1098~100],as:[1098~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:50,fm:rlJTBw3+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1d*.10764|1d1|1e.10764|1e1|1f.10764|1f1|1g,idMap:1d*,rend:1,renddet:IMG.qs,rmeas:1,metricId:grpm1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
X-Server-Name
dt61ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
SetEvent
analytics.carambo.la/ Frame 759C
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetEvent
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
107.23.33.56 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-107-23-33-56.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
6753877076500981
s8t.teads.tv/vast/
883 B
758 B
XHR
General
Full URL
https://s8t.teads.tv/vast/6753877076500981
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2a02:26f0:10e:2b0::36f1 , European Union, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
Software
/ Express
Resource Hash
f6f7dfa7be01acb6716b0fc7706cc6c727305fa26294d880ba4b7257a4ddab2e

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:39 GMT
content-encoding
gzip
etag
W/"373-GTA9R5N+J6iyrd9ZZW5fS89b6Ms"
status
200
x-powered-by
Express
vary
Accept-Encoding
access-control-allow-methods
GET,POST
content-type
application/xml; charset=utf-8
access-control-allow-origin
https://in.reuters.com
access-control-max-age
86400
access-control-allow-credentials
true
access-control-allow-headers
*
content-length
476
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c546919d-8bb7-702a-c085-df658dd8fbd9&tv={c:7SN2mg,pingTime:1,time:1413,type:p,clog:[{piv:86,vs:i,r:,w:300,h:600,t:371}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1413,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:371,wc:0.0.1600.1200,ac:1140.685.300.600,am:i,cc:1140.685.300.600,piv:86,obst:0,th:0,reas:,bkn:{piv:[1050~75],as:[1050~300.600]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:30,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1c2|1c3|1c4|1c5|1d1|1d2|1e.10764|1e1|1f1|1g,idMap:1c*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.37.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
daldt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:39 GMT
X-Server-Name
dt59dal.dal.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=f5247e9b-52cd-408c-188e-2e22e65a3693&tv={c:7SN2mo,pingTime:1,time:1415,type:p,clog:[{piv:100,vs:i,r:,w:2,h:2,t:379}],es:0,sc:0,ha:1,gm:1,slTimes:{i:1415,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:379,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1042~100],as:[1042~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:153,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1c6|1d1|1d2|1e*.10764|1e1|1f1|1g,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.37.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
daldt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:39 GMT
X-Server-Name
dt47dal.dal.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=f5247e9b-52cd-408c-188e-2e22e65a3693&tv={c:7SN2mp,pingTime:1,time:1416,type:pf,clog:[{piv:100,vs:i,r:,w:2,h:2,t:379}],es:0,sc:0,ha:1,gm:1,slTimes:{i:1416,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:379,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1043~100],as:[1043~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:153,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1c6|1d1|1d2|1e*.10764|1e1|1f1|1g,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:39 GMT
X-Server-Name
dt61ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=f5247e9b-52cd-408c-188e-2e22e65a3693&tv={c:7SN2mp,pingTime:1,time:1416,type:c,clog:[{piv:100,vs:i,r:,w:2,h:2,t:379}],es:0,sc:0,ha:1,gm:1,slTimes:{i:1416,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:379,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1043~100],as:[1043~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:153,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1c6|1d1|1d2|1e*.10764|1e1|1f1|1g,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0,metricId:publ1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:39 GMT
X-Server-Name
dt35ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=f5247e9b-52cd-408c-188e-2e22e65a3693&tv={c:7SN2mp,pingTime:1,time:1416,type:c,clog:[{piv:100,vs:i,r:,w:2,h:2,t:379}],es:0,sc:0,ha:1,gm:1,slTimes:{i:1416,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:379,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1044~100],as:[1044~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:153,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1c6|1d1|1d2|1e*.10764|1e1|1f1|1g,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0,metricId:grpm1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.39.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
amidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:39 GMT
X-Server-Name
dt61ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
player-sprite.svg
a.teads.tv/media/format/v3/assets/default/ Frame 7F59
9 KB
4 KB
Image
General
Full URL
https://a.teads.tv/media/format/v3/assets/default/player-sprite.svg
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , European Union, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
3ba7f40e2b4080979389e9b81e6d0ed155e9b7f74b3310bc1289ee70cba2035d

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:39 GMT
content-encoding
gzip
last-modified
Fri, 22 Mar 2019 10:29:23 GMT
x-amz-request-id
B5D043D353C735BA
etag
"6a80cb691946e09ba579b0f8456aae28"
vary
Accept-Encoding
content-type
image/svg+xml
status
200
cache-control
private, must-revalidate, max-age=16070400
x-bucket
1
accept-ranges
bytes
content-length
3379
x-amz-id-2
RLsmtz+G2/Pkj4kQqeIqfzaVQoP/E9FONsFP1660TdnYxuP8Yc4hAOE7TsSE38N9bu6+VA2oowU=
expires
Fri, 27 Sep 2019 14:15:39 GMT
truncated
/ Frame 7F59
669 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
35463ce93e7c820faa404db98d939ff640ae78ca0e29be043861853c9e07c586

Request headers

Response headers

Content-Type
image/svg+xml
6753877076500981
s8t.teads.tv/vpaid/ Frame 440C
114 KB
22 KB
Script
General
Full URL
https://s8t.teads.tv/vpaid/6753877076500981
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2a02:26f0:10e:2b0::36f1 , European Union, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
Software
/ Express
Resource Hash
1dc6ba91a57b68348d571e9f3125fd28d691ec51b2912647ad67ee1ce1e26f5d

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:39 GMT
content-encoding
gzip
access-control-allow-origin
*
x-powered-by
Express
etag
W/"1c8c4-q+B2QMYxvUBPJ3231I+jlnLbWKY"
vary
Accept-Encoding
access-control-allow-methods
GET,POST
content-type
application/javascript; charset=utf-8
status
200
access-control-max-age
86400
access-control-allow-credentials
false
access-control-allow-headers
*
content-length
22081
SetConsentStatus
analytics.carambo.la/ Frame 759C
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetConsentStatus
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
107.23.33.56 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-107-23-33-56.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:38 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=0&fi=0&apd=57&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=in.reuters.com&L1id=20159232&L2id=277213512&L3id=139199112&L4id=138204787707&S1id=3735912&S2id=38032032&ord=1553523337647&r=261264286308&t=meas&bedc=1&q=1&nu=1&ib=1&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
184.51.10.56 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a184-51-10-56.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:39 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:39 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=0&fi=0&apd=57&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=in.reuters.com&L1id=20159232&L2id=277213512&L3id=139199112&L4id=138204787707&S1id=3735912&S2id=38032032&ord=1553523337647&r=261264286308&t=nht&bedc=1&q=2&nu=1&ib=1&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
184.51.10.56 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a184-51-10-56.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:39 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:39 GMT
prebid.min.js
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/external/ Frame 759C
166 KB
51 KB
XHR
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/external/prebid.min.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 Ashburn, United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40DC) /
Resource Hash
6d71ed34d66c51fa4df5083638eeb34238a296d6dee8d8478c4fac57ed460bd3

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:39 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
2023ED4227741F60
x-cache
HIT
status
200
content-length
52263
x-amz-id-2
nk8RHERyu9u74U1W0GMmsAF4ksfy/CZU66oAE2NRODuq8qsRHb/U6CMrAj17zHS3EA5OmKNsnRU=
last-modified
Mon, 25 Mar 2019 13:32:05 GMT
server
ECS (fcn/40DC)
etag
"745226c1eef587c14ea09a0cc51b51be"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
accept-ranges
bytes
moatvideo.js
z.moatads.com/teads245638586802/
304 KB
92 KB
Script
General
Full URL
https://z.moatads.com/teads245638586802/moatvideo.js
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.211.10.211 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-211-10-211.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
2e385a8f8e65827c8008a5b79813c0f7c35b732aa5f10a827e9a97a75536d9bc

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:39 GMT
Content-Encoding
gzip
Last-Modified
Fri, 22 Mar 2019 22:07:56 GMT
Server
AmazonS3
x-amz-request-id
7DFC92EE74B2322E
ETag
"d4ffa77da08747294bbf9de0320b1830"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=8911
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
94091
x-amz-id-2
Qif/qI4ZeTLsmrNKV/8rks0nRNWScgnYx8Tlq3sgfxOVDgmGRzusKBlCnaLUmRiZRD0V+fIPkWI=
truncated
/ Frame 440C
2 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9d02d662da8a47fb5fb610b545007507b6017028043dbb63cd09ec897d3b9627

Request headers

Response headers

Content-Type
image/png
truncated
/ Frame 440C
715 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5a3f1dd74233f605e511f1b5b244bedf85ac88ba264caf4d6401bc7ec2017dcd

Request headers

Response headers

Content-Type
image/png
2.0.0
s8t.teads.tv/sdk/ Frame 783C
469 KB
70 KB
Script
General
Full URL
https://s8t.teads.tv/sdk/2.0.0
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2a02:26f0:10e:2b0::36f1 , European Union, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
Software
/ Express
Resource Hash
325354042be9d67b7fc3ec8d12f288f7dec1ab871781cbf0b5c9355755e88e71

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:39 GMT
content-encoding
gzip
access-control-allow-origin
*
x-powered-by
Express
etag
W/"752b4-cRxQJPwzHljPEy0goqMkNd614BM"
vary
Accept-Encoding
access-control-allow-methods
GET,POST
content-type
application/javascript; charset=utf-8
status
200
access-control-max-age
86400
access-control-allow-credentials
false
access-control-allow-headers
*
content-length
71539
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=adAvailable-success&pageId=48951&pid=78309&gid=[insertionId]&slot=native&env=js-web&pfid=[pfid]&f=1&ts=1553523338006&fv=2.21.54-for-3319
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.211.0.4 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-211-0-4.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Mon, 25 Mar 2019 14:15:39 GMT
cache-control
max-age=0, no-cache, no-store
content-type
image/gif
content-length
23
expires
Mon, 25 Mar 2019 14:15:39 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=0&fi=0&apd=324&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=in.reuters.com&L1id=20159232&L2id=277213512&L3id=139199112&L4id=138204787707&S1id=3735912&S2id=38032032&ord=1553523337647&r=261264286308&t=hdn&bedc=1&q=3&nu=1&ib=1&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
184.51.10.56 Cambridge, United States, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a184-51-10-56.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:39 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:39 GMT
s.js
mb.moatads.com/
142 B
406 B
Script
General
Full URL
https://mb.moatads.com/s.js?url=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&confidence=2&pcode=teads245638586802&callback=MoatBSJsonpRequest_79847210
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/teads245638586802/moatvideo.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.177.109.169 London, United Kingdom, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-35-177-109-169.eu-west-2.compute.amazonaws.com
Software
nginx/1.7.9 /
Resource Hash
2adf2be5248efd4a178290b928a86fab17fb99d94d662ab8ea06a365f513b6e0

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:40 GMT
Server
nginx/1.7.9
Etag
"b6ac43f33b53dc2381d8d5adf1e711ebb67d0e4c"
Content-Type
text/html; charset=UTF-8
Cache-Control
max-age=900
Connection
keep-alive
Timing-Allow-Origin
*
Content-Length
142
pixel.gif
px.moatads.com/
43 B
409 B
Image
General
Full URL
https://px.moatads.com/pixel.gif?e=17&i=TEADSVIDEOJS2&hp=1&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=8&f=0&j=&o=3&t=1553523339770&de=636132738441&m=0&ar=87e8ab4-clean&q=22&cb=0&cu=1553523339770&ll=2&lm=0&ln=0&r=0&em=0&en=0&d=11809_Dell%3A96212_Dell%20-%20SB%20-%20FR%2FDE%20Q1%20-%20True%20Visits%20CPiV%20phase%202%3A318400_Dell_Germany_True%20Visits_Precision_I%3A293681_DE_Landscape%20Scroller_Precision&zMoatGSR=1&zMoatWRW=-&zMoatWRH=-&zMoatOrigSlicer1=19164&zMoatOrigSlicer2=78309&zMoatTPL=-&zMoat_ad_entity_id=6833&zMoat_connection=0_NONE&zMoat_domain=reuters.com&zMoat_subdomain=in.reuters.com&zMoat_wid=19164&zMoat_pid=-&zMoatGM_NATVID=-&zMoatD_ARTD=-&zMoatD_FQD=-&zMoatD_MPD=-&zMoatD_VTD=-&zMoatSRE=-&zMoatVSD=-&zMoatCustomParams=-&zMoatJS=-&zMoat_connection_entity_id=0&zMoatGSSC=-&zMoatAuctID=66bf0bad-c049-4c85-b20c-661a9d55cddb&qs=1&ph=&pj=standard&gu=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&bo=19164&bd=78309&zMoatDomain=reuters.com&zMoatSubdomain=in.reuters.com&gw=teads245638586802&fd=1&ac=1&it=500&fs=161704&na=1174193773&cs=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , European Union, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:39 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 25 Mar 2019 14:15:39 GMT
track
studio-t.teads.tv/ Frame 783C
23 B
157 B
Image
General
Full URL
https://studio-t.teads.tv/track?action=studio_load&studio_cid=6753877076500981&referer=&ts=1553523339852&sid=174675&gid=318400&cid=293681&pid=78309&env=js-web&slot=native
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , European Union, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Mon, 25 Mar 2019 14:15:39 GMT
cache-control
max-age=0, no-cache, no-store
content-type
image/gif
content-length
23
expires
Mon, 25 Mar 2019 14:15:39 GMT
de_scroller_precision-1551175829891.jpg
s8t.teads.tv/creative-6753877076500981/ Frame 783C
246 KB
247 KB
Image
General
Full URL
https://s8t.teads.tv/creative-6753877076500981/de_scroller_precision-1551175829891.jpg
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2a02:26f0:10e:2b0::36f1 , European Union, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
ac20ca13f5dc0f7c0dc0b0a5488acb24f2d7ed3bad4bbca71d171c27cee29bd9

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:39 GMT
last-modified
Tue, 26 Feb 2019 10:10:31 GMT
server
AmazonS3
x-amz-request-id
5A4A6A1E16886FF4
etag
"6a1c595261477efd5a20e07594769c85"
access-control-max-age
86400
access-control-allow-methods
GET,POST
content-type
image/jpeg
status
200
access-control-allow-credentials
false
accept-ranges
bytes
access-control-allow-headers
*
content-length
251610
x-amz-id-2
uuou7LcED5dPbZZwPbnqDggRfuS+mu6pgrjnfZaolQrvLWQgJSel1Wd0DwU+cQtTlVImJYtea0Q=
access-control-allow-origin
*
de_scroller_precision-1551175829891.jpg
s8t.teads.tv/creative-6753877076500981/
246 KB
0
Image
General
Full URL
https://s8t.teads.tv/creative-6753877076500981/de_scroller_precision-1551175829891.jpg
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2a02:26f0:10e:2b0::36f1 , European Union, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
ac20ca13f5dc0f7c0dc0b0a5488acb24f2d7ed3bad4bbca71d171c27cee29bd9

Request headers

Response headers

date
Mon, 25 Mar 2019 14:15:39 GMT
last-modified
Tue, 26 Feb 2019 10:10:31 GMT
server
AmazonS3
x-amz-request-id
5A4A6A1E16886FF4
etag
"6a1c595261477efd5a20e07594769c85"
access-control-max-age
86400
access-control-allow-methods
GET,POST
content-type
image/jpeg
status
200
access-control-allow-credentials
false
accept-ranges
bytes
access-control-allow-headers
*
content-length
251610
x-amz-id-2
uuou7LcED5dPbZZwPbnqDggRfuS+mu6pgrjnfZaolQrvLWQgJSel1Wd0DwU+cQtTlVImJYtea0Q=
access-control-allow-origin
*
protobuf.min.js
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/external/ Frame 759C
69 KB
21 KB
XHR
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/external/protobuf.min.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 Ashburn, United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/4198) /
Resource Hash
04b075859121bd8bae2825f760da6f0a2f0a5e9c7755370a55d51c961e41354c

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:41 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
3E550225F6C14EF5
x-cache
HIT
status
200
content-length
21141
x-amz-id-2
DJDzJ3vO0FxElkS4VInls6LXe5LCwrlZH6CXilPC2Yho1B+AF8CjLmNz9XPIC7veC2J/5SUoMiI=
last-modified
Mon, 25 Mar 2019 13:32:08 GMT
server
ECS (fcn/4198)
etag
"0b2aa9f2e7a587c31a287a8c3cdc3acd"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
accept-ranges
bytes
KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
fonts.gstatic.com/s/roboto/v18/ Frame 759C
10 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v18/KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:819::2003 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
4352380f92ce7f9a4a4a23306b992bed10055dbfffe90987cc72083e583fc280
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://fonts.googleapis.com/css?family=Roboto:500,300,700,400
Origin
https://in.reuters.com

Response headers

date
Fri, 08 Mar 2019 22:08:31 GMT
x-content-type-options
nosniff
last-modified
Mon, 16 Oct 2017 17:32:51 GMT
server
sffe
age
1440430
content-type
font/woff2
status
200
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-origin
*
content-length
10748
x-xss-protection
1; mode=block
expires
Sat, 07 Mar 2020 22:08:31 GMT
mem5YaGs126MiZpBA-UNirkOUuhpKKSTjw.woff2
fonts.gstatic.com/s/opensans/v15/ Frame 759C
9 KB
9 KB
Font
General
Full URL
https://fonts.gstatic.com/s/opensans/v15/mem5YaGs126MiZpBA-UNirkOUuhpKKSTjw.woff2
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:819::2003 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
50dda9aac0fcea362bdda27ae7833240485ad5a20ccc105c1cd13ea26802a8bd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,600,300,700,800
Origin
https://in.reuters.com

Response headers

date
Sat, 09 Mar 2019 02:13:10 GMT
x-content-type-options
nosniff
last-modified
Wed, 11 Oct 2017 21:49:48 GMT
server
sffe
age
1425751
content-type
font/woff2
status
200
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-origin
*
content-length
8916
x-xss-protection
1; mode=block
expires
Sun, 08 Mar 2020 02:13:10 GMT
siab.js
cdn.tynt.com/ Frame 7553
14 KB
5 KB
Script
General
Full URL
https://cdn.tynt.com/siab.js
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
fb6a12c91506c41a4d524c7bd0a37cbec57f543fabb42d612fb1b35014fe51f9

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:42 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Mon, 10 Dec 2018 17:12:01 GMT
server
cloudflare
etag
W/"5c0e9e61-3869"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=259200
cf-ray
4bd17f984a32352a-LHR
expires
Thu, 28 Mar 2019 14:15:42 GMT
SetAdsRequest
analytics.carambo.la/ Frame 759C
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetAdsRequest
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.238.88.79 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-238-88-79.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:41 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
jstag
us-ads.openx.net/w/1.0/ Frame 40EA
48 KB
18 KB
Script
General
Full URL
https://us-ads.openx.net/w/1.0/jstag
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
173.241.240.220 New York, United States, ASN36089 (OPENX-AS1 - OPENX TECHNOLOGIES, INC., US),
Reverse DNS
ox-173-241-240-220.xa.dc.openx.org
Software
OXGW/16.128.2 /
Resource Hash
9bb53ed6e788de99c749b9f630021f66216c437086dd8a42c5a7e224cf9f16de

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:42 GMT
content-encoding
gzip
server
OXGW/16.128.2
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
content-length
17997
expires
Mon, 25 Mar 2019 15:15:42 GMT
SetAdsRequest
analytics.carambo.la/ Frame 759C
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetAdsRequest
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.238.88.79 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-238-88-79.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:42 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
SetHbBidRequestProto
analytics.carambo.la/ Frame 759C
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetHbBidRequestProto
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.24.5/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.224.155.9 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-224-155-9.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:41 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
bFJBfaR2Or54kOaKkv7mNO.js
sc.tynt.com/script/sc/ Frame 7553
2 KB
1 KB
Script
General
Full URL
https://sc.tynt.com/script/sc/bFJBfaR2Or54kOaKkv7mNO.js
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
cfb5e4589613ee0a4cf258ae7e38a69b03cba03284c700bfd9f4c1318c380b58
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:42 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
status
200, 200 OK
vary
Accept-Encoding
x-xss-protection
1; mode=block
x-request-id
e603e8ac-b6a8-4c1e-8204-d03558b68cc3
x-runtime
0.002379
x-content-digest
c920fcfd4e33d79a4bf712356b40ad60f0d1f136
last-modified
Sun, 17 Mar 2019 14:26:07 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
x-frame-options
SAMEORIGIN
content-type
text/javascript; charset=utf-8
cache-control
max-age=3600, public, s-maxage=172800
cf-ray
4bd17f988a89352a-LHR
x-rack-cache
fresh
expires
Mon, 18 Mar 2019 14:18:22 GMT
p
ic.tynt.com/b/
0
286 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1553523342144&dn=SIAB&iso=0&img=https%3A%2F%2Fs2.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20190319%26t%3D2%26i%3D1368087844%26w%3D1200%26r%3DLYNXNPEF2I1KH&ct=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug&t=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug%20%7C%20Reuters&cu=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab-idINKCN1R02DG&ah=https%3A%2F%2Fin.mobile.reuters.com%2Farticle%2Famp%2FidINKCN1R02DG
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
204
date
Mon, 25 Mar 2019 14:15:42 GMT
server
nginx/1.14.0
p3p
policyref="/w3c/p3p.xml", CP="CUR ADM OUR NOR STA NID", CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
sic.js
cdn-sic.33across.com/1/javascripts/ Frame 7553
405 KB
121 KB
Script
General
Full URL
https://cdn-sic.33across.com/1/javascripts/sic.js
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.38.14 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
70f71e3eb4a274044473cb5a7a0bd8fa3b2c5663900e2684eaa5fccdeeefdae3

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:42 GMT
content-encoding
gzip
etag
W/"5c8fadb3-65583"
cf-cache-status
HIT
last-modified
Mon, 18 Mar 2019 14:39:47 GMT
server
cloudflare
x-powered-by
Love
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
max-age=300
cf-ray
4bd17f993b7e7295-AMS
expires
Mon, 25 Mar 2019 14:19:18 GMT
acj
us-ads.openx.net/w/1.0/ Frame 40EA
Redirect Chain
  • https://us-ads.openx.net/w/1.0/acj?ai=f314b08e-347c-42c7-b4c2-bc97c8db0959&o=2236788485&callback=OX_2236788485&ju=https%3A//in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-...
  • https://us-ads.openx.net/w/1.0/acj?cc=1&ai=f314b08e-347c-42c7-b4c2-bc97c8db0959&o=2236788485&callback=OX_2236788485&ju=https%3A//in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-...
2 KB
1 KB
Script
General
Full URL
https://us-ads.openx.net/w/1.0/acj?cc=1&ai=f314b08e-347c-42c7-b4c2-bc97c8db0959&o=2236788485&callback=OX_2236788485&ju=https%3A//in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A+reuters%252FINhealth+%2528News+%252F+IN+%252F+Health%2529&jr=&auid=539343028&dims=&adxy=&res=1600x1200x24&plg=pm&ch=UTF-8&tz=0&ws=300x250&ifr=1&tws=1600x1200&mt=1
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
173.241.240.220 New York, United States, ASN36089 (OPENX-AS1 - OPENX TECHNOLOGIES, INC., US),
Reverse DNS
ox-173-241-240-220.xa.dc.openx.org
Software
OXGW/16.128.2 /
Resource Hash
83da6eab399b7f1954db17ad521d9855089e399238bef96ecf52b4a1f4eac04c

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:42 GMT
content-encoding
gzip
server
OXGW/16.128.2
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
private, max-age=0, no-cache
content-type
application/json
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

status
302
date
Mon, 25 Mar 2019 14:15:42 GMT
server
OXGW/16.128.2
content-length
0
location
https://us-ads.openx.net/w/1.0/acj?cc=1&ai=f314b08e-347c-42c7-b4c2-bc97c8db0959&o=2236788485&callback=OX_2236788485&ju=https%3A//in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A+reuters%252FINhealth+%2528News+%252F+IN+%252F+Health%2529&jr=&auid=539343028&dims=&adxy=&res=1600x1200x24&plg=pm&ch=UTF-8&tz=0&ws=300x250&ifr=1&tws=1600x1200&mt=1
p3p
CP="CUR ADM OUR NOR STA NID"
pd
eu-u.openx.net/w/1.0/ Frame 458D
Redirect Chain
  • https://eu-u.openx.net/w/1.0/pd?plm=1&ph=94ef58655625200a8cfc5b15afcd0b94ad52d590
  • https://eu-u.openx.net/w/1.0/pd?cc=1&plm=1&ph=94ef58655625200a8cfc5b15afcd0b94ad52d590
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?cc=1&plm=1&ph=94ef58655625200a8cfc5b15afcd0b94ad52d590
Requested by
Host: us-ads.openx.net
URL: https://us-ads.openx.net/w/1.0/jstag
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
173.241.240.143 New York, United States, ASN36089 (OPENX-AS1 - OPENX TECHNOLOGIES, INC., US),
Reverse DNS
ox-173-241-240-143.xa.dc.openx.org
Software
OXGW/16.128.2 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?cc=1&plm=1&ph=94ef58655625200a8cfc5b15afcd0b94ad52d590
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
accept-encoding
gzip, deflate, br
cookie
i=dd2c8f94-7f82-750f-8141-f3a5ca85e01b|1553523342
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

status
200
vary
Accept
set-cookie
i=dd2c8f94-7f82-750f-8141-f3a5ca85e01b|1553523342; Version=1; Expires=Tue, 24-Mar-2020 14:15:42 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1553523342|gu; Version=1; Expires=Tue, 09-Apr-2019 14:15:42 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.128.2
p3p
CP="CUR ADM OUR NOR STA NID"
date
Mon, 25 Mar 2019 14:15:42 GMT
content-type
text/html
content-encoding
gzip

Redirect headers

status
302
set-cookie
i=dd2c8f94-7f82-750f-8141-f3a5ca85e01b|1553523342; Version=1; Expires=Tue, 24-Mar-2020 14:15:42 GMT; Max-Age=31536000; Domain=.openx.net; Path=/
server
OXGW/16.128.2
p3p
CP="CUR ADM OUR NOR STA NID"
location
https://eu-u.openx.net/w/1.0/pd?cc=1&plm=1&ph=94ef58655625200a8cfc5b15afcd0b94ad52d590
date
Mon, 25 Mar 2019 14:15:42 GMT
content-length
0
siab.js
cdn.tynt.com/ Frame E28C
0
0

v2
de.tynt.com/deb/
4 B
199 B
Script
General
Full URL
https://de.tynt.com/deb/v2?id=bFJBfaR2Or54kOaKkv7mNO&dn=SIAB&cc=1&r=
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.188 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip188.208-100-17.static.steadfastdns.net
Software
/
Resource Hash
d21021784cda31eeae5c8295e047a14bda6ed5a9b5963fca9e7ceb398a9c9179

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
200
date
Mon, 25 Mar 2019 14:15:42 GMT
cache-control
max-age=86400
expires
Tue, 26 Mar 2019 14:15:42 GMT
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
content-length
4
content-type
application/javascript
v2
de.tynt.com/deb/
4 B
199 B
Script
General
Full URL
https://de.tynt.com/deb/v2?m=xch&id=bFJBfaR2Or54kOaKkv7mNO&dn=SIAB&cc=1&r=
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.188 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip188.208-100-17.static.steadfastdns.net
Software
/
Resource Hash
d21021784cda31eeae5c8295e047a14bda6ed5a9b5963fca9e7ceb398a9c9179

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
200
date
Mon, 25 Mar 2019 14:15:42 GMT
cache-control
max-age=86400
expires
Tue, 26 Mar 2019 14:15:42 GMT
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
content-length
4
content-type
application/javascript
gpt.js
www.googletagservices.com/tag/js/ Frame 6A2C
32 KB
11 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:81f::2002 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
72441f0d1ab491d6e4258caa4c5fb2bd4898ca2e7a2cef2736eddddf63195990
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:42 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"116 / 792 of 1000 / last-modified: 1553297005"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
10789
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:42 GMT
sic.css
cdn-sic.33across.com/1/stylesheets/ Frame 7553
13 KB
3 KB
Stylesheet
General
Full URL
https://cdn-sic.33across.com/1/stylesheets/sic.css
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.38.14 San Francisco, United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
fa238bf0f420895cece4f5f7a329c6c6fe493902254b4f22d6f368b9148bc551

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:42 GMT
content-encoding
gzip
etag
W/"5c8fad88-3447"
cf-cache-status
HIT
last-modified
Mon, 18 Mar 2019 14:39:04 GMT
server
cloudflare
x-powered-by
Love
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
status
200
cache-control
max-age=300
cf-ray
4bd17f9b0c8a7295-AMS
expires
Mon, 25 Mar 2019 14:18:37 GMT
authorize
sic.33across.com/ Frame 7553
2 KB
2 KB
Script
General
Full URL
https://sic.33across.com/authorize?version=2.52.1&agent=Mozilla%2F5.0%20(Macintosh%3B%20Intel%20Mac%20OS%20X%2010_13_5)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F67.0.3396.87%20Safari%2F537.36&product=siab&userId=&sessionId=&publisherURL=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&referrerURL=&viewportWidth=300&viewportHeight=250&screenWidth=1600&screenHeight=1200&scrollX=0&scrollY=0&pageWidth=300&pageHeight=250&pageVisibility=visible&publisherId=bFJBfaR2Or54kOaKkv7mNO&publisher=reuters_3_300_B.com&displayableSizes=300x250&_=1553523342562&callback=_tynt_jp.a3pi1hqw6
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.174 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip174.208-100-17.static.steadfastdns.net
Software
/ Love
Resource Hash
8dbaf0ff163894482da5a8532231d813339dee37337e87ec85efcf1670173b9e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:42 GMT
content-encoding
gzip
x-content-type-options
nosniff
access-control-allow-origin
*
x-powered-by
Love
vary
Accept-Encoding
access-control-allow-methods
GET, POST, PUT, DELETE
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
status
200, 200 OK
access-control-allow-credentials
true
content-type
text/javascript; charset=utf-8
access-control-allow-headers
X-Requested-With, Authorization
etag
W/"696-LDBazTLRF7WzqpIjjVPIMt/fs2o"
p
ic.tynt.com/b/
0
123 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1553523342144&dn=SIAB&iso=0&img=https%3A%2F%2Fs2.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20190319%26t%3D2%26i%3D1368087844%26w%3D1200%26r%3DLYNXNPEF2I1KH&ct=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug&t=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug%20%7C%20Reuters&cu=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab-idINKCN1R02DG
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
204
date
Mon, 25 Mar 2019 14:15:42 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
integrator.js
adservice.google.de/adsid/ Frame 6A2C
109 B
171 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=in.reuters.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:806::2002 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:42 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-type
application/javascript; charset=UTF-8
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
104
x-xss-protection
1; mode=block
integrator.js
adservice.google.com/adsid/ Frame 6A2C
109 B
171 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=in.reuters.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2a00:1450:4001:809::2002 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:42 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-type
application/javascript; charset=UTF-8
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,44,43,39",quic=":443"; ma=2592000; v="46,44,43,39"
content-length
104
x-xss-protection
1; mode=block
pubads_impl_319.js
securepubads.g.doubleclick.net/gpt/ Frame 6A2C
160 KB
57 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_319.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
172.217.16.130 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s46-in-f2.1e100.net
Software
sffe /
Resource Hash
cf65e308f1c461e06038b45d5bfa27689e22241f6b673b7d540d35cdd0ca4c32
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:42 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 07 Mar 2019 16:13:36 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
58724
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:42 GMT
p
ic.tynt.com/b/
0
123 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1553523342144&dn=SIAB&iso=0&img=https%3A%2F%2Fs2.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20190319%26t%3D2%26i%3D1368087844%26w%3D1200%26r%3DLYNXNPEF2I1KH&ct=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug&t=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug%20%7C%20Reuters
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
204
date
Mon, 25 Mar 2019 14:15:42 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=ebb091c9-7026-aa6d-8f59-8e12f233d78e&tv={c:7SN3jU,pingTime:5,time:5191,type:p,clog:[{piv:100,vs:i,r:,w:970,h:250,t:160}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5191,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:160,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[5053~100],as:[5053~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:160,fm:rlJTBw3+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1d*.10764|1d1|1e.10764|1e1|1f.10764|1f1|1g,idMap:1d*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.37.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
daldt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:42 GMT
X-Server-Name
dt59dal.dal.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=ebb091c9-7026-aa6d-8f59-8e12f233d78e&tv={c:7SN3jV,pingTime:5,time:5192,type:pf,clog:[{piv:100,vs:i,r:,w:970,h:250,t:160}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5192,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:160,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[5054~100],as:[5054~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:160,fm:rlJTBw3+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1d*.10764|1d1|1e.10764|1e1|1f.10764|1f1|1g,idMap:1d*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.37.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
daldt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:42 GMT
X-Server-Name
dt47dal.dal.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
p
ic.tynt.com/b/
0
123 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1553523342144&dn=SIAB&iso=0&img=https%3A%2F%2Fs2.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20190319%26t%3D2%26i%3D1368087844%26w%3D1200%26r%3DLYNXNPEF2I1KH&ct=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
204
date
Mon, 25 Mar 2019 14:15:42 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
jpt
ib.adnxs.com/ Frame 7553
51 B
1 KB
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251243&size=300x250&referrer=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&prod=SIAB&psa=0&pf=90&cc=0&gm=67&gf=28&ag1=40&ag2=27&ag3=25&33xvis=0&callback=_tynt_jp.a1nr8qwnp
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.80 , European Union, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
Software
nginx/1.13.4 /
Resource Hash
99c25da59cb064dd9fa2f50f2e3514ee722e42cb61c1fe655e987825155beda5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:45 GMT
AN-X-Request-Uuid
4949fb3b-89c2-4d72-9515-76a97cca044d
Content-Type
application/javascript; charset=utf-8
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
X-Proxy-Origin
185.130.184.118; 185.130.184.118; 251.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.222.244:80
Content-Length
51
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame 7553
51 B
1 KB
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251239&size=300x250&referrer=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&prod=SIAB&psa=0&pf=30&cc=0&gm=67&gf=28&ag1=40&ag2=27&ag3=25&33xvis=0&callback=_tynt_jp.afxoz5fz8
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.80 , European Union, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
Software
nginx/1.13.4 /
Resource Hash
845704b477a811e99687ed440544dd5b65d69acc54b0674f97be677d16ce67b6
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:45 GMT
AN-X-Request-Uuid
9ace0bc5-47db-4b78-be85-4eca03ec1bc9
Content-Type
application/javascript; charset=utf-8
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
X-Proxy-Origin
185.130.184.118; 185.130.184.118; 251.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.51:80
Content-Length
51
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame 7553
51 B
1 KB
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251244&size=300x250&referrer=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&prod=SIAB&psa=0&pf=30&cc=0&gm=67&gf=28&ag1=40&ag2=27&ag3=25&33xvis=0&callback=_tynt_jp.ai6gcnl53
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.80 , European Union, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
Software
nginx/1.13.4 /
Resource Hash
267a0501409c57584e4c65da4b0afe3b498624cc8c5d43e49a9af82588bcb281
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:45 GMT
AN-X-Request-Uuid
181f6039-1d2f-47a6-a954-d32850cf9077
Content-Type
application/javascript; charset=utf-8
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
X-Proxy-Origin
185.130.184.118; 185.130.184.118; 251.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.222.244:80
Content-Length
51
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 72F6
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
173.241.240.220 New York, United States, ASN36089 (OPENX-AS1 - OPENX TECHNOLOGIES, INC., US),
Reverse DNS
ox-173-241-240-220.xa.dc.openx.org
Software
OXGW/16.128.2 /
Resource Hash
e32579612a0e34fdaeb1d34b0b9b3e6b58b2241db10f71554136dddf614a8db5

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:43 GMT
content-encoding
gzip
server
OXGW/16.128.2
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
content-length
57430
expires
Mon, 25 Mar 2019 15:15:43 GMT
jstag
33across-d.openx.net/w/1.0/ Frame FD00
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
173.241.240.220 New York, United States, ASN36089 (OPENX-AS1 - OPENX TECHNOLOGIES, INC., US),
Reverse DNS
ox-173-241-240-220.xa.dc.openx.org
Software
OXGW/16.128.2 /
Resource Hash
645458c9856ed3c558e3e2367fb5d57552a6d50d51cd23faeca7aad563ad3886

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:43 GMT
content-encoding
gzip
server
OXGW/16.128.2
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
content-length
57431
expires
Mon, 25 Mar 2019 15:15:43 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 6E13
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
173.241.240.220 New York, United States, ASN36089 (OPENX-AS1 - OPENX TECHNOLOGIES, INC., US),
Reverse DNS
ox-173-241-240-220.xa.dc.openx.org
Software
OXGW/16.128.2 /
Resource Hash
b8f7f109c078e3ab547a6e9defaa505ba3a9215efa44f40218006b08d51bdaad

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:43 GMT
content-encoding
gzip
server
OXGW/16.128.2
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
content-length
57432
expires
Mon, 25 Mar 2019 15:15:43 GMT
exchange
ssc.33across.com/api/ Frame 7553
141 B
550 B
XHR
General
Full URL
https://ssc.33across.com/api/exchange
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.198.189.190 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-198-189-190.compute-1.amazonaws.com
Software
nginx/1.14.0 + Phusion Passenger 5.3.1 /
Resource Hash
f31479d1c2b35d22ccb765f9a28d9bf83a03d5b5170776911cecd359077187a3

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
text/plain

Response headers

date
Mon, 25 Mar 2019 14:15:43 GMT
content-encoding
gzip
server
nginx/1.14.0 + Phusion Passenger 5.3.1
status
200, 200 OK
vary
Accept-Encoding, Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://in.reuters.com
access-control-allow-credentials
true
p
ic.tynt.com/b/
0
123 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1553523342144&dn=SIAB&iso=0&img=https%3A%2F%2Fs2.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20190319%26t%3D2%26i%3D1368087844%26w%3D1200%26r%3DLYNXNPEF2I1KH&ct=GSK%20reports%20positive%20data%20from%20trial%20of%20endometrial%20cancer%20drug
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
204
date
Mon, 25 Mar 2019 14:15:43 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=c546919d-8bb7-702a-c085-df658dd8fbd9&tv={c:7SN3oK,pingTime:5,time:5411,type:p,clog:[{piv:86,vs:i,r:,w:300,h:600,t:371}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5411,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:371,wc:0.0.1600.1200,ac:1140.685.300.600,am:i,cc:1140.685.300.600,piv:86,obst:0,th:0,reas:,bkn:{piv:[5048~75],as:[5048~300.600]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:399,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1c2|1c3|1c4|1c5|1d1|1d2|1e.10764|1e1|1f1|1g,idMap:1c*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.37.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
daldt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:43 GMT
X-Server-Name
dt59dal.dal.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
308 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=f5247e9b-52cd-408c-188e-2e22e65a3693&tv={c:7SN3oM,pingTime:5,time:5407,type:p,clog:[{piv:100,vs:i,r:,w:2,h:2,t:379}],es:0,sc:0,ha:1,gm:1,slTimes:{i:5407,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:379,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[5034~100],as:[5034~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:381,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1c6|1d1|1d2|1e*.10764|1e1|1f1|1g,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.37.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
daldt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:43 GMT
X-Server-Name
dt59dal.dal.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=f5247e9b-52cd-408c-188e-2e22e65a3693&tv={c:7SN3oN,pingTime:5,time:5408,type:pf,clog:[{piv:100,vs:i,r:,w:2,h:2,t:379}],es:0,sc:0,ha:1,gm:1,slTimes:{i:5408,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:379,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[5035~100],as:[5035~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:381,fm:rlJTBxl+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1c3|1c4|1c5|1c6|1d1|1d2|1e*.10764|1e1|1f1|1g,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:43 GMT
X-Server-Name
dt37.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
acj
33across-d.openx.net/w/1.0/ Frame 72F6
445 B
894 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=255e6e5d7538a2&ju=https%3A//in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A+reuters%252FINhealth+%2528News+%252F+IN+%252F+Health%2529&jr=&nl=28&ul=52&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier1&c.pf=90&c.cc=0&c.gm=67&c.gf=28&c.ag1=40&c.ag2=27&c.ag3=25&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=0&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
173.241.240.220 New York, United States, ASN36089 (OPENX-AS1 - OPENX TECHNOLOGIES, INC., US),
Reverse DNS
ox-173-241-240-220.xa.dc.openx.org
Software
OXGW/16.128.2 /
Resource Hash
201ac34055441db80d1553d1e83071ef8dfc02b6786cfb8828059ab9ca9b6544

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:43 GMT
content-encoding
gzip
server
OXGW/16.128.2
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://in.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
expires
Mon, 26 Jul 1997 05:00:00 GMT
p
ic.tynt.com/b/
0
123 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1553523342144&dn=SIAB&iso=0&img=https%3A%2F%2Fs2.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20190319%26t%3D2%26i%3D1368087844%26w%3D1200%26r%3DLYNXNPEF2I1KH
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
204
date
Mon, 25 Mar 2019 14:15:43 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
acj
33across-d.openx.net/w/1.0/ Frame 6E13
445 B
896 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=2abe5db5df1c8b&ju=https%3A//in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A+reuters%252FINhealth+%2528News+%252F+IN+%252F+Health%2529&jr=&nl=28&ul=52&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=0&c.gm=67&c.gf=28&c.ag1=40&c.ag2=27&c.ag3=25&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=0&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
173.241.240.220 New York, United States, ASN36089 (OPENX-AS1 - OPENX TECHNOLOGIES, INC., US),
Reverse DNS
ox-173-241-240-220.xa.dc.openx.org
Software
OXGW/16.128.2 /
Resource Hash
c64326444102e07fc9299ea372636372f85e993f783fd1fcd690b91af2369d05

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:43 GMT
content-encoding
gzip
server
OXGW/16.128.2
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://in.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
expires
Mon, 26 Jul 1997 05:00:00 GMT
acj
33across-d.openx.net/w/1.0/ Frame FD00
445 B
896 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=2f5e7b654a29d7&ju=https%3A//in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A+reuters%252FINhealth+%2528News+%252F+IN+%252F+Health%2529&jr=&nl=28&ul=52&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier2&c.pf=30&c.cc=0&c.gm=67&c.gf=28&c.ag1=40&c.ag2=27&c.ag3=25&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=0&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
173.241.240.220 New York, United States, ASN36089 (OPENX-AS1 - OPENX TECHNOLOGIES, INC., US),
Reverse DNS
ox-173-241-240-220.xa.dc.openx.org
Software
OXGW/16.128.2 /
Resource Hash
ceb1cb38dee2f8ff80b62ba91d25db9ab9fe2711cd13cc0a7827721cf6e6df28

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Mon, 25 Mar 2019 14:15:43 GMT
content-encoding
gzip
server
OXGW/16.128.2
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://in.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
expires
Mon, 26 Jul 1997 05:00:00 GMT
pd
eu-u.openx.net/w/1.0/ Frame AB31
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
173.241.240.143 New York, United States, ASN36089 (OPENX-AS1 - OPENX TECHNOLOGIES, INC., US),
Reverse DNS
ox-173-241-240-143.xa.dc.openx.org
Software
OXGW/16.128.2 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
accept-encoding
gzip, deflate, br
cookie
pd=v2|1553523342|gu; i=bd74d8c1-b0d8-7913-956a-e2f75f6604ec|1553523342; p_synced=jQ
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

status
200
vary
Accept
set-cookie
i=bd74d8c1-b0d8-7913-956a-e2f75f6604ec|1553523342; Version=1; Expires=Tue, 24-Mar-2020 14:15:43 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1553523342.1|gu.mWkifcgqiysLmOn0oagi; Version=1; Expires=Tue, 09-Apr-2019 14:15:43 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.128.2
p3p
CP="CUR ADM OUR NOR STA NID"
date
Mon, 25 Mar 2019 14:15:43 GMT
content-type
text/html
content-encoding
gzip
pd
eu-u.openx.net/w/1.0/ Frame 413D
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
173.241.240.143 New York, United States, ASN36089 (OPENX-AS1 - OPENX TECHNOLOGIES, INC., US),
Reverse DNS
ox-173-241-240-143.xa.dc.openx.org
Software
OXGW/16.128.2 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
accept-encoding
gzip, deflate, br
cookie
pd=v2|1553523342|gu; i=bd74d8c1-b0d8-7913-956a-e2f75f6604ec|1553523342; p_synced=jQ
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

status
200
vary
Accept
set-cookie
i=bd74d8c1-b0d8-7913-956a-e2f75f6604ec|1553523342; Version=1; Expires=Tue, 24-Mar-2020 14:15:43 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1553523342.1|gu.mWkifcgqiysLmOn0oagi; Version=1; Expires=Tue, 09-Apr-2019 14:15:43 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.128.2
p3p
CP="CUR ADM OUR NOR STA NID"
date
Mon, 25 Mar 2019 14:15:43 GMT
content-type
text/html
content-encoding
gzip
p
ic.tynt.com/b/
0
123 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1553523342144&dn=SIAB&iso=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

status
204
date
Mon, 25 Mar 2019 14:15:43 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
pd
eu-u.openx.net/w/1.0/ Frame A480
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
173.241.240.143 New York, United States, ASN36089 (OPENX-AS1 - OPENX TECHNOLOGIES, INC., US),
Reverse DNS
ox-173-241-240-143.xa.dc.openx.org
Software
OXGW/16.128.2 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8
referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
accept-encoding
gzip, deflate, br
cookie
i=bd74d8c1-b0d8-7913-956a-e2f75f6604ec|1553523342; p_synced=jQ; pd=v2|1553523342.1|gu.mWkifcgqiysLmOn0oagi
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Response headers

status
200
vary
Accept
set-cookie
i=bd74d8c1-b0d8-7913-956a-e2f75f6604ec|1553523342; Version=1; Expires=Tue, 24-Mar-2020 14:15:43 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1553523342.1|gu.nwrsmWkifcsHqGgqmuiynIsLomgemOnsn0oagi; Version=1; Expires=Tue, 09-Apr-2019 14:15:43 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.128.2
p3p
CP="CUR ADM OUR NOR STA NID"
date
Mon, 25 Mar 2019 14:15:43 GMT
content-type
text/html
content-encoding
gzip
ads
securepubads.g.doubleclick.net/gampad/ Frame 6A2C
474 B
412 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2882958100037206&correlator=1510855258359545&output=json_html&callback=googletag.impl.pubads.callbackProxy1&impl=fif&adsid=NT&eid=21061742%2C21063065&vrg=319&npa=1&guci=1.2.0.0.2.1.0.0&plat=1%3A32776%2C2%3A32776%2C8%3A32776&sc=1&sfv=1-0-32&iu=%2F32867010%2FSIAB_300x250&sz=300x250&scp=c%3D50%26r%3D110%26d%3Dreuters_3_300_B.com%26g%3DbFJBfaR2Or54kOaKkv7mNO%26gd%3DbFJBfaR2Or54kOaKkv7mNO%253Adesktop%26pf%3D30%26cc%3D0%26gm%3D67%26gf%3D28%26ag1%3D40%26ag2%3D27%26ag3%3D25%26vis%3D0%26pre%3Dapnx%253A0%2Cox%253A0%2Cttx%253A0%26pre_sz%3Dapnx%253A0x0%2Cox%253A0x0%2Cttx%253A0x0%26tier%3Dapnx%253A0%2Cox%253A0%2Cttx%253A0%26hb%3D0%26rsh%3D0&cookie_enabled=1&cdm=in.reuters.com&bc=15&lmt=1553523343&dt=1553523343624&dlt=1553523342556&idt=143&ea=0&frm=23&biw=1585&bih=1200&isw=1&ish=1&oid=3&adx=-8560&ady=-7075&adk=62473835&uci=tv8yj7w7datq&ifi=1&ifk=2178898317&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&nhd=3&iag=63&url=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&top=https%3A%2F%2Fin.reuters.com%2Farticle%2Fus-gsk-dostarlimab%2Fgsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG%3FfeedType%3DRSS%26feedName%3Dhealth%26utm_source%3Dfeedburner%26utm_medium%3Dfeed%26utm_campaign%3DFeed%253A%2Breuters%252FINhealth%2B%2528News%2B%252F%2BIN%2B%252F%2BHealth%2529&dssz=4&icsg=170&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1x0&msz=300x250&blev=1&bisch=1&ga_vid=1531255086.1553523344&ga_sid=1553523344&ga_hid=348183501&fws=256
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
172.217.16.130 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s46-in-f2.1e100.net
Software
cafe /
Resource Hash
b01821149497e011d71575fe31df7a136be57388f4ddfa78bcecf91e8e2d83f8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 14:15:43 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
322
x-xss-protection
1; mode=block
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
https://in.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_319.js
securepubads.g.doubleclick.net/gpt/ Frame 6A2C
67 KB
25 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_319.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
172.217.16.130 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s46-in-f2.1e100.net
Software
sffe /
Resource Hash
c11b9a046106f278a5fb5411e95c1ba5d6f06daf9e4bfa98da51c523e4157388
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

date
Mon, 25 Mar 2019 14:15:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 07 Mar 2019 16:13:36 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,44,43,39"
content-length
25393
x-xss-protection
1; mode=block
expires
Mon, 25 Mar 2019 14:15:43 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-32/html/ Frame 6A2C
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-32/html/container.html?n=3
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_319.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:820::2001 , Ireland, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Purpose
prefetch
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

fpi.js
ap.lijit.com/www/delivery/ Frame 7553
5 KB
3 KB
Script
General
Full URL
https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Requested by
Host: in.reuters.com
URL: https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.14 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
bb2bdc2c4ff2e9d8688e9f4a69e4466857403ecb3a6d78ffb2591ff30244edba

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:44 GMT
Content-Encoding
gzip
Server
nginx
ETag
W/"5bfedfac-1534"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
private, no-cache, no-store, must-revalidate, max-age=0
Transfer-Encoding
chunked
X-Sovrn-Pod
ap1ams1
Expires
Thu, 01 Jan 1970 00:00:01 GMT
sync
ap.lijit.com/ Frame 7553
49 KB
16 KB
Script
General
Full URL
https://ap.lijit.com/sync
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.9 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
f28a9dd34d2e7cd1a404124f62a68056c5041eda4fc6ad7538657778aea96348

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Date
Mon, 25 Mar 2019 14:15:44 GMT
Content-Encoding
gzip
Last-Modified
Wed, 28 Nov 2018 18:34:20 GMT
Server
nginx
ETag
W/"5bfedfac-c373"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
max-age=86400, must-revalidate
Transfer-Encoding
chunked
X-Sovrn-Pod
ap3ams1
Expires
Tue, 26 Mar 2019 14:15:44 GMT
/
onetag-geo.s-onetag.com/
23 B
397 B
XHR
General
Full URL
https://onetag-geo.s-onetag.com/
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:6e00:5:ae3a:ba00:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
ad16e1b37490fca28df99d039d6373d2fee4d894fcd279d95b90ae872f4d860f

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36
Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Origin
https://in.reuters.com

Response headers

date
Mon, 25 Mar 2019 13:48:43 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront), 1.1 64150aec025f89247bcddad7c210f6cb.cloudfront.net (CloudFront)
age
1621
x-amzn-requestid
b474fcef-4f04-11e9-a6ac-2978f8a4e027
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600
x-amz-apigw-id
XGdZVE3-SK4FhFg=
content-length
23
x-amz-cf-id
JF_Y_9JTlgCv-MnEImMC7O2wmICz_RWe3sOCn1LD87cxA7G8H-nQlg==
adcfg
ap.lijit.com/ Frame 7553
159 B
588 B
Script
General
Full URL
https://ap.lijit.com/adcfg?zoneid=577991&tid=fdc3e869c83c4bc8972ef20fc185561375ba8ab5&mode=1&dmn=in.reuters.com
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/sync
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.9 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
d1d107076ea12608f2e8c793297facc4e6002ee2a90866a40b9c6cd33a036f5e

Request headers

Referer
https://in.reuters.com/article/us-gsk-dostarlimab/gsk-reports-positive-data-from-trial-of-endometrial-cancer-drug-idINKCN1R02DG?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_13_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/67.0.3396.87 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 25 Mar 2019 14:15:44 GMT
Content-Encoding
gzip
Server
nginx
Vary
Accept-Encoding
P3P
CP="CUR ADM OUR NOR STA NID"
Cache-Control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
Transfer-Encoding
chunked
X-Sovrn-Pod
ap3ams1
Content-Type
application/x-javascript; charset=UTF-8
Expires
Fri, 20 Mar 2009 00:00:00 GMT

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
cdn.tynt.com
URL
https://cdn.tynt.com/siab.js?Y77FaY9MHX&_ADTIME_&$RANDOM&%%CACHEBUSTER%%&

Verdicts & Comments Add Verdict or Comment

167 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| onselectstart object| onselectionchange function| queueMicrotask object| analytics object| dataLayer object| google_tag_manager function| postscribe object| Reuters object| parallelMediaHosts object| tag object| firstScriptTag object| player function| onYouTubeIframeAPIReady function| onPlayerPlaybackQualityChange function| onPlayerReady function| onPlayerStateChange object| player2 function| onYouTubeIframeAPIReady2 function| onPlayerReady2 function| onPlayerPlaybackQualityChange2 function| onPlayerStateChange2 object| player3 function| onYouTubeIframeAPIReady3 function| onPlayerReady3 function| onPlayerPlaybackQualityChange3 function| onPlayerStateChange3 object| player4 function| onYouTubeIframeAPIReady4 function| onPlayerReady4 function| onPlayerPlaybackQualityChange4 function| onPlayerStateChange4 object| player5 function| onYouTubeIframeAPIReady5 function| onPlayerReady5 function| onPlayerPlaybackQualityChange5 function| onPlayerStateChange5 object| player7 function| onYouTubeIframeAPIReady7 function| onPlayerReady7 function| onPlayerPlaybackQualityChange7 function| onPlayerStateChange7 undefined| script object| _sf_async_config number| _sf_startpt object| _cb_shared object| YT object| YTConfig function| onYTReady object| yt function| ytDomDomGetNextId object| ytEventsEventsListeners object| ytEventsEventsCounter object| _cbm object| __core-js_shared__ object| RTVEmbedder object| RCOM_Data function| webpackJsonp object| core object| scrollMonitor object| gptadslots object| googletag function| admantx_callback object| evidon function| __cmp function| renderComponent function| commonPopup function| dianomiLoadContext function| ready function| dianomiContextElement object| e number| abp function| _fbq function| fbq string| GoogleAnalyticsObject function| ga function| normalize object| lazyLoadOptions object| google_tag_data object| gaplugins object| gaGlobal string| segment_user_id function| _extends function| LazyLoad object| google_optimize object| gaData number| _sf_endpt object| _comscore object| reutersDil string| topic_channel string| channel string| content_type string| adblock undefined| edition undefined| platform string| keyword_slug string| content_channel string| content_title string| inline_type string| dcontent_channel string| channel_list object| admp_vars object| reutersDilInstance function| DIL function| getCookie function| udm_ object| ns_p object| COMSCORE object| pSUPERFLY_mab object| _cbq object| pSUPERFLY object| pSUPERFLY_video object| _cbv_strategies object| _cbv function| g_consentGiven string| state object| __onetag object| TRUE_ANTHEM object| _ghosteryGdprNotice object| __ev_hover object| advBidxc function| _mR function| _mD object| _mnHM object| __iasPET function| iasDataHandler object| closure_memoize_cache_ object| googleToken object| googleIMState object| google_js_reporting_queue function| processGoogleToken undefined| google_measure_js_timing object| GPT_jstiming boolean| google_noFetch boolean| google_DisableInitialLoad number| __google_ad_urls_id string| TF6129H number| google_unique_id object| google_reactive_ads_global_state function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter object| __google_ad_urls boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| teadsscript object| Moat#G26 boolean| Moat#EVA object| MoatSuperV26 object| MoatDataJsonpRequest object| Cbola string| cbola_pageViewId object| __IntegralASExec object| teads undefined| ct undefined| et undefined| hourElapsed undefined| msg undefined| pixelDomain undefined| pxSrc undefined| px object| callbacks object| MoatBSJsonpRequest_79847210 object| Moat#PML#26#1.2 object| time object| _33Across

11 Cookies

Domain/Path Name / Value
.dianomi.com/ Name: __cfduid
Value: d3bba317eb8322516d977d2f4c1e6694f1553523333
in.reuters.com/ Name: _cb_ls
Value: 1
.reuters.com/ Name: ajs_user_id
Value: %22958155fa-26fc-4af3-a41d-2705e782258e%22
in.reuters.com/ Name: _chartbeat2
Value: .1553523334347.1553523334347.1.BSBjeMCxh2-ACKpazeBTLwH8BIGHbl.1
.reuters.com/ Name: _gat
Value: 1
.reuters.com/ Name: ajs_anonymous_id
Value: %22958155fa-26fc-4af3-a41d-2705e782258e%22
in.reuters.com/ Name: _cb_svref
Value: null
.reuters.com/ Name: _fbp
Value: fb.1.1553523333998.1529929311
in.reuters.com/ Name: _cb
Value: y8sn8DmpYjIDGSOa3
.reuters.com/ Name: _gid
Value: GA1.2.2031189717.1553523334
.reuters.com/ Name: _ga
Value: GA1.2.1135711109.1553523334

24 Console Messages

Source Level URL
Text
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
BODY ITEMS
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/in/top-nav/finance?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/in/top-nav/finance/markets?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/in/top-nav/news/top-news?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/article.bundle.js(Line 1)
Message:
track page:
console-api log (Line 1)
Message:
Blocking Ads: No
console-api log URL: https://www.dianomi.com/js/contextfeed.js?(Line 14)
Message:
args
console-api log URL: https://www.dianomi.com/js/videofeed.js?id=1236(Line 21)
Message:
no video id
console-api log (Line 1)
Message:
comscore new global fired
console-api log (Line 2)
Message:
segment identify user with traits:
console-api log (Line 3)
Message:
evidon pid 15885 loaded via GTM
console-api log URL: https://c.betrad.com/pub/gdprnotice.js(Line 1)
Message:
gdprnotice
console-api warning URL: https://connect.facebook.net/en_US/fbevents.js(Line 25)
Message:
[Facebook Pixel] - Unable to parse JSON-LD tag. Malformed JSON found: ' { "@context": "http://schema.org", "@type": "NewsArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://in.reuters.com/article/us-gsk-dostarlimab-idINKCN1R02DG" }, "headline": "GSK reports positive data from trial of endometrial cancer drug", "url": "https://in.reuters.com/article/us-gsk-dostarlimab-idINKCN1R02DG", "image": { "@type": "ImageObject", "url": "https://s2.reutersmedia.net/resources/r/?m=02&d=20190319&t=2&i=1368087844&w=1200&r=LYNXNPEF2I1KH", "width": "800", "height": "800" }, "thumbnailUrl": "https://s2.reutersmedia.net/resources/r/?m=02&d=20190319&t=2&i=1368087844&w=1200&r=LYNXNPEF2I1KH", "dateCreated": "2019-03-19T18:19:07+0000", "dateModified": "2019-03-19T18:19:07+0000", "datePublished": "2019-03-19T18:19:07+0000", "author": { "@type": "Person", "name": "Reuters Editorial" }, "publisher": { "@type": "Organization", "name": "Reuters", "logo": { "@type": "ImageObject", "url": "https://s3.reutersmedia.net/resources_v2/images/reuters_social_logo.png", "width": "200", "height": "200" } }, "description": 'GlaxoSmithKline said on Tuesday a study testing its experimental drug dostarlimab in women with recurrent or advanced endometrial cancer showed promising results.', "articleSection": "Sports", "creator": ["Reuters Editorial"], "keywords": ["US","GSK","DOSTARLIMAB","Obstetric / Gynaecological Conditions","Company News","Western Europe","Content produced in Bangalore","Pharmaceuticals (TRBC)","Cancer","Asia / Pacific","Europe","Philippines","Pharmaceuticals and Medical Research (TRBC)","Medical Regulatory Issues","Drug and Device Development","Healthcare (TRBC)","United Kingdom", "Article", "Health"], "about":"Article" } '.
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
Require Evidon Consent:
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
Setup media.net with GDPR applied, user not consent
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
GPT SET NON PERSONAL
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
GPT ENABLE SERVICES
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/article-2019-01-1-e6cf22b0/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api debug URL: https://static.adsafeprotected.com/sca.17.4.95.js(Line 32)
Message:
a: 0.001953125ms

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

33across-d.openx.net
a.teads.tv
adservice.google.com
adservice.google.de
analytics.carambo.la
ap.lijit.com
api.segment.io
async01.admantx.com
be-ms.teads.tv
beacon.tru.am
c.betrad.com
c.evidon.com
cdata.carambo.la
cdn-sic.33across.com
cdn.adsafeprotected.com
cdn.segment.com
cdn.tynt.com
cdneast-xch.media.net
cdnjs.cloudflare.com
cmp.teads.mgr.consensu.org
connect.facebook.net
content.carambo.la
contextual.media.net
de.tynt.com
dfp-gateway.s-onetag.com
dt.adsafeprotected.com
eu-u.openx.net
evidon.mgr.consensu.org
feeds.reuters.com
fonts.googleapis.com
fonts.gstatic.com
geo.moatads.com
get.s-onetag.com
hbx-lg.media.net
iabmap.evidon.com
ib.adnxs.com
ic.tynt.com
in.reuters.com
inimage.carambo.la
l.betrad.com
logging.carambo.la
mab.chartbeat.com
mb.moatads.com
media.carambo.la
onetag-geo.s-onetag.com
pagead2.googlesyndication.com
ping.chartbeat.net
pixel.adsafeprotected.com
pixel.watch
px.moatads.com
queso-cdn.prod.reuters.tv
reuters.demdex.net
reutersdfpcw319687550988.s.moatpixel.com
route.carambo.la
s.mnet-ad.net
s.ytimg.com
s2.reutersmedia.net
s3.amazonaws.com
s8t.teads.tv
sb.scorecardresearch.com
sc.tynt.com
securepubads.g.doubleclick.net
sic.33across.com
ssc.33across.com
static.adsafeprotected.com
static.chartbeat.com
static.reuters.com
static.reutersmedia.net
stats.g.doubleclick.net
studio-t.teads.tv
sync.teads.tv
t.teads.tv
tpc.googlesyndication.com
tru.am
us-ads.openx.net
vendorlist.consensu.org
wireapi.reuters.com
www.dianomi.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.reuters.com
www.youtube.com
xtr.carambo.la
z.moatads.com
cdn.tynt.com
104.107.252.81
104.121.166.105
104.16.38.14
104.16.87.26
104.18.135.13
104.244.36.20
104.244.37.20
104.244.39.20
107.21.45.69
107.23.33.56
13.35.253.108
13.35.253.126
13.35.253.26
13.35.253.89
152.195.39.46
172.217.16.130
173.241.240.143
173.241.240.220
18.130.64.138
184.51.10.56
185.33.223.80
199.166.0.26
199.166.0.32
2.18.232.7
2.18.235.40
208.100.17.174
208.100.17.185
208.100.17.188
23.201.172.224
23.211.0.4
23.211.10.211
23.62.140.165
2600:9000:200d:1a00:a:1858:cf00:93a1
2600:9000:200d:2e00:1e:ef1b:aa40:93a1
2600:9000:200d:4a00:18:1fcd:348:2461
2600:9000:200d:6e00:5:ae3a:ba00:93a1
2600:9000:200d:8a00:1f:287:d208:7ea1
2600:9000:200d:c600:a:52eb:a100:93a1
2600:9000:200d:e200:10:27b4:f500:93a1
2600:9000:200d:f200:1:af78:4c0:93a1
2606:4700:20::6819:a222
2606:4700:20::6819:a322
2606:4700::6813:c697
2a00:1450:4001:806::2002
2a00:1450:4001:809::2002
2a00:1450:4001:80b::2008
2a00:1450:4001:816::200e
2a00:1450:4001:817::2013
2a00:1450:4001:818::2004
2a00:1450:4001:819::2003
2a00:1450:4001:81b::2003
2a00:1450:4001:81b::200a
2a00:1450:4001:81f::2002
2a00:1450:4001:820::2001
2a00:1450:4001:821::200e
2a00:1450:4001:824::200e
2a00:1450:400c:c08::9a
2a02:26f0:10e:2b0::36f1
2a02:26f0:6c00:293::2c92
2a03:2880:f01c:216:face:b00c:0:3
2a03:2880:f11c:8083:face:b00c:0:25de
2a04:4e42::714
34.196.59.29
34.198.189.190
34.199.180.208
34.200.61.129
34.224.155.9
34.225.209.175
34.227.6.108
34.238.88.79
35.177.109.169
35.177.17.175
50.17.234.205
52.210.90.34
52.216.177.109
54.194.108.5
54.228.236.185
54.236.153.59
54.69.157.105
66.81.204.228
72.251.249.14
72.251.249.9
99.86.0.85
02786b36ef8ae43e6cd51b1670e3d95eea85dbbd5a53ff944b766f8284a14909
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
04b075859121bd8bae2825f760da6f0a2f0a5e9c7755370a55d51c961e41354c
083e9afdbf6c8112bd0514631879b933cdd193c56b738226aec672dec09def8d
086f588ad27a084c11b408ccc9d0593d4f212a64d3e3980b289b3a1624f4d42c
0af0d03a424f77c527ea1c62ea1518db6cfc115c18fa1aad533144badb68db70
0c7058f172497e5587aef179cedbadedc9d02abe80271542c77197b29968d970
0d86f42c59e0d5c9cfa54d68252681e3fc67fe6b12250e9353ffb75e7b0ebf8c
0e39b51dcc333757c9c3bd279c035939ecfd59be5cb1187e4670d2dd9a58894d
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
11edb75f32c33081d57b4b7686b0414bbee1743df4373187b97e60cc12dc039e
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254
146e9baf322645af7587b7681aecb0fc23910c2a83bda43f0014f0370fad3299
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc
1a74494c99d46aa44458591e0724b24afd1847632472895735fc5a10b6075154
1dc6ba91a57b68348d571e9f3125fd28d691ec51b2912647ad67ee1ce1e26f5d
1ece21a14a99e3913393d4d4dcf707713cb1e7bc8b0a9043f9081e076581484d
1f0796eb2b7826dbb3bec622b30eba32e290381144a1b96b08546575f5777e39
201ac34055441db80d1553d1e83071ef8dfc02b6786cfb8828059ab9ca9b6544
206f0eabacd22ac264d69e707b23dbf1d62c7a71fec411fb1705d41d10f3d3b8
20a41dab8271e265f869e045bc7f7a96cf9263829ae739109fd4f319394dfcf3
22319cb3b15cdd7ecfd35159216d2223c53d0127690078f07651d1e46090b4db
24e480e4659fbae818853a38f8a3036f529f539024dc3e772c0b594ce02ea9db
26634beb0e97c92114659791ef1d7050ddd1f16064091252f574fcc0eb700fcd
267a0501409c57584e4c65da4b0afe3b498624cc8c5d43e49a9af82588bcb281
27676ea482895bdddd3f3796f430a812e11364efc224227c86973a52398966c2
2817e6f17de2973f0e5cba1ca2371a9d277467a0b639cd9141fa3bcb77a6e460
28cb9032373bd7a48fceea492954b473347822ded61a27526cce1ac7d48c8b60
2adf2be5248efd4a178290b928a86fab17fb99d94d662ab8ea06a365f513b6e0
2d90ad9018fcaf71b7bfa876f1b5051a67b17986918b9fb8779e0e6a6dc438e9
2e385a8f8e65827c8008a5b79813c0f7c35b732aa5f10a827e9a97a75536d9bc
2e6224436b6a35ffc181585c3f9e0bf5b89bed3fd5000257ad5e5b29ed59e631
2e81e8eb235ae05f59b40689c70be201d956443e72caca782f2db21645384fef
2f8f81232d0a24a74e81a5c717efa4144cfeae6a4b8eacbebe95a7e3d60191e1
325354042be9d67b7fc3ec8d12f288f7dec1ab871781cbf0b5c9355755e88e71
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7
35463ce93e7c820faa404db98d939ff640ae78ca0e29be043861853c9e07c586
3a70587b8d37d4764aa4e3d8e8fadf3d7fb1abb461db10f7aff9cfe5173a61e6
3ad6849c327eac0d747d48c9e8d0430e5599933b668c944154f8228ec48b19ac
3b420041dd63461e2edc880aa82dc9c06a0c6fb0e7404eec6391840be8cbfe04
3ba7f40e2b4080979389e9b81e6d0ed155e9b7f74b3310bc1289ee70cba2035d
3c514d4fb8244af230a89d2203522c6a67a55a3f161cfd4fca9f53301c0588ff
3ca19e57c9a2465ae4df271316ba4d29e7ff7f113a2a2c5297780c0b7a0ac09d
3cf7db9d05610a9898b552a5090814d8fff880fb5b81710e3a1e26cf05f66e57
3d858c48241a603112056117a38ec1080ec75fde215a540498e6d6c12268896e
3da096eadec42f2ee70ba0d51e8a54704543b5b67a957732d8c244cd90b731ab
3e552578c7d450b023f2cd9d28f830be4335c3acc6c4ab6dadda0769f09e5f22
4352380f92ce7f9a4a4a23306b992bed10055dbfffe90987cc72083e583fc280
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a
45610b21279531a97f9566b0f0f8a1d287a45ae4bc6bc545971af5cd7e393cc6
4567d5c16bac5949e5f6e06d032478f0cca65fdfd3a8b30af2e6edda37fb280f
490c6a95e66f9d9c29cb001434c4c8b252ceed75066b7d35a695266648b803ee
4ac25d017a457385759e549fe1d85a71eb47691f8bd3b61094f100a303dc820e
4ac950f8088629c4d35e54e04eb5c18543ebc15b23873d351b57e3b6118e064d
4b51cad50779921c134fe5f8a46df29da7bdedf5f643c331d192b6057af97992
4bb59a50dcc6257d0f5d33a5a7331b5013d8a086eaf8077406c3aa8163501f68
4dd51e6b250e15946ca0af835e0511093c82c5678115aac3055645d889a1681a
4e75f5bbf505e72bd2fc760536a94e16ee82202ec60757a8815a0273dc5ae85d
50dda9aac0fcea362bdda27ae7833240485ad5a20ccc105c1cd13ea26802a8bd
5277212dab850fc46e54bfe713c3c433f4939d6f320afea5c93f30bbfa1b1b48
52dc24c0429ea6ccc5b579a6da8bb79bf41e471fe5108a62009f3c2e195551c0
57a5832e107631b871e4ed9b7af901c7cb9ee1e698b027e82b41f31fe69c1f17
58d94b06f15b9a1ea02b26e3a0454a7921cda64a5769657e333cba9d9a0bb485
59fe519ac2a0c1fce428cbc990749a5630ddcbbd05b48fcfa0ebd3ea7ad2b56a
5a3f1dd74233f605e511f1b5b244bedf85ac88ba264caf4d6401bc7ec2017dcd
5ac16a501f716813dec0c475081cb4122b79779d5de129259cf5048f7fa7a2ff
60a628485980712dc7dd6ac839c2e328c04e945b3e675b510827a632cdb88af2
60fdb35f6ad4bb9182219967e37128a310ac24a1ce67bc8cadb11ad956de8aac
6444118d84f1e81114a8f2fe394aa7b0edf6bf86668577a67d04e4f7e6bd5718
645458c9856ed3c558e3e2367fb5d57552a6d50d51cd23faeca7aad563ad3886
64d149eb162e7815255c1431fb2ba07c00b871f3146bd1c889c89851ec302ff5
68517d453d51f6476d856ef4c46f4152f36566fc724f8bd189027fc82edd0418
6bb981959d783d83df88b9aa48738948c9a8a22c1a31b8cb5305d3e338ebf9a7
6d71ed34d66c51fa4df5083638eeb34238a296d6dee8d8478c4fac57ed460bd3
6e16d30cf64d4a2ff0614436310336b3cf414c79822f4348f8000fe62d67477e
6f23d93c9b8e3ca26f6fcc6be6a8d087e43a3f5795daa3c61017071642f66f3c
70f71e3eb4a274044473cb5a7a0bd8fa3b2c5663900e2684eaa5fccdeeefdae3
71585936e03aaa0996c8240a34d0224ceed3ec8e523c4eb34905c3be9a02baab
72441f0d1ab491d6e4258caa4c5fb2bd4898ca2e7a2cef2736eddddf63195990
734371ae3281d7a36957ab5d66796041b7cfa199ecc0a58c51cad5322587cc3e
7464555aae6d8d87b77f7170fba1698ff64f7454ded58627ca1819246e9a9969
76c393f564f53c19e795307e622edc8657a603f7a816c2646385697286d11313
77aa89a4f58bdf884b1895414d526769c93071f10dbb049938bc769ebbb8aae7
796c46ec10bc9105545f6f90d51593921b69956bd9087eb72bee83f40ad86f90
7c603a0659e260e2a4487c5dea0d42768c61dfb2c715196ead40c8db21fc1621
82d4e605d2a736fb91d6256e79d772019f71cc5279f2713b1376f19a21128d41
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
83da6eab399b7f1954db17ad521d9855089e399238bef96ecf52b4a1f4eac04c
845704b477a811e99687ed440544dd5b65d69acc54b0674f97be677d16ce67b6
88a6166fa6dd4c7268e1eefb1e70b390133fd2940d5f6445cc0c0c937b08b787
8a36294c08a28c71073ce603810e15d375cb5392cd32c76971d686f6e0564549
8ac1703c1c34b2be426deda409d39258f82fae17f13e645f377f337a954aedde
8baa355558d41a0af243bfc867f248d10107adfd104db64fff48879d04cd7c16
8dbaf0ff163894482da5a8532231d813339dee37337e87ec85efcf1670173b9e
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
95a2e9aed9e09d7581a742007ff2808dbec5e5f5894d94943c0150410163d536
975e6969cc083d374166ad06d0fc6863b4cf2cb7fd90f46314c38ea5d77cd0ec
9776fb4402707939346bf12db9d01cd2ad0fc9cdb981ef59d83533993e179995
99781410070a5dd4d753fdb8a46f4272082b5be64541dcfcb1b2d3c4aea09c6c
99c25da59cb064dd9fa2f50f2e3514ee722e42cb61c1fe655e987825155beda5
9b133863146a5f391e8cee0842cafc7498ae89b6f79edbecfc842055342c1fe2
9bb53ed6e788de99c749b9f630021f66216c437086dd8a42c5a7e224cf9f16de
9d02d662da8a47fb5fb610b545007507b6017028043dbb63cd09ec897d3b9627
a144f2c5946d910e318f43138264fef4887e59af57888a757674b5af3729d131
a3b59cf3c15a5896f4224c367d24e647fe14e411b8024dcc87aa37783e0cf110
a53cace67554f81442e51e226b5d85179cbde388f477a6847d867e6c6cdadda6
a6368fa1fc1fcf5df2e6f14d6731cab91089c9c5322b00668745dbf579d37f3e
ac20ca13f5dc0f7c0dc0b0a5488acb24f2d7ed3bad4bbca71d171c27cee29bd9
ad16e1b37490fca28df99d039d6373d2fee4d894fcd279d95b90ae872f4d860f
ae62fb7dca96004b13d628bf9deaa48d592259489d50369e6998929cfafe590f
b01821149497e011d71575fe31df7a136be57388f4ddfa78bcecf91e8e2d83f8
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b
b48ef5a7bc3d64c9e962bd440b6071266a0b7fa786f5c9556e283d025ead506b
b494d71dbc08cdcfe3522576523b805177a7939408aad5daf3a9571945b389db
b5605c49d6a00754b08b5175fbdfae03be4ed39a2781637a5e6bc1f80dcca007
b5faebd111e07583ed8e0bfbbee9a942ba8979fcdc759fa258368b74a487d397
b68ef84092a1b0e218c39af2a4133261f35e2f68c80378a322653922fa5fdc50
b8f7f109c078e3ab547a6e9defaa505ba3a9215efa44f40218006b08d51bdaad
bb2bdc2c4ff2e9d8688e9f4a69e4466857403ecb3a6d78ffb2591ff30244edba
c089d5570af7c19f84b5c9825bfbc9a100a4bfae105993c65bab9c6d41f74dbd
c11b9a046106f278a5fb5411e95c1ba5d6f06daf9e4bfa98da51c523e4157388
c12cfe3245b034d5354184f739ae0b54bcfd061434643d69446737fb395eaf15
c27d1864c396dafb6dbe4f4646f182c1a3d817e6d4e27b3fad4e6c4ceb9ccb5a
c3cdd90682c611b09c2e5c4ce771243414465b8fc63fb17ab111ab018f4c6708
c5a714898ef3772037e79d2a72a4be13d1933dcd98c52c6ca43aac138990abe3
c64326444102e07fc9299ea372636372f85e993f783fd1fcd690b91af2369d05
c6f72f2813eb9bf94f41334602e76ab3a3950c10ae0990b19943eeaebe8dfde8
c81712eca20b5e5bdb4349735583beff2fac3eae2bed58a7ac7ec84f7987de2c
c85a8e7c2d1d0583578b2afd3a1ce469797bfa5c9d5598cba25f51f839348ec8
c9f8bb83cd34c1d421bfa0e597741ceeefe2c0ca535b556af24408a8de707b86
ca29a9646f1d38999895936bf9cc7e6c841aac0d6a6bd15f1ba503383e890ffe
ca3d163bab055381827226140568f3bef7eaac187cebd76878e0b63e9e442356
ca551709a399f6d3aa0aa1c8a3ad07dc8be5ea1236c110902b3aa812bbcbd6a5
cc11628ee489395e239bc94ea6dc8d5b1908e6b957cc5c9a9e05a64793f77e28
cdf37abc779725211fb9fc7dda24738b809f83075b4d19fee90638ed19da8c20
ceb1cb38dee2f8ff80b62ba91d25db9ab9fe2711cd13cc0a7827721cf6e6df28
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda
cf65e308f1c461e06038b45d5bfa27689e22241f6b673b7d540d35cdd0ca4c32
cfb5e4589613ee0a4cf258ae7e38a69b03cba03284c700bfd9f4c1318c380b58
cfe9da4bdec377e2f10a16320897a92198e50960a236af433ce1a1c013213bd6
d1d107076ea12608f2e8c793297facc4e6002ee2a90866a40b9c6cd33a036f5e
d21021784cda31eeae5c8295e047a14bda6ed5a9b5963fca9e7ceb398a9c9179
d7d62426c6b87d35cef5c2c873355aa44edffcf4a7f927f1c51b10694ea4f6ed
d80e45b8ebadb6ecb006c36d672912bd30fb3416aaa59d925f4dbfd529439446
d84a123811bd2d2ce924417daeb7a4e2622259ee306fc9c9e78182c8fe4319c4
da1558557545d89fbfa46db07072c3000c75d6a098a90408c024d0ce2ef7cf9c
de069646544a0a1ac42be17cde90c5b4d1ea08c6276af11bad3c40f60adac8eb
dff46486a11e8e9c5785ce5d037c4e9e507511c5cb404a044602c68a777b0e7b
e32579612a0e34fdaeb1d34b0b9b3e6b58b2241db10f71554136dddf614a8db5
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
e6455d8e78d8ee3c169d4014f94bde87579dc9e406d94adbf69f80bedc4a05f6
ec54f770e5f1b9567d276aaabf61f841cde499706f5a2ceb9437cf06bd7d2b85
ec8b3cd2573ee83da12227aaf2c4040c42e3c10fa058db9c5c365bd55680ff4f
ecf0ed9914d45ab52dbf03fed3609c91e60d0478dac715167a37b21802d4558b
ee0768f9d2def8b13df284410776f5d755109e77b5c0ca17d8895f65b343a0cd
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037
ef10755ae767bc000f36cd102120b4c828d6c3284212b870dc498cb69898093c
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
efa53018168de90dbab20ff40675e17e7d847337627caf059c4dbb29d4a8a2be
f01d25f7a76e0682a7a43230c32bef653eaf28b8a6f7a683ebb88bf8c6aa4f50
f28a9dd34d2e7cd1a404124f62a68056c5041eda4fc6ad7538657778aea96348
f31479d1c2b35d22ccb765f9a28d9bf83a03d5b5170776911cecd359077187a3
f6f7dfa7be01acb6716b0fc7706cc6c727305fa26294d880ba4b7257a4ddab2e
f9784f57729f84391b084eed9e944e048f771129d65e9b58f34095fdfba86473
f9c3d3eeaec20f8de08ff53907538a31f77119f3bc08a44c8a9749d27b2fe594
fa238bf0f420895cece4f5f7a329c6c6fe493902254b4f22d6f368b9148bc551
fb6a12c91506c41a4d524c7bd0a37cbec57f543fabb42d612fb1b35014fe51f9
fb9007c254c493be4a067de535b19a30f5e5aef3d5b19f58b1c72d2c65a04f79
fbc7dfc344e77520010894e63b438d714b423106c9aef004ddcf21e15b114397